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Scope of the thesis
The stability and integrity of the genome is crucial for all cellular life on earth. This integrity is con-
tinuously challenged by internal and external genotoxic agents. These agents cause DNA damages 
which interfere with important cellular processes like replication of the genome and transcription 
of the genetic code. To protect the DNA against these agents, a complex network of dedicated 
DNA repair- and associated signalling pathways is in place. Collectively, these pathways are known 
as the DNA Damage Response (DDR).
 NER is the main pathway for mammalian cells to remove UV-induced DNA lesions. The 
recognition of lesions in NER is either achieved by stalling of active RNA polymerase II during 
transcription or the stable binding of the protein XPC to the lesion. Although the majority of the 
factors involved in NER damage recognition have been identified, little is known about the mo-
lecular mechanisms and the regulation of this crucial step. The aim of the research described in 
this thesis focusses on the damage recognition, its regulation, and downstream effects in the NER 
pathway. 
 Chapter I provides the needed background by introducing the current knowledge of the 
DDR pathways and their functioning. We discuss how proteins are modified and how this influenc-
es cellular signalling. Additionally we introduce different microscopy techniques and associated 
Monte Carlo modelling approaches used in this thesis.
The Ubiquitin and SUMO protein modifications introduced in Chapter I, play key roles in cellular 
signalling pathways.
 In Chapter II we identify a new SUMO-targeted ubiquitin ligase (STUbL), RNF111/Arka-
dia. Utilizing its special SIM domains it specifically recognizes poly-SUMO chains on target proteins. 
Subsequently, it promotes non-proteolytic K63-linked ubiquitylation of the target protein using 
UBC13-MMS2 as the cognate E2 enzyme. RNF111 promotes ubiquitylation of the SUMOylated 
form of XPC, the damage sensor in NER. This ubiquitylation regulates the binding of XPC to the 
damaged DNA.
 In Chapter III we go in further detail of what role the ubiquitylation of XPC by RNF111 
plays in the NER pathway. We show that RNF111 is required for efficient repair of UV-induced DNA 
lesions. Furthermore, the RNF111-mediated ubiquitylation promotes the release of XPC from the 
lesion after NER initiation. This release of XPC is needed to ensure stable incorporation of the 
NER endonucleases XPG and ERCC1/XPF. This sequential modification of XPC upon UV irradiation 
represents an extra layer of control of the NER reaction. Under natural conditions, NER mostly 
operates at low damage levels, occasionally interrupted by higher levels, for instance by exposure 
to intense sunlight. Although highly relevant, knowledge on how cells respond to such fluctuations 
is sparse if not absent. 
 In Chapter IV we show that cells switch between transcription-coupled repair (TCR) and 
global genome repair (GGR) dependent on damage load and therefore not only depend on the 
genomic location of the DNA lesion. At DNA damage concentrations below a threshold level, re-
cruitment of the NER machinery by the global damage-sensor XPC is suppressed using regulatory 
ubiquitylation by E3 ligase Cul4a. Above threshold, damage-bound XPC switches to active recruit-
ment of core NER factors. This bimodal switch allows cells under mild genotoxic stress to prioritize 
repair of the highly cytotoxic lesions that block transcription and are detected by RNA polymerase 
II in transcribed strands of active genes.
 The bimodal switch described in chapter IV is very well suited to be described by Monte 
Carlo simulation. In Chapter V we use in silico experiments using in house modeling software to 
build on the experimental data. We hypothesized models with and without feedback loop systems 
governing this bimodality and see if damage marking can play a role. Furthermore we simulate 
what the effects are of competition for XPA by RNA polymerase II (TCR) and XPC (GGR). This data 
combined is used to further elucidate the regulatory mechanism described and propose new in 
vivo experiments.

Chapter I
General introduction
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All cellular life we know depends on an intact and stable genome. It serves as a blueprint for the 
mechanisms of life and insures proper behaviour of all cellular functions. In eukaryote species 
the genome is stored by the nucleus. This compartmentalisation not only allows regulation of the 
different processes acting on the genome, but also protects it. The genome is comprised of two 
intertwined, anti-parallel polynucleotide chains of Deoxyribonucleic Acid (DNA). These chains are 
shaped as a double helix which are highly condensed into structures called chromosomes. This 
condensation is established by tightly wrapping the DNA double helix around the nucleosome, an 
eight subunit complex of specialized proteins called histones.
The polynucleotide chains contain the genetic code. This code is established by the order in which 
four different nucleotides are present in the chains. These nucleotides are adenine (A), guanine 
(G), thymine (T), and cytosine (C). Each of these four nucleosides can be covalently bound to the 
phosphate group of the next via the sugar group, forming a helical sugar-phosphate backbone. 
DNA molecules consist of two of these biopolymer strands coiled around each other to form a 
double helix. The helical double strand nature of the DNA is established by the pairing rules of the 
nucleotides. Via either two or three hydrogen bonds, respectively, adenine pairs with thymine and 
guanine pairs with cytosine. Three nucleotides together form a so-called codon, which codes for a 
specific amino acid which is part of a protein.
 
Complete proteins are coded in the DNA as a gene. When a protein is needed these genes are 
transcribed in a process known as transcription. During transcription the DNA-sequence is copied 
to a temporary messenger from which a protein can be synthesised. This temporary messenger 
is Ribonucleic acid (RNA). Similar to DNA, RNA is composed of a chain of nucleotides. In contrast 
to DNA it is more often found as a single-strand folded unto itself. Another difference with DNA is 
the use of uracil (U) instead of thymine (T). Messenger RNAs (mRNAs) carry the genetic information 
the ribosomes, which are responsible in translating the mRNA to protein.
When a cell divides a complete copy of the genetic code has to be transferred to each daughter 
cell. This tightly regulated process, called replication, ensures the propagation of the genetic code 
and forms the basis for biological inheritance over many cellular generations.
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Figure 1. Different DNA damages, their sources, and the linked repair pathways. Many different 
endogenous and exogenous sources continuously damage the DNA (upper row). The cell has developed 
specific pathways to deal with these different types of lesions: mismatch repair (MMR), double strand break 
repair (HR, NHEJ), nucleotide excision repair (NER), and base excision repair (BER) (lower row). Adapted from 
Hoeijmakers et al, Nature 2001. 
DNA Damage and DNA repair
DNA integrity is constantly challenged by internal and external DNA-damaging agents that induce 
DNA lesions. When not properly repaired DNA lesions may result in malignant transformation or 
accelerated ageing. Errors which arise in the genetic code can have an impact on all levels of the 
cell and its survival. Insults can stem from different sources, either externally or internally (Figure 
1). For instance, the ultraviolet (UV) wavelengths in sunlight induce lesions in one of the strands of 
the double helix and ionizing radiation induce Double Strand Breaks (DSBs) (van Gent et al., 2001; 
Ravanat et al., 2001; Sancar, 1996). DNA damage can also be induce by internal insults like the 
formation of reactive oxygen species (ROS) which are created during normal cellular metabolism 
which have important functions in cellular signalling (Finkel, 2011). However, they can also oxidize 
DNA resulting in base modifications, abasic sites, non-conventional single-strand breaks and intra/
interstrand DNA crosslinks (Waris and Ahsan, 2006). If left unrepaired, these lesions can have a 
myriad of negative effects on a cells functioning. Damaged DNA can result in problems during 
transcription and replication, cause mutations and other chromosomal aberrations. In turn, these 
effects can increase the risk of developing cancer or contribute to premature aging (Niedernhofer 
et al., 2006, 2011; de Boer et al., 2002). Therefore, it is easily understood that the genome is well 
maintained and protected against the dangerous effects of DNA damage by what is called the DNA 
Damage Response (DDR). This response combines several specialized DNA repair systems working 
and communicating alongside DNA damage signalling pathways (Jackson and Bartek, 2009).
14
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Non-homologues end joining (NHEJ) and homologous recombination (HR)
DSBs are breaks in both strands of the DNA double helix. DSBs can stem from external sources 
like ionizing irradiation, but also occur during normal cellular processes like mitosis (Fulford et 
al., 2001; Inagaki et al., 2010). These breaks are repaired via either one of two pathways: non-
homologues end joining (NHEJ) or homologous recombination (HR). In NHEJ the two broken ends 
of the DNA helix are simply ligated using special ligating enzymes. Because of this lack of quality 
control, the NHEJ pathway is the most error prone of the two: nucleotides can be lost or added to 
the DNA during the ligation step, changing the genetic code and possibly introducing mutations 
(Weterings and van Gent, 2004). In repair of DSBs through the HR-pathway, the intact copy of the 
sister chromatid serves as a template to repair the damage, which reduces the possibility that 
errors occur. This template however, is only available in cells which are in either G2 phase, or 
partly during S-Phase, of the cell cycle. This explains why cells frequently use NHEJ to deal with 
DSBs: The vast majority of the cells in our bodies do not cycle. This cell phase is known as G0 and 
in this phase the DNA is not replicated. Therefore these cells only use the more error-prone NHEJ 
pathway to deal with their DSBs (Kanaar et al., 1998). 
Detection of DSBs by NHEJ is performed by the Ku70/80 heterodimer (Figure 2, left pathway). This 
complex binds at the ends of the broken dsDNA and serves as a scaffold at which subsequent 
repair factors can dock. (Walker et al., 2001). Among the factors are members of the DNA-PKcs 
(for DNA protein kinase catalytic subunit) family (Gottlieb and Jackson, 1993). After binding of these 
factors an auto-phosphorylation step takes place and the DNA ends are aligned (Chan and Lees-
Miller, 1996). The DNA ends are then resected by the nuclease Artemis and the MRN complex. 
The MRN complex consists of Meiotic Recombination 11 homolog A (MRE11A), RAD50, and Nibrin 
(NBS1) (Ma et al., 2002; Mahaney et al., 2009). This resection step is where nucleotides can be lost 
and the main reason why NHEJ is not error-free. The resected ends are then ligated together by 
the Ligase IV/XRCC4 complex (Grawunder et al., 1997; Mari et al., 2006).
HR is initiated when the MRN complex binds to the ends of the broken DNA (Figure 2, right 
pathway). The MRN complex is likely to stabilize the broken DNA and is implicated in activation 
of the checkpoint kinase ataxia telangiectasia-mutated (ATM) (de Jager et al., 2001; Lavin, 
2008). Following the recognition of the DSB, two nucleases, CtBP-interacting protein (CtIP) and 
Exonuclease 1 (EXO1), resect the 5’ DNA ends at the break. This exposes a 3’ ssDNA overhang 
to which Replication protein A (RPA) binds to protect this ssDNA. (Lee et al., 1998; Tauchi et al., 
2002). Under influence of the protein breast cancer 2, early onset (BRCA2) RPA is replaced by 
monomers of RAD51 which form into a nucleoprotein filament on the ssDNA ends. The RAD51 
filament mediates homology search and strand invasion in the homologous dsDNA template. The 
subsequently formed joint molecule is called a displacement loop (D-loop). The newly formed 
3’-end then serves as a primer for the novel DNA synthesis, which is promoted by the dsDNA-
dependant ATPase RAD54. Two different options for resolving the damage are now available. 
The first option entails the invasion of the homologous template by the second end of DNA in 
a RAD51-mediated fashion (second strand invasion). The resulting joint structures are called 
Holliday Junctions (HJs) which can be resolved by specific endonucleases. To complete the repair 
reaction the resulted pieces of DNA are ligated together. The second option is when the first 
invading DNA strand is displaced from the joint molecule, but re-anneals with the second end 
of the break in a process termed synthesis-dependent strand annealing (SDSA) (Sung and Klein, 
2006; Lisby and Rothstein, 2009). 
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As already stated before, the persistence of damaged DNA can have grave consequences. An 
example where these consequences become apparent is when mutations in the gene coding for 
BRCA2 cause abnormal behaviour of the protein. This can lead to damages not being processed 
(correctly) and mutations in other genes will accumulate. This in turn can lead to uncontrolled cell 
growth and cancer. Mutations in BRCA2 are mostly linked to breast cancer, but can also cause 
ovarian cancer, prostate cancer, and pancreatic cancer (Antoniou et al., 2003; Struewing et al., 
1997; Ryan et al., 2014). 
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Figure 2. Schematic overview of double-strand break repair via non-homologous end-joining (NEHJ) or 
homologous recombination (HR). In the NHEJ pathway the recognition of the DSB is initiated by the KU70/
KU80 heterodimer which coordinates the activity of the downstream repair factors and serves as a scaffold. 
Subsequently, the heterodimer recruits DNA-PKcs which phosphorylates and thereby activates the nuclease 
ARTEMIS. Together with the MRN complex, ARTEMIS then processes the DNA ends to make them suitable to be 
ligated. This ligation step is then performed by a ligase complex consisting of XRCC4, XLF, and LIGIV.
In the HR pathway the DSB is recognized by the MRN complex. This complex then recruits the phosphatidylinositol 
3-kinase ATM, which in turn phosphorylates histone H2AX and others to invoke repair and checkpoint signalling. 
The DNA is resected and the resulting ssDNA is bound by RPA, which is subsequently replaced by RAD51. This 
protein then promotes the invasion of the ssDNA to the homologous DNA template. The resulting synapsis is 
then used for new DNA synthesis, dissolution, and repair. HR is less error-prone than the NHEJ pathway since 
it uses nucleotide sequence in the homologous sister chromatid to restore genetic information in the broken 
strand. Figure adapted from Lans et al, Epigenetics & chromatin 2012
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Base excision repair (BER)  
Apart from damages affecting the structural integrity of whole chromosomes, also the bases of the 
DNA helix can become damaged and non-bulky small nuclease lesions can be formed. Such lesions 
are most often caused by reactive oxygen species (ROS) which are produced during normal cellular 
metabolism. Other sources include the oxidation, deamination, and alkylation of nucleotides 
which in turn result in the formation of damaged nucleotide derivatives such as 8-dihydroguanine 
(8-oxoG), 8-oxo-7, 3-methyladenine, and hypoxanthine (Hegde et al., 2008). 8-oxoG lesions are 
the most harmful of this set and can lead to GC to TA transversion during replication. To deal with 
these types of lesions the Base Excision Repair (BER) pathway is in place. This pathway excises the 
damaged or incorrect nucleotide and replaces it with the correct one (Kim and Wilson, 2012).The 
downstream steps of BER are also used in dealing with single-strand breaks (SSBs).Recognition 
of lesions in this pathway is achieved by specific glycosylases, each recognizing a specific type or 
subgroup of damaged bases (Figure 3). The known DNA glycosylases which have been described in 
literature have a broad overlap in their specificity, leading to high levels of redundancy (Hang et al., 
1997; Engelward et al., 1997; Klungland et al., 1999). In general, DNA-glycosylases recognize and 
remove damaged nucleotides by a process called ‘base flipping’. The glycosylase continuously tries 
to bind to the DNA by bending the DNA double helix. When this is performed at the site of a lesion 
the bending of the double helix causes the damaged base to flip out and enter the binding pocket 
of the enzyme. (Huang et al., 2003). Subsequently the N-glycosidic bond between the substrate 
base and the 2’-deoxyribose is cleaved by endonucleases specific for the resulting apurinic/
apyrimidinic (AP) site. The major AP endocuclease in mammals is AP-endonuclease 1 (APE1) and is 
thought to perform more than 95% of the total AP site incision activity (Demple and Sung, 2005). 
The incision leaves a SSB which, depending on the recognizing glycosylase, can be processed by 
either short-patch BER (SP-BER) or long-patch BER (LP-BER). When processed by SP-BER, the single 
nucleotide gap is filled by DNA polymerase β (Polβ) and the DNA ends are ligated together by the 
XRCC1-DNA ligase IIIα (Dianov and Hübscher, 2013). If the gap is processed by LP-BER, the APE1 
induced nick on the 5’ end of the AP site leads to recruitment of Proliferating Cell Nuclear Antigen 
(PCNA) and DNA polymerase δ (Polδ). The recruitment of these enzymes displaces the strand 
while Polδ incorporates 2 to 8 nucleotides of new DNA. This strand displacement produces a DNA 
flap that is refractory to ligation and needs to be resolved. Flap structure-specific endonuclease 1 
(FEN1) is recruited and degrades the displaced DNA fragment, after which DNA ligase 1 can ligate 
the remaining ends of the newly incorporated nucleotides (Robertson et al., 2009).
The clinical consequences of defective BER are not as common as with the earlier discussed 
DSBs pathways. This might be because most of severe defects in core BER factors seem to be 
incompatible with life. Mouse knock outs with Polβ, APE1, and DNA ligase 1 are embryonic lethal 
(Maynard et al., 2009). This however does not mean there are no links to disease at all. It has been 
found that about 30% of all human tumours have mutations in Polβ. In 50% of these cases only 
one amino acid has changed (Starcevic et al., 2004). Another example is the decreased expression 
of APE1 in patients with sporadic amyotrophic lateral sclerosis (ALS)(Kisby et al., 1997). These and 
other examples show that it is more mutations and problems with regulation of the BER pathway 
that have pathological impact.
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Figure 3. Schematic overview of the base-excision repair (BER) pathway. The lesion is recognized by a 
lesion type specific glycosylase. This glycosylase flips the damaged base out of the DNA helix by compressing 
the DNA backbone and driving the base into the active site of the glycosylase. The base is then cleaved from 
the sugar-phosphate backbone of the DNA double helix. This results in an abasic site which is recognised by the 
endonuclease APE1. After recognition APE1 incises the strand of DNA leading to one of two possible pathways. 
In short-patch BER the resulting one nucleotide gap is filled by DNA Polβ and the DNA ends are ligated together 
by the XRCC1-DNA ligase IIIα. 
If the gap is processed by long patch BER the APE1 induced nick on the 5’ end of the AP site leads to recruitment 
PCNA and DNA Polδ, causing displacement of the strand and incorporation of 2 to 8 nucleotides of new DNA 
by Polδ. This strand displacement produces a DNA flap that is refractory to ligation and needs to be resolved. 
Flap structure-specific endonuclease 1 (FEN1) is recruited and degrades the displaced DNA fragment, after 
which DNA ligase 1 can ligate the remaining ends of the newly incorporated nucleotides. Figure adapted from 
Hoeijmakers, Nature 2001
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Mismatch Repair (MMR)  
During replication and recombination, erroneous insertion, deletion or mis-incorporation of 
bases can occur. These spontaneous mutations occur on average at a frequency of 1 per 109-
1010 base pairs per cell division in humans (Drake, 1991). To increase the fidelity of the copying 
process, amongst other measures, the DNA mismatch repair (MMR) pathway is in place. The MMR 
pathway recognizes and repairs these mismatches and by doing so decreases the frequency of 
spontaneous mutations 50-1000 fold (Iyer et al., 2006).
MMR is initiated in eukaryotes during replication (Modrich, 2006). There are two possible modes 
of recognition (Figure 4). In the case of base-base mismatches or when there are one or two base 
loops, the mismatch is bound by a heterodimer of MutSα homologues (MSH2/MSH6). If there 
are larger base loops the mismatch is bound by MutSβ homologues (MSH2/MSH3) (Acharya and 
Wilson, 1996). This is followed by an ATP-dependent conformational change of MutS proteins, 
which results in the recruitment of MutLα homologues (MLH1/PMS2) or MutLβ homologues 
(MLH1/PMS1) heterodimers. The MutL heterodimers then translocate in either direction to search 
for strand discontinuity and nick the 3’or 5’ side of the mismatched based on the orientation of 
the PCNA clamp. In this way, MMR distinguishes the nascent and the template strands (Pluciennik 
et al., 2010). The EXO1 exonuclease then degrades the stretch of DNA harbouring the mismatch, 
leaving a short stretch of ssDNA, which is protected by binding of RPA. The stretch is then filled by 
the DNA Polδ and remaining nicks are ligated by DNA ligase I (Iyama and Wilson, 2013).
Defects in the MMR pathway are most known in the context of hereditary nonpolyposis colorectal 
cancer (HNPCC). In this form of colon cancers mutation of MLH1 and MSH2 cause defective MMR, 
mostly resulting in changes in the lengths of dinucleotide repeats of the nucleobases cytosine and 
adenine (Fishel et al., 1993; Papadopoulos et al., 1994). This causes repeats with, amongst others, 
a CACACACACA... sequence which greatly destabilize the genome and causes mutation of genes.
Interstrand Cross-Link (ICL) repair  
Interstrand cross-links (ICLs) are lesions in which two DNA strands in the double helix are 
covalently linked. ICLs can arise from endogenously produced metabolites from peroxidised lipids 
and the metabolism of dietary components e.g. coffee, ripe fruit and alcohol (Clauson et al., 2013). 
Exogenous sources include chemical compounds which are often used as chemotherapeutic 
drugs, such as mitomycin C (MMC) and cisplatin (Muniandy et al., 2010). Research has shed some 
light on the repair of ICLs, but the exact molecular components and kinetics are not all identified. 
Up till now 16 causative proteins have been identified. Repair is performed by a complex 
combination of these Fanconi Anemia (FA) proteins and factors from nucleotide excision repair 
(NER), HR, Translesion synthesis (TLS) (Deans and West, 2011).
The FA pathway is initiated by the binding of the ATP-dependent DNA helicase FANCM Fanconi 
anemia, complementation group M (FANCM) to a stalled replication fork (Kee and D’Andrea, 2012). 
FANCM then unwinds the DNA, creating ssDNA to which RPA binds (Schwab et al., 2010). The 
binding of RPA then induces ATR-mediated signalling which leads to activation of the core FA 
complex. Of this 12 subunit large complex, Fanconi anemia, complementation group L (FANCL) 
mono-ubiquitylates the Fanconi anemia, complementation group D2 (FANCD2), Fanconi anemia, 
complementation group L (FANCL) heterodimer (D2/l) (Cole et al., 2010; Garner and Smogorzewska, 
2011). Monoubiquitinated D2/l is recruited to the site of damage and functions as a docking site 
for downstream structure-specific nucleases. These nucleases include endonuclease excision 
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repair cross-complementing protein 1-Xeroderma pigmentosum group F (ERCC1-XPF), the 
MUS81- Essential Meiotic Endonuclease 1 (EME1) complex, SLX1, and FANCD2/FANCI-associated 
nuclease 1 (FAN1) (Ciccia et al., 2008). On either side of the covalently linked nucleotides an 
incision is made by these nucleases. This leaves an unhooked crosslink which is still tethered 
to the complementary strand. Docking protein SLX4 interacts with all of these nucleases and is 
thought to coordinate the unhooking reaction, but it is still unknown how this is achieved. To 
bypass the unhooked crosslink TLS polymerases REV1 and Pol ζ are recruited. HR is then induced 
by downstream FA proteins initiating RAD51-dependent strand invasion (Kim and D’Andrea, 2012). 
Subsequently NER removes the remaining unhooked adduct and fills the resulting gap. In a final 
step the Ubiquitin carboxyl-terminal hydrolase 1 (USP1)/ WD repeat-containing protein 48 (UAF1) 
complex deubiquitylates D2/l to complete the pathway (Nijman et al., 2005a). 
Covalently linked strands of the DNA double helix are extremely hazardous since they block 
transcription as well as replication, and may disrupt overall chromatin structure. Where other 
forms of DNA damage are mostly mutagenic, interstrand cross-links (ICLs) are mostly clastogenic, 
i.e., they give rise to or induce disruption or breakages of chromosomes leading to sections of the 
chromosome being deleted, added, or rearranged. These damages can produce the gain, loss, or 
rearrangement of chromosomal segments and/or cause sister chromatid exchanges (Noll et al., 
2006).
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hMSH2/3 (MutSβ)
DNA Polδ/ε
PCNA complex
hMLH1/hPMS2 (MutLα)
Exonuclease (5'– 3')
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DNA resynthesis
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Figure 4. Schematic overview of the mismatch repair 
(MMR) pathway. There are two possible modes of 
recognition of nucleotide mismatches or base loops 
in the double stranded DNA. In the case of base-base 
mismatches or when there are one or two base loops 
(bases in one strand of the DNA without a conjugated 
base), the mismatch is bound by a heterodimer of MutSα 
homologues (MSH2/MSH6). If the damage consist of larger 
base loops the mismatch is bound by MutSβ homologues 
(MSH2/MSH3). 
This is followed by an ATP-dependent conformational 
change of MutS proteins, which results in the recruitment 
of MutLα homologues (MLH1/PMS2) or MutLβ homologues 
(MLH1/PMS1) heterodimers. The MutL heterodimers 
then translocate in either direction to search for strand 
discontinuity and nick the 3’or 5’ side of the mismatched 
based on the orientation of the PCNA clamp. In this way, 
MMR distinguishes the nascent and the template strands. 
The EXO1 exonuclease then degrades the stretch of 
DNA harbouring the mismatch, leaving a short stretch of 
ssDNA, which is protected by binding of RPA. The stretch is 
then filled by the DNA Polδ and remaining nicks are ligated 
by DNA ligase I. Figure adapted from Hoeijmakers, Nature 
2001.
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Nucleotide excision repair (NER)  
Nucleotide excision repair (NER) removes a wide variety of structurally unrelated DNA lesions. 
This wide variety of lesions have in common that they are all, to some degree, helix-distorting and 
locally impair proper Watson and Crick base pairing. One source which can cause these lesions 
is the UV-C irradiation which our cells receive from sunlight. This UV-C irradiation leads to the 
formation of dimeric photoproducts involving two the adjacent pyrimidine bases. Examples of 
these lesions are cyclobutane pyrimidine dimers (CPDs) and pyrimidine- (6,4)-pyrimidone pho-
toproducts (6-4PPs). Other known causes for these bulky lesions are certain chemotherapeutic 
agents such as cisplatin, and chemicals in cigarette smoke (Kim and Choi, 1995; Cadet et al., 2005). 
Both transcription and replication are severely hampered by these bulky lesions and need to be 
resolved. An example of a problem in transcription is when RNA polymerase II encounters such a 
lesion. When this happens the elongation reaction stalls. This unresolved stalling can lead to single 
or double strand breaks, re-arrangements, mutations and ultimately apoptosis and premature ag-
ing (Ljungman and Zhang, 1996). Nucleotide Excision Repair (NER) is the pathway in place to cope 
with these lesions and it consists of more than 30 highly coordinated proteins performing the 
multi-step repair process. This process can be divided in the following steps: damage recognition, 
DNA helix unwinding, damage verification, lesion excision, DNA synthesis and ligation (Figure 5). 
Damage recognition: 
There are two essentially different mechanisms by which NER recognises damages: transcription-
coupled repair (TC-NER) and global genome repair (GG-NER) (Hanawalt and Spivak, 2008; Gillet and 
Schärer, 2006). In the TC-NER pathway, lesions are detected by the stalling of a RNA polymerase 
II (RNAP2) when it is actively transcribing a gene. RNAP2-stalling then triggers recruitment of 
secondary factors, including Cockayne syndrome A and B (CSA, CSB), to initiate the formation of a 
functional TC-NER complex (Hanawalt, 2002; Fousteri et al., 2006).
Lesions in other parts of the genome, including the non-transcribed strands of active genes, are 
detected by GG-NER. The DNA binding protein Xeroderma pigmentosum group C (XPC) is the 
main damage sensor in GG-NER (Masutani et al., 1994; Sugasawa et al., 1998; Nishi et al., 2005). It 
forms a complex together with RAD23B and Centrin-2. In vitro experiments have shown that XPC 
binds to a myriad of different DNA structures that cause DNA helix destabilisation and even bind 
to nucleotide mismatches which do not activate NER in vivo (Sugasawa et al., 2001). The model 
proposed for the binding of XPC is based on crystal structures of the yeast XPC homologue RAD4 
bound to a DNA molecule containing a CPD (Min and Pavletich, 2007). XPC binds to a small piece 
of ssDNA opposite of the lesion caused by the disrupted base pairing. This binding is performed 
by inserting the carboxy-terminal double β-hairpin of XPC at the junction between the dsDNA and 
the ssDNA. If this is possible, it leads to stable binding of XPC and possibly extending the ssDNA to 
enable recruitment of downstream NER factors. 
Although this binding mechanism works very well in the case of 6-4pps, XPC is not able to 
recognize a lesion if the distorting effect of the lesion on the DNA helix is too small. This is for 
instance the case with CPD lesions. These lesions create too little distortion to be efficiently 
recognized by the XPC-complex alone. Therefore, full function of XPC requires additional factors, 
like the UV-damaged DNA-binding (UV-DDB) complex (Moser et al., 2005; Chu and Yang, 2008). 
This heterodimer complex consists of two subunits, DNA damage-binding protein 1 (DDB1) and 
DNA damage-binding protein 2 (DDB2). This complex directly binds to the CPD lesion and acts as 
secondary damage-recognition factor by stimulating the binding of XPC (Wakasugi et al., 2002; 
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Scrima et al., 2008; Groisman et al., 2003). This is achieved by DDB2 directly binding to the lesion, 
extruding the lesion into its binding pocket and thereby kinking the DNA in such a way that the 
damage is exposed, thereby facilitating subsequent XPC binding. 
DNA helix unwinding and lesion verification: 
After lesion recognition has taken place, either by TCR or GGR, the same core NER machinery is 
recruited. First, the DNA helix is unwound by the general Transcription factor II H (TFIIH) and the 
lesion is verified. This process makes the lesion accessible for downstream NER proteins (Sugasawa 
et al., 2009; Volker et al., 2001; Giglia-Mari et al., 2004; Ranish et al., 2004). Unwinding is performed 
by two subunits, Xeroderma pigmentosum group B (XPB) and Xeroderma pigmentosum group 
D (XPD), which are ATP dependent helicases that unwind a stretch of 30 nucleotides of the helix 
containing the lesion (Schaeffer et al., 1993; Coin et al., 1998). Apart from this role of TFIIH during 
the NER reaction, this ten subunit large protein the helicase capabilities also plays a major role 
during transcription (Zurita and Merino, 2003). 
Although there is still ample discussion about the order of binding in the NER reaction (Luijsterburg 
et al., 2010), currently it is thought that after opening of the helix, Xeroderma pigmentosum group A 
(XPA) and RPA get access to the NER complex. The precise role of XPA is not fully understood, but it 
is regarded the key player in this step of the NER reaction. It is not only associated with stimulating 
lesion verification by TFIIH but also interacts with almost all other NER proteins. Therefore it is 
considered to be the central coordinator and directs the precise positioning of the complex before 
the incision step of the pathway (Sugasawa et al., 2009; Schärer, 2013). After the unwinding of the 
DNA the undamaged strand needs to be protected from endonucleases. This is achieved by the 
binding of RPA, which protects the ssDNA and stabilizes the open complex formation together with 
XPA and TFIIH (Gourdin et al., 2014) 
Lesion excision and gap filling: 
The heterotrimeric RPA also correctly positions the endonuclease Xeroderma pigmentosum group 
G (XPG) and the heterodimeric ERCC1-XPF complex (de Laat et al., 1998; Rademakers et al., 2003; 
O’Donovan et al., 1994; Zotter et al., 2006; Sijbers et al., 1996). When verification of the lesion and 
proper orientation of the core NER factors is complete the endonucleases XPG and ERCC1-XPF 
incise the 3’ and the 5’ side of the damage, respectively. The excised piece of ssDNA containing 
the lesion is then released and degraded, leaving a RPA protected single-strand gap to be filled. 
Gap filling is initiated by the replication machinery including DNA polymerases δ, ε or κ, Replication 
factor C (RPC) and Proliferating Cell Nuclear Antigen (PCNA) (Ogi et al., 2010). As a final step, the 
nick in the DNA backbone is sealed by either DNA ligase I or III (LigI or LigIII) (Moser et al., 2007)
Defects in the NER process are best illustrated by several rare, autosomal recessive disorders. 
Xeroderma pigmentosum (XP) is one of these disorders. XP is caused by mutations in the XP genes 
(XPA through XPG). Patients who suffer from this disease show dry skin (xeroderma), abnormal 
pigmentation in sun exposed skin (pigmentosum), photohypersensitivity of the skin, and an 
almost 10.000-fold increased risk for skin cancer in patients below 20 years of age (DiGiovanna 
and Kraemer, 2012). Another disease linked to NER is Cockayne syndrome (CS). CS is caused by 
mutations in either CSB or CSB, both important proteins needed when RNAP2 stalls at a lesion. 
Like XP patients, CS patients also show a photohypersensitivity of the skin but they do not harbor 
the same increased risk for skin cancer (Nance and Berry, 1992; Pines et al., 2010). Furthermore, 
CS patients show severe developmental, neurological, and premature aging features. 
22
I
Figure 5. Schematic overview of the nucleotide excision repair pathway (NER). Lesions can be detected by 
in two different ways. In global genome NER (GG-NER) helix-destabilising lesions are recognised by XPC-RAD23-
CETN2 and UV-DDB complexes. In transcription-coupled repair (TC-NER) the lesions is recognised by stalling of 
a RNA polymerase II (RNA PolII) at the lesion in the transcribed strand of the active gene. Stalling of RNA PolII 
leads to stable binding of CSB, UVSSA and other proteins. After recognition, either by RNA PolII or XPC, the 
core NER machinery is recruited. Helicase transcription Factor II H (TFIIH) opens the DNA around the damage 
and XPA binds to verify the lesion and the orientation of all the repair factors. RPA is recruited to stabilise the 
ssDNA created by the unwinding of the helix. Subsequently the specific endonucleases XPF-ERCC1 and XPG 
excise the damaged strand on the 5’and 3’ side respectively. This results in a 25-30 nt ssDNA gap which is 
filled by replication machinery proteins PCNA and several DNA polymerases (δ, ε and/or κ). In the final step the 
remaining nick is sealed by DNA ligase I or IIIα.
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Post Translational Modifications (PTMs)
When a protein is translated and correctly folded into its mature form, the cell still controls its 
behaviour and lifespan. These control levels are largely achieved by post-translational modifications 
(PTMs). Chemical groups are specifically added to or removed from specific residues of the protein 
to turn on, turn off, tune, change, or destroy the protein. Tight regulation by PTMs of the concerted 
actions of proteins is vital in all cellular processes, including the DDR. 
The DDR pathways consist of multiple steps in which timing, localisation and availability of involved 
proteins are key factors to ensure a proper and swift handling of DNA damages. For this reason 
the importance of the existence of DNA damage signalling pathways cannot be understated. Apart 
from (de)activating specific proteins, signalling can induce cell cycle arrest in G1/S phase transition, 
intra S or G2/M phase transition. This arrest gives cells the time to repair the encountered damage. 
If the damage load is too high and DDR mechanisms cannot cope with the damages in time, 
signalling persists, which can result in cellular senescence or apoptosis. This ensures that cells 
do not propagate faulty or broken DNA and aberrant cellular processes in daughter cells do not 
wreak havoc. The cell has multiple signalling pathways and mechanisms to its disposal, foremost 
using PTMs to achieve this tight regulation of processes. In the following paragraphs the most 
important will be discussed.
Phosphorylation  
Kinases and phosphatases are well-known (de)activators and regulators of cellular processes 
and play a major role in several DDR pathways. Three crucial kinases of the phosphatidylinositol 
3-kinase-like kinases (PIKKs) family are ataxia telangiectasia-mutated (ATM), ataxia telangiectasia 
and Rad3-related kinase (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-
PKcs) (Falck et al., 2005; Jackson and Bartek, 2009). These kinases induce a signalling cascade 
by phosphorylating downstream targets, for instance p53 and Checkpoint kinase 1 and 2 (Chk1 
and Chk2). Phosphorylation and stabilisation of p53 can occur after UV irradiation which in turn 
can trigger cell cycle arrest or apoptosis (Mckay et al., 1998; Ljungman et al., 1999). Members 
of this family are also responsible for one of the most prominent chromatin modifications after 
DNA damage, namely the phosphorylation of histone variant H2A.X. This phosphorylation is 
mediated by DSB recognition by the MRN complex which triggers ATM to phosphorylate H2A.X 
(the phosphorylated variant is therefore often referred to as γ-H2AX). Another example where 
phosphorylation plays a role is when the kinase ATR is triggered by replication blockage to 
phosphorylate downstream repair factors after UV irradiation or hypoxia (Koundrioukoff et al., 
2004; Foiani et al., 2000; Abraham, 2004). It has been shown that at least part of this activity 
in replicating and non-replicating cells is dependent upon GG-NER activity (Marini et al., 2006; 
Marteijn et al., 2009; Hanasoge and Ljungman, 2007).
 
PARylation  
Poly(ADP-ribosyl)ation or PARylation was discovered in the 1960s and has since been associated 
with the DDR (Nishizuka et al., 1967; Chambon et al., 1963). PARylation is the process where an 
ADP-ribosyl moiety is covalently linked to a target protein. Poly(ADP-ribose)polymerase (PARP) 
catalyses this process by using NAD+ as a substrate and cleaving off the nicotinamide during the 
covalent linkage. Chains of ADP-ribose units can be formed by elongation of the first unit to create 
branched polymer structures which are termed poly(ADP-ribose) (PAR) (Bürkle and Virág, 2013). 
DDB2, the protein aiding XPC in recognizing certain cryptic lesions is an example of a protein 
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which can be PARylated. UV-dependent PARYylation of DDB2 induces chromatin de-condensation. 
PARylation also suppresses ubiquitylation-dependent degradation and promotes DNA binding 
(Luijsterburg et al., 2012). In turn, DDB2 promotes the poly(ADP ribosyl) polymerase 1 dependent 
(PARP1) PARylation of chromatin. This PARylation aids the recruitment of the ATP dependent 
chromatin remodelling enzyme Amplified in Liver Cancer 1 (ALC1). Although the specific role of 
ALC1 is unclear it is speculated it is needed to modulate chromatin structure through nucleosome 
sliding. This in turn would allow for recruitment of XPC on CPDs and stimulates NER (Pines et al., 
2012). 
Acetylation and Methylation  
Modifications which change the structure of chromatin are indicated to have a positive influence 
on the NER process. Acetylation is typically associated with open chromatin and active transcription 
(Kuo and Allis, 1998). When this type of chromatin is hyper-acetylated by inhibiting the de-
acetylation using de-acetylase inhibitors the repair rate is significantly increased (Ramanathan 
and Smerdon, 1989). Methylation is also a mark for either active or inactive chromatin, depending 
on which variant of histones are either mono- or tri-methylated. Studies performed in yeast 
have for instance shown that histone-3-lysine-79 (H3K79) methylation by Disruptor Of Telomeric 
silencing 1 (DOT1p) is required for efficient UV damage response. Disruption of this methylation 
results in UV hypersensitivity and the lack of an intra-S phase checkpoint (Bostelman et al., 2007; 
Giannattasio et al., 2005).
Ubiquitylation and ubiquitin-like modifications 
Protein ubiquitylation is an important PTM in many cellular processes. Ubiquitin (Ub) is a highly 
conserved 76 amino acid, 8.5 kDa (small) protein. Ubiquitylation of lysine residues controls the 
localization, activity and stability of almost all proteins (Grabbe and Dikic, 2009). Ub (and Ub-
likes) can be covalently attached to the ε-amino group of lysine residues or in less frequent cases 
the N-terminal amino group of the target protein (Ciechanover, 1994; Ciechanover and Ben-
Saadon, 2004). Target ubiquitylation is orchestrated by three enzymes: the Ub-activating E1, the 
Ub-conjugating E2 and the Ub-ligating E3 (Hershko and Ciechanover, 1998) (Figure 6). In the first 
step the E1 enzyme uses ATP to form an E1-thiolester-Ub intermediate. This activated Ub is then 
in the second step transferred and conjugated from the E1 to the active site E2, hence called the 
conjugation step. The third, final step involves ligating the Ub to the target protein. In general, 
the Ub-conjugated E2 binds to a target specific E3 ligase, which in turn covalently couples the 
C-terminal glycine Ub-residue to a lysine residue of the target protein via an isopeptide bond 
(Pickart, 2001). 
Currently only two E1 enzymes for ubiquitin are identified in the human genome (Jin et al., 2007; 
Pelzer et al., 2007), while there are over 30 E2 enzymes with which they can interact (Markson et al., 
2009; Michelle et al., 2009). Subsequently, E2 enzymes can associate with more than 600 putative 
E3 ligases known in the human genome (Li et al., 2008). The E3 enzymes can be (sub)divided 
in 3 families (Berndsen and Wolberger, 2014) depending on one specific characterizing domain: 
homologues to E6-AP-carboxyl-terminus (HECT) domain (Scheffner and Kumar, 2014), Really 
interesting new gene (RING) domain (Deshaies and Joazeiro, 2009) and the RING-between-RING 
(RBR) domain ligases (Wenzel and Klevit, 2012). E3s containing a HECT domain and RBR E3s are 
catalytically active, in contrast to the RING E3s. The HECT domain consists of roughly 350 residues 
in a bi-lobal conformation. The N-terminal lobe harbours an E2-binding site and the C-terminal 
lobe contains a cysteine which can accept Ub from the E2 before conjugation and allow for 
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chain-specific polyubiquitylation of the target (Kim and Huibregtse, 2009). The RBR family has a 
similar, but subtle different activity. Here an E2 first binds to the first RING domain thereafter 
transferring the Ub to a cysteine residue in the second RING domain. As a final step, the Ub is then 
transferred to the target protein. The largest family is that of the RING E3s, which only mediate the 
direct transfer of the Ub to the target protein. 
For the ubiquitin-like proteins Small Ubiquitin-like Modifier (SUMO) and Neural-precursor-cell-
Expressed Developmentally Down-regulated 8 (NEDD8) similar mechanisms of conjugation to 
target proteins have been described (Matunis et al., 1996; Kamitani et al., 1997). 
This multistep process seems to ensure a high level of regulation and specificity by increasing 
the amount of possible combinations in each step. Examples have been found were transfer of 
the Ub was E3 independent and the E2 directly ligates the Ub to the target protein (van Wijk and 
Timmers, 2010). Next to the combinations between the E1, E2, and E3 enzymes, the possibility 
of poly-ubiquitylation discussed in the next section adds even more possible combinations and 
possibilities for the cell to regulate and fine-tune processes. 
Poly-Ubiquitylation 
When a single Ub has been conjugated to the target protein at one or more lysines (mono-
ubiquitylation) it is also possible to conjugate more Ubs to this first one resulting in a chain of 
Ubs (poly-ubiquitylation). All the available lysine residues (K6, K11, K29, K33, K48 and K63) of the 
original conjugated Ub have been reported to be used for this poly-ubiquitylation step, resulting 
in (branched) chains of either one type of linkage. It is also possible that the chains are comprised 
of a mix of linkages within the chain. 
The best-known and most abundant form of poly-ubiquitylation in the cell is that of K48 chains. 
This form of ubiquitylation is primarily a signal for degradation by the 26S proteasome (Chau et 
al., 2014). Another example are K63 chains, which have been found to be involved in ribosomal 
functioning, endocytosis and DNA repair (Hicke, 1999; Spence et al., 2000; Bergink and Jentsch, 
2009). Other chains have been found as secondary degradation signals (K11) or signals preventing 
degradation (K6) (Kulathu and Komander, 2012).
Mixed poly-ubiquitin chains have not been extensively studied because current techniques poorly 
discriminate between branched and unbranched chains of Ub, but recently a study tried to shed 
more light on the subject. In this study it was shown that the specific signalling capabilities of for 
instance K63 chains and K48 chains are retained. This could indicate that mixed chains can carry 
multiple signals which can still be discriminated by their receptors (Nakasone et al., 2013). Since 
these chains are structurally different, this provides the cell with an extensive network of regulation 
layers. The addition of different Ub-chains to various lysine residues changes the function of the 
target protein (Li and Ye, 2008; Komander and Rape, 2012).
De-ubiquitylating enzymes (DUBs) 
Like all PMTs, ubiquitylation is reversible. As there are specific proteins which can attach one or 
more Ubs to a target protein there are also specific proteases which can cleave off Ub or even 
engage in editing of the complete Ub chain (Clague et al., 2012; Komander et al., 2009). These 
de-ubiquitylating enzymes (DUBs) can be general in their activity, but there are also specialized 
DUBs known which can be either chain- or substrate-specific (Nijman et al., 2005b). It is interesting 
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to note that the majority of these DUBs are not specific in their activity. This is very common in 
biological regulatory systems, where it seems easier to have very specific modifying enzymes for 
PTMs, but unspecific de-modifiers for these same PTMs.
Ubiquitylation in NER 
Lesion recognition by the GG-NER pathway and numerous other steps in the NER pathway have 
been found to be regulated by (de)ubiquitylation. The UV-DDB associates with the cullin 4A 
(CUL4A)-regulator of cullins 1 (ROC1) E3-ubiquitin ligase (CTRL) via its conserved C-terminus. The 
ligase activity of the UV-DDB-E3 complex is inhibited by deneddylation of the CUL4a subunit by 
the COP9 signalosome (CSN). Upon UV irradiation CSN dissociates and allows neddylation after 
lesion binding (Groisman et al., 2003). This activation leads to poly-ubiquitylation of DDB2 and 
XPC, but has different effects on both of them. Poly-ubiquitylation of DDB2 upon UV irradiation 
results in rapid degradation of DDB2 by the 26S proteasome (Yeh et al., 2012; Fitch et al., 2003). 
However, poly-ubiquitylation of XPC does not lead to its degradation but in vitro has shown to 
increase the affinity for DNA lesions (Sugasawa et al., 2005). Interestingly, in vivo the ubiquitylated 
form of XPC was not only found in the chromatin bound faction but also in the soluble nuclear 
fraction of the chromatin immune-precipitation experiments (Wang et al., 2005; Sugasawa et al., 
2005). This could indicate that the modification has a trans-effect throughout the nucleus and is 
not only lesion specific.
RAD23 has been held responsible for the protection against proteasomal degradation of 
XPC. Cells lacking HR23A and HR23B display dramatic reduction of XPC levels, which can be 
counteracted by blocking the 26S proteasome (Ng et al., 2003). In contrast it has also been shown 
RAD23 is essential for binding of XPC to lesions. Experiments in RAD23A and RAD23B double 
knock-out mouse embryonic fibroblast (MEF) cells reveal that after UV irradiation XPC does not 
bind to lesions. Intriguingly, RAD23 itself does not accumulate on UV-induced lesions. Fluorescence 
recovery after photobleaching (FRAP) experiments show that the mobility of RAD23 after UV 
irradiation is slightly higher than in absence of damage. Therefore it is hypothesized that RAD23 
leaves the XPC complex upon lesion recognition and stable binding by XPC (Bergink et al., 2012). 
This seems to conflict with the earlier mentioned observations that XPC ubiquitylation takes place 
almost simultaneously with binding (Sugasawa et al., 2005), and suggests that RAD23 is not the 
factor protecting XPC from degradation. This suggests there is another factor responsible for the 
ubiquitylated form of XPC not being degraded. A possible explanation to this is offered in chapter 
4 were we show that the ubiquitylation of XPC is responsible for a molecular switch needed for 
binding of XPC to the lesion.
Recently, the ubiquitin E3 ligase ring finger protein 111 (RNF111) was identified as a factor 
promoting XPC ubiquitylation (Poulsen et al., 2013). RNF111 is a member of the family of 
SUMO-targeted ubiquitin ligases (STUbLs), which facilitate crosstalk between SUMOylation and 
ubiquitylation (Prudden et al., 2007; Sun et al., 2007; Uzunova et al., 2007). In chapters 2 and 
3 of this thesis we show that RNF111 specifically targets SUMOylated XPC and modifies it with 
K63-linked ubiquitin chains in a UBC13-dependent manner. We show that although RNF111 is 
not essential for GG-NER, it strongly enhances the repair reaction by stimulating the release of 
XPC from damaged DNA, thereby enabling the progress of the NER reaction by recruitment of the 
endonucleases XPG and XPF/ERCC1. 
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Figure 6. Schematic overview of the ubiquitylation pathway. The covalent binding of a Ubiquitin (Ub) 
molecule to a lysine residue in a target protein takes place in three distinct enzymatic steps. The Ub is activated 
by the activating E1 enzyme. A thioester bond is formed between the Ub C-terminus and an internal cysteine 
residue of the E1. In the next step the activated Ub is transferred to the active-site cysteine of a Ub conjugating 
E2 enzyme. The final step involves a Ub ligating E3 enzyme which catalyses the formation of an isopeptide 
bond between the C-terminal glycine residue of the Ub and a lysine of the substrate protein. Currently there 
are three type of E3 enzymes known: HECT E3s, RING E3s, and RING-between-RING (RBR) E3s. With RING E3s 
the activated Ub is transferred directly from the E2 to the substrate protein. Both with HECT and RBR E3s the 
activated Ub is first transferred from the E2 to the E3 and only then to the substrate protein. The difference 
between the HECT and the RBR E3s is that the first is also catalytically active, meaning that it can also activate a 
Ub without help from a specific E2. With each step in the processes the specificity is increased by increasing the 
number of possible pairings. Up till now only two E1s are identified, 30 E2s, and more than 600 putative E3s. 
(Figure adapted from Schwertman, 2014)
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Signalling, feedback loops and bi-stability
In chapter 4 of this thesis we discuss in detail the binding of the damage sensor XPC in GG-NER. 
We describe how it responds in a bi-stable manner when cells are subjected to certain doses of 
UV irradiation. This bi-stable response is controlled by a tightly regulated feedback loop system. In 
this chapter we find that the signalling which controls these feedback loops also operates in trans 
through the whole nucleus. Here these concepts are introduced and explained.
The extensive array of reversible PTMs the cell has to its disposal makes it possible to create 
highly intricate signalling pathways. Next to their high sensitivity, these signalling pathways are also 
suitable for relaying rapid messages and cell cycle decision making (Kholodenko, 2006). Positive 
and negative feedback loops are the bases of this high level of intricacy and sensitivity. Positive 
feedback loops provide the cell with means to amplify a signal, where negative feedback loops 
can attenuate signals. These signals can be combined one or several times to provide different 
outcomes of the signal. One of these outcomes is the phenomenon of bi-stability. The concept 
of bi-stability says that a dynamic system can be in either of two equilibrium states. Due to this 
property it can also been regarded as a ‘switch’ in the system (Tyson et al., 2003). A basic example 
of a feedback loop system can be found in figure 7A. In this example a balance is preserved 
between a phosphatase and a kinase, both being stimulated by the resulting protein. 
Numerous biological systems are known that are regulated in a switch-like manner by bi-stability. 
One example is the polarization of budding yeast (Figure 7B). The first rapid loop involves the 
activity cycling of Cell Division Control protein 42 homolog (CDC42). The second slower loop 
consists of the actin-mediated transport of CDC42 (Wedlich-Soldner et al., 2004). A system 
also incorporating a fast positive feedback loop with a slower feedback is the calcium signalling 
cascade, which is present in many cell types (Figure 6C). This cascade incorporates the induction 
of a prolonged Ca+ signals by using two types of positive feedback loops (Figure 4a). The first loop 
is centred around rapid release of Ca+ which is mediated by inositol 1,4,5-trisphosphate (IP3). The 
second loop is slower and induces Ca+ influx mediated by the depletion of Ca+ stores (Berridge, 
2001; Lewis, 2001).
Systems with interacting loops have been identified over the years. One of the examples in this 
category is the system responsible for the maturation of the Xenopus oocyte (Figure 7D). The 
first rapid acting feedback loop reacts to progesterone maturation stimuli by phosphorylating 
and dephosphorylating the Cyclin-dependent kinase 1 (CDC2), Cell Division Control protein 25 
homolog (CDC25), and Myelin transcription factor 1 (Myt1). In this loop CDC2 promotes the 
activation of the Cdc2 activator Cdc25, and simultaneously promotes inactivation of the CDC2 
inhibitor MYT1. A slower positive feedback loop is active between CDC2, Mitogen-Activated Protein 
Kinase (MAPK), Mos kinase, and MYT1. In this feedback loop CDC2 stimulates Mos activity, which 
in turn stimulates MAPK. MAPK in turn stimulates Mos, but inhibits the activity of MYT1. MYT1 is a 
negative regulator of CDC2, which in turn also is a negative regulator of MYT1 (Xiong and Ferrell, 
2003; Brandman et al., 2005). The combination of a slow and a faster loop give rise to certain 
advantages over single loop systems. In these systems the switch will produce its outcome rapidly 
due to the rapid activation of the fast loop. Turning this system into its ‘off’ position goes slower 
due to the kinetics of the slow loop. By this mechanism the activation and deactivation times can 
be independently tuned (Brandman et al., 2005). 
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Figure 7. Schematic overview of feedback loops in several cellular systems and possible responses to 
stimuli. (A) Schematic of a basic feedback loop system. Protein A is phosphorylated by a kinase to form A-p, 
which on itself stimulates the kinase. In the reverse loop, A-p is dephosphorylated. This process is stimulated 
by protein A itself. (B) Schematic overview of the feedback loops involved in establishing the polarity in budding 
yeast. (C) Schematic overview of the feedback loops involved in mammalian calcium signal transduction. (D) 
Schematic overview of the feedback loops involved in the maturation of the Xenopus oocyte. (E) Schematic 
representation of a bi-stable response. When a the stimulus drops below the level at which the kinase was 
triggered, the activity of the kinase does not drop immediately. This process is phenomenon is known as 
hysteresis. (F) Overview of activity of a protein over time when a feedback loop system employs one or more 
loops. Adapted from Brandman et al, 2005
Positive and negative feedback loops have also been proposed to play a role in the DDR. Most of 
the research is focused on p53 regulatory pathway which controls DNA repair, cell cycle arrest, 
apoptosis, and cellular senescence. In brief, the p53 protein is considered the master switch of 
cell cycle fate after DNA damage or other stress: either the cell repairs the damage and continues 
to live or the cell is incapable of repair and apoptosis is induced. Much research has focused on 
elucidating the precise mechanism behind this decision making process, but much is still not 
clear. Many proteins have been found to act in positive and negative feedback loops regulating 
the stability of p53 and all the effectors in the feedback loops themselves. An added level of 
complexity is provided by the difference in insults and the effectors playing a role in the specific 
pathways dealing with them. In the repair of DSBs several feedback loops have been found or 
proposed (Puszyński et al., 2008; Zhang et al., 2011). The first loop is between p53 and Mouse 
Double Minute 2 homolog (MDM2). MDM2 binds and degrades p53, which prevents p53 from 
stabilizing. Upon detection of DSBs the Ataxia Telangiectasia Mutated (ATM) protein inhibits the 
function of MDM2 and stabilizes p53. ATM itself is inhibited by Protein phosphatase 1D (Wip1). 
Simultaneously stabilized p53 activates a cascade in which Phosphatase and Tensin Homolog 
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(PTEN) activates Protein kinase B (Akt), which in turn stimulates MDM2 function. If the signal which 
stabilizes p53 persists a positive feedback loop involving Cytochrome C (CytoC) and Caspase 3 
(Casp3) is activated, leading to apoptosis 
As the previous paragraphs illustrates, simple or intricate feedback loop systems are abundant in 
biological systems. PTMs play a crucial role in regulating decision making process and can have 
subtle or an ‘all or nothing’ character. In chapter 5 of this thesis we will use the biological data we 
obtained and integrate this in models containing these feedback loops to gain better insight into 
which key players could be interesting targets for biological experiments. 
Confocal microscopy and methods
Ever since the development of the first microscopes by Zacharias Jansen (~1585–1632) and 
Cornelis Drebbel (1572–1633) and the pioneering work of Antoni van Leeuwenhoek (1632–1723), 
microscopy has been a staple technique in biology. Technical improvements lead to microscopes 
with higher resolution and combined with new visualization techniques, like phase contrast 
microscopy (Zernike, 1955), the technique only grew in power. Immuno-histochemical techniques 
made it possible to specifically stain and visualize protein localisation and structures which could 
not be seen before. A problem of conventional fluorescence microscopy is the out-of-focus light: 
besides the in-focus fluorophores, light from fluorophores out of the focal plane of the objective 
will also be observed and will result in blurred images. To resolve this problem the out-of-focus 
light was blocked using a pinhole in front of the detector and one in front of the light source 
(Marvin Minsky, 1961 US patent 3013467) (Davidovits and Egger, 1969, 1971). Confocal setups 
which were truly usable for biological experimentation were introduced in the 1980s. With the 
advent of fast computer systems and laser technology, two independent groups managed to set 
up the first real confocal laser scanning microscope (CLSM) (Cox and Sheppard, 1983; Brakenhoff 
et al., 1985). These modern confocal microscopes use a laser as a light source. The detection and 
excitation pinhole are in conjugated focal planes, hence the term confocal. Since only in-focus 
fluorescence is detected the quality of the image is greatly improved.
Studying the dynamics of cellular processes in general and the work described in this thesis, 
mostly on damage detection in NER only became possible after the revolution which swept the life 
science research community: the genetic labelling of proteins with fluorescent proteins. Before 
this, following specific moieties of proteins inside a living cell was not feasible to the extent where 
full blown experiments could be designed, and thorough comparison between different proteins 
under varying conditions could be made, since roughly only two techniques were available: 
microinjection of fluorescently conjugated antibodies or immune fluorescent techniques. To 
study the behaviour of proteins over time cells were fixed at different time points, permeabilized 
and stained using dyes or fluorescent antibodies. With the discovery of the green fluorescent 
protein (GFP) the dynamic behaviour of proteins could be assessed in living cells in real time. 
Immune fluorescent techniques also were improved due to the independence of specific labelling 
antibodies.
GFP is a 27 kDa protein which was initially isolated from the jellyfish Aequorea Victoria (Tsien, 
1998). The protein absorbs blue light at 395 nm and has one emission peak at a wavelength 
of 508 nm. Mutagenesis of the wild type GFP resulted in versions of the protein with enhanced 
characteristics like improved brightness and more efficient expression due to humanised codons 
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(Heim et al., 1994; Lippincott-Schwartz and Patterson, 2003). Proteins with characteristics similar 
to GFP were discovered in several other, mostly marine, species. Fluorescent proteins ranging 
from cyan to red were found in reef Anthozoa greatly broadening the spectrum of available 
fluorescent proteins (Matz et al., 1999). In the Discosoma species an even better red fluorescent 
protein DsRed was found and using mutagenesis optimized for human expression (Baird et al., 
2000). Further improvements in the available colour spectrum of fluorescent proteins came from 
yellow fluorescent proteins which were either found in other species or created by mutagenesis 
of GFP (Shagin et al., 2004; Masuda et al., 2006). 
Illumination of a chromophore with a specific wavelength can induce conversions between 
chromophore stereoisomers or induce photochemical reactions. These illumination-dependent 
changes in spectral properties can be exploited to create fluorescent proteins which can be 
turned in an on- or off-state by illumination at specific wavelengths (Lukyanov et al., 2005). There 
are two types of fluorescent proteins of which the properties can be altered, photo-activatable 
and photo-switchable proteins. Photo-activatable fluorescent proteins only turn fluorescent after 
having been illuminated at a specific shorter wavelength then their final excitation wavelength, 
usually 405 nm. Photo-convertible fluorescent proteins can be switched from one emission 
wavelength to another longer wavelength. Photo-switchable fluorescent proteins can be switched 
between an active fluorescent state to an inactive state by illuminating with a specific wavelength 
(Remington, 2006; Shaner et al., 2007). With the growing availability of these tools new applications 
have been developed. An example is the use of photo-activatable fluorescent proteins to image 
with sub-diffraction limit resolutions, immensely increasing the resolution with which structures 
can be visualized (Betzig et al., 2006; Willig et al., 2006).
Fluorescence Recovery After Photobleaching (FRAP)
Next to (confocal) microscopy, methods which are focused on imaging structures in high resolution, 
other techniques focus on extracting quantitative parameters. FRAP is one of these techniques. 
FRAP was developed in the 1970s and was mostly focused on the mobility of fluorescently labelled 
proteins in cellular membranes. With this technique one of the physical properties of fluorescent 
molecules can be exploited, namely that when the molecule absorbs a very intense light pulse 
in its excitation spectrum the molecule irreversibly loses its ability to fluoresce (Axelrod et al., 
1976; Koppel et al., 1976; Peters et al., 1974). When the technique was introduced one of the 
biggest drawbacks was that it required custom-built microscopy systems and at the time relied 
on chemical fluorescently labelled proteins. When commercialized CLSMs were introduced in the 
1990s, which were very powerful with respect to resolution, speed, sensitivity and flexibility, FRAP 
became more popular. This coincided with the discovery of the GFP protein which appeared to be 
highly suited for FRAP experiments and the field measuring protein dynamics using this technique 
rapidly expanded (Houtsmuller et al., 1999; Phair and Misteli, 2000; McNally et al., 2000; Stenoien 
et al., 2001; Mochizuki et al., 2001).
The setup of a FRAP experiment is straightforward: selectively a specific small volume within a larger 
volume is photobleached, i.e. the fluorescent property of the used tag is irreversible removed by 
brief irradiation with a high intensity laser, and the recovery of fluorescence in the bleached area is 
measured over time (Figure 8). This can be a single spot (spot-FRAP) or a complete strip spanning 
the entire nucleus of a cell (strip-FRAP) or any other region within a cell of interest (Soumpasis, 
1983; Farla et al., 2004; Hoogstraten et al., 2008; van Royen et al., 2009). Depending on the mobility 
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Figure 8. Examples of different FRAP applications that have been developed to study the dynamics of 
nuclear proteins. 
strip-FRAP. Especially useful when signals are relatively low due to low expression of the tagged protein. Here 
a strip spanning the entire nucleus is bleached and the fluorescence monitored at regular intervals in the 
bleached strip.
spot-FRAP. Straightforward FRAP experiment based on bleaching only a diffraction limited spot. As with strip-
FRAP the recovery of the fluorescence is monitored in the bleached region.
FLIP-FRAP. One half of the nucleus is bleached. Fluorescence is measured in both the bleached and the non-
bleached half. Due to the long redistribution time, shorter residence times can be distinguished from longer 
residence times.
FLIP. An area at a distance of nuclear accumulation is bleached. The velocity at which fluorescence is lost in the 
distant accumulation is a measure for the residence time at the accumulation. The point in time where a new 
steady state is reached being a good measure for residence time.
iFRAP. The complete nucleus is bleached, except for a small area around a nuclear accumulation. The loss of 
fluorescence in the accumulation immediately after bleaching, fully represents the releasing molecules, which 
is a direct measure for the rate of exchange between the accumulation and the rest of the nucleus.
Bleach
Time (s) Redistribution
strip-FRAP
spot-FRAP
FLIP-FRAP
FLIP
iFRAP
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of the tagged proteins several scenarios can then unfold. If proteins are fully mobile, proteins from 
outside the bleached area will immediately diffuse into the bleached region and will contribute 
to the recovery of the fluorescent signal (Figure 9a, green and yellow curves). This recovery will 
continue until a new equilibrium in fluorescent intensity has been established. If a fraction of the 
labelled proteins or all the labelled proteins are immobilized, then the labelled proteins will not 
move into the bleached area and no or an incomplete recovery of the fluorescent signal will occur 
(Figure 9a, red curve). Finally, transient binding and immobilization of proteins will give rise to a 
secondary recovery in the bleached region (Figure 9a, blue curve). This secondary recovery occurs 
due to the release of transiently immobilized labelled proteins during the FRAP experiment. When 
the volume of the bleached area is relatively large compared to the volume to which labelled 
proteins are confined, the final recovery of the fluorescence will not be to the pre-bleach level.
FRAP variants
Other variants of the FRAP technique are available to investigate specific research questions. 
Another technique to study transient or long term immobilisation is the Fluorescence Loss In 
Photobleaching (FLIP)-FRAP method (Farla et al., 2004) (Figure 8 and Figure 9B and 9C). In a FLIP-
FRAP experiment a region distant from the bleach region is monitored simultaneously with the 
FRAP region. In most experiments a strip at either pole of the nucleus is used for this. The region 
distant from the bleach region is regarded as the FLIP region. By subtracting the FRAP results from 
the FLIP results a FLIP-FRAP curve can be obtained which is a measure for the transient and long 
term immobile fractions.
 
FLIP can also be used as a stand-alone method: it can be used to study accumulations or 
fluorescence in small compartments, for instance DNA repair foci or protein binding to telomeres 
(Essers et al., 2002; Mattern et al., 2004) (Figure 8). An area at a distance of the accumulation is 
bleached. If there is no drop in fluorescence in the accumulation this means that the bleached 
molecules do not exchange with the molecules in the accumulation and are permanently 
immobilized. However, if the fluorescence in the accumulation does decrease the molecules are 
transiently immobilized. By measuring the velocity at which the fluorescence is lost and a new 
steady stated is reached, the residence time of the molecules can be determined.
 
The rate of exchange between a compartment or an accumulation can also be determined by 
using the inverse FRAP (iFRAP) method (Figure 8). The method was introduced to measure the 
rate at which molecules in the nucleolus exchange with the surrounding nucleoplasm (Dundr 
et al., 2002). In a typical iFRAP experiment the complete volume of the nucleus is bleached with 
exception of the accumulation or compartment of interest. The observed loss of fluorescence 
in the accumulation largely represents the release of labelled proteins. This gives the technique 
a distinct advantage over the FLIP technique since with iFRAP there hardly is any turnover of 
fluorescent proteins in the accumulation with non-bleached proteins from the nucleoplasm. As 
a result no further complicated analytical methods have to be used to determine the rate of 
exchange (Koff).
FRAP curve normalisation
For interpretation and representation of the gathered data several methods of normalisation can 
be applied. The most straight forward way is to express the data relative to the pre-bleach value: 
Inorm,t = (It–Ibackground)/(Ipre-bleach–Ibackground),where Ipre-bleach is the measurement, or preferably the average 
of a number of measurements before the bleach and Ibackground is the signal level where 
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Figure 9. Schematic representation of FRAP curves resulting from different scenarios. (A) spot and strip-
FRAP. The curves represent different possible curves resulting from a typical spot- or strip-FRAP experiment 
(See figure 8). All curves are expressed relative to pre-bleach values. Freely diffusing GFP-tagged molecules 
can recover completely, but the final fluorescence level will be lower, especially in the case of a strip-FRAP 
experiment, since a substantial portion of the molecules are bleached (typically 10-20% in an average strip-
FRAP experiment. Fast diffusing tagged molecules (green curve) will lead to faster fluorescence recovery faster 
than slow diffusing tagged molecules (yellow curve). Molecules which are transiently immobilised (blue curve), 
for instance by brief interactions with chromatin can be identified by the secondary recovery visible in the curve. 
Long term immobilised tagged molecules show incomplete fluorescence recovery (red curve) compared to the 
free diffusing molecules. The difference between these curves is a measure for the immobile fraction, but the 
percentage of bleached molecules should be taken into consideration. (B) FLIP and FRAP. The curves represent 
different possible curves resulting from a typical half-FRAP (FLIP-FRAP) experiment before subtracting either 
curve from the other (See figure 8). Curves from fast diffusing tagged molecules (green solid and dotted curves) 
meet after a short period of time. Slower diffusing tagged molecules will take a longer time (yellow solid and 
dotted lines), but also here the fluorescent signal will recover in both halves of the bleached nucleus. If there 
is a fraction of the molecules immobilised (red solid and dotted curves), the fluorescence in both halves of the 
nucleus will not fully recover to the same level and the resulting curves will not meet. (C) FLIP-FRAP. When the 
resulting FRAP curves of a half-FRAP experiment are subtracted from the FLIP curves the time it takes for the 
system to equilibrate can be read directly, including the potential presence of an immobile fraction: the green 
and the yellow curves reach 0, where the red curve does not. The difference between the red curve and the 
x-axis is a measure for the bound fraction of tagged molecules. (D) iFRAP. This method has the advantage that 
the resulting curves only represent the turn over or off-rate (Koff) of the tagged molecules. Molecules with a large 
Koff (green curve) will dissociate faster leading to a fast decrease of fluorescence in the measured region. If the 
Koff is lower the time until all molecules have dissociated will take longer (yellow curve).
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no fluorescence is present. A second method of normalisation is an extension of the first option, 
here taking into account the fluorescence intensity directly after bleaching (I0). This value can be 
expressed by taking the intensity values relative to the intensity directly after bleaching, as well as 
to the pre-bleach intensity: (Inorm,t) = (It – I0)/(Ipre-bleach – I0). By doing so, the resulting curves enable 
a qualitative visual estimate of the size of any potentially present immobile fractions, minus the 
fraction removed by the bleach pulse. Lastly, the values can be normalized by expressing the 
intensities relative to the level after complete recovery (Ifinal) and the intensity directly after bleaching 
(I0): It, norm = (It – I0)/(Ifinal – I0). The resulting curve runs from 0 directly after bleaching to 1 after 
final recovery. This allows for a direct comparison of the diffusion rates without being hampered 
by the effects of potential immobile fractions. The resulting curves of this method can also be 
quantitatively analysed by fitting the data to mathematically derived equations representing the 
diffusion process and the transient immobilization.
 
FRAP curve analysis using Monte Carlo simulations
Analytical techniques developed for FRAP quantification are mostly based on mathematical 
analytical models of diffusion of the labelled molecules. These mathematical models are often highly 
simplified to be able to solve these differential equations describing the model. Photobleaching of 
the chromophore is often considered as an irreversible process, boundary effects are neglected, 
a reduced set of spatial dimensions is used, or the full point spread function of the focused laser 
beam is replaced by a geometrical approximation or even a cylinder. Though, there are several 
examples of methods which succeed to capture the essence of FRAP experiments (Axelrod et al., 
1976; Soumpasis, 1983; Blonk et al., 1993; Carrero et al., 2003). and improvements can be made 
by incorporating more of the now simplified parameters. Since this can lead to very complex 
and sometimes unsolvable mathematical problems another approach to analyse FRAP data can 
be applied: a computer model of the FRAP procedure and the behaviour of (labelled) molecules 
inside small volumes (Siggia et al., 2000) using a straightforward Monte Carlo method (Houtsmuller 
et al., 1999; Hoogstraten et al., 2002; Farla et al., 2004). These simulations have the advantage that 
they can incorporate experimentally obtained parameters. Next to that, properties describing the 
microscope optical path can be used. This includes, but is not limited to: the shape of the laser 
beam and the 3D intensity distribution during all the stages of the experiment, the size and shape of 
the cell nucleus, and the photochemical properties (bleaching and ‘blinking’ parameters, quantum 
yield) of the fluorescent label. Simulations can then be run with these fixed parameters in place. 
By varying the three protein mobility parameters (the diffusion coefficient, the duration of binding 
of individual molecules, and the immobile fractions) simulated FRAP curves can be generated and 
subsequently fitted to the original curves. This approach of Monte Carlo simulations provides a 
very comprehensible, flexible, and scalable tool to analyse FRAP experiments by fitting the in vivo 
obtained FRAP curves to their in silico simulated counterparts.
36
I
References
Abraham, R.T. 2004. PI 3-kinase related kinases: “big” players in 
stress-induced signaling pathways. DNA Repair (Amst). 
3:883–7. doi:10.1016/j.dnarep.2004.04.002.
Acharya, S., and T. Wilson. 1996. hMSH2 forms specific mispair-
binding complexes with hMSH3 and hMSH6. Proc. …. 
93:13629–13634.
Antoniou, A., P.D.P. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. 
Hopper, N. Loman, H. Olsson, O. Johannsson, A. Borg, B. 
Pasini, P. Radice, S. Manoukian, D.M. Eccles, N. Tang, E. 
Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. 
Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, 
K. Syrjäkoski, O.-P. Kallioniemi, D. Thompson, C. Evans, J. 
Peto, F. Lalloo, D.G. Evans, and D.F. Easton. 2003. Average 
risks of breast and ovarian cancer associated with BRCA1 
or BRCA2 mutations detected in case Series unselected 
for family history: a combined analysis of 22 studies. Am. J. 
Hum. Genet. 72:1117–30. doi:10.1086/375033.
Axelrod, D., D.E. Koppel, J. Schlessinger, E. Elson, and W.W. Webb. 
1976. Mobility measurement by analysis of fluorescence 
photobleaching recovery kinetics. Biophys. J. 16:1055–69. 
doi:10.1016/S0006-3495(76)85755-4.
Baird, G.S., D. a Zacharias, and R.Y. Tsien. 2000. Biochemistry, 
mutagenesis, and oligomerization of DsRed, a red 
fluorescent protein from coral. Proc. Natl. Acad. Sci. U. S. 
A. 97:11984–9. doi:10.1073/pnas.97.22.11984.
Bergink, S., and S. Jentsch. 2009. Principles of ubiquitin and 
SUMO modifications in DNA repair. Nature. 458:461–7. 
doi:10.1038/nature07963.
Bergink, S., W. Toussaint, M.S. Luijsterburg, C. Dinant, S. Alekseev, 
J.H.J. Hoeijmakers, N.P. Dantuma, A.B. Houtsmuller, and 
W. Vermeulen. 2012. Recognition of DNA damage by XPC 
coincides with disruption of the XPC-RAD23 complex. J. 
Cell Biol. 196:681–8. doi:10.1083/jcb.201107050.
Berndsen, C.E., and C. Wolberger. 2014. New insights into ubiquitin 
E3 ligase mechanism. Nat. Struct. Mol. Biol. 21:301–7. 
doi:10.1038/nsmb.2780.
Betzig, E., G.H. Patterson, R. Sougrat, O.W. Lindwasser, S. Olenych, 
J.S. Bonifacino, M.W. Davidson, J. Lippincott-Schwartz, 
and H.F. Hess. 2006. Imaging intracellular fluorescent 
proteins at nanometer resolution. Science. 313:1642–5. 
doi:10.1126/science.1127344.
Blonk, J., A. Don, H. Aalst, and J. Birmingham. 1993. Fluorescence 
photobleaching recovery in the confocal scanning 
light microscope. J. Microsc. 169:363–374. 
doi:10.1111/j.1365-2818.1993.tb03312.x.
De Boer, J., J.O. Andressoo, J. de Wit, J. Huijmans, R.B. Beems, H. van 
Steeg, G. Weeda, G.T.J. van der Horst, W. van Leeuwen, 
A.P.N. Themmen, M. Meradji, and J.H.J. Hoeijmakers. 
2002. Premature aging in mice deficient in DNA repair 
and transcription. Science. 296:1276–9. doi:10.1126/
science.1070174.
Bostelman, L.J., A.M. Keller, A.M. Albrecht, A. Arat, and J.S. 
Thompson. 2007. Methylation of histone H3 lysine-79 by 
Dot1p plays multiple roles in the response to UV damage 
in Saccharomyces cerevisiae. DNA Repair (Amst). 6:383–
95. doi:10.1016/j.dnarep.2006.12.010.
Brakenhoff, G.J., H.T. van der Voort, E. a van Spronsen, W. a 
Linnemans, and N. Nanninga. 1985. Three-dimensional 
chromatin distribution in neuroblastoma nuclei shown 
by confocal scanning laser microscopy. Nature. 317:748–
749. doi:10.1038/317748a0.
Brandman, O., J.E. Ferrell, R. Li, and T. Meyer. 2005. Interlinked 
fast and slow positive feedback loops drive reliable 
cell decisions. Science. 310:496–8. doi:10.1126/
science.1113834.
Bürkle, A., and L. Virág. 2013. Poly(ADP-ribose): PARadigms and 
PARadoxes. Mol. Aspects Med. 34:1046–65. doi:10.1016/j.
mam.2012.12.010.
Cadet, J., E. Sage, and T. Douki. 2005. Ultraviolet radiation-
mediated damage to cellular DNA. Mutat. Res. 571:3–17. 
doi:10.1016/j.mrfmmm.2004.09.012.
Carrero, G., D. McDonald, E. Crawford, G. de Vries, and M.J. 
Hendzel. 2003. Using FRAP and mathematical modeling 
to determine the in vivo kinetics of nuclear proteins. 
Methods. 29:14–28. doi:10.1016/S1046-2023(02)00288-
8.
Chambon, P., J. Weill, and P. Mandel. 1963. Nicotinamide 
mononucleotide activation of a new DNA-dependent 
polyadenylic acid synthesizing nuclear enzyme. Biochem. 
Biophys. Res. …. 11:39–43.
Chan, D.W., and S.P. Lees-Miller. 1996. The DNA-dependent protein 
kinase is inactivated by autophosphorylation of the 
catalytic subunit. J. Biol. Chem. 271:8936–41. doi:10.1074/
jbc.271.15.8936.
Chau, V., J.W. Tobias, A. Bachmair, D. Marriott, D.J. Ecker, D.K. 
Gonda, A. Varshavsky, and D.J. Eckert. 2014. Multiubiquitin 
in a Targeted Lysine Specific to Is Confined Short-Lived 
Protein. 243:1576–1583.
Chu, G., and W. Yang. 2008. Here comes the sun: recognition 
of UV-damaged DNA. Cell. 135:1172–4. doi:10.1016/j.
cell.2008.12.015.
Ciccia, A., N. McDonald, and S.C. West. 2008. Structural and 
functional relationships of the XPF/MUS81 family of 
proteins. Annu. Rev. Biochem. 77:259–87. doi:10.1146/
annurev.biochem.77.070306.102408.
Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic 
pathway. Cell. 79:13–21.
Ciechanover, A., and R. Ben-Saadon. 2004. N-terminal 
ubiquitination: more protein substrates join in. Trends 
Cell Biol. 14:103–6.
Clague, M.J., J.M. Coulson, and S. Urbé. 2012. Cellular functions of 
the DUBs. J. Cell Sci. 125:277–86. doi:10.1242/jcs.090985.
Clauson, C., O.D. Schärer, and L. Niedernhofer. 2013. Advances 
in understanding the complex mechanisms of DNA 
interstrand cross-link repair. Cold Spring Harb. Perspect. 
Biol. 5:a012732. doi:10.1101/cshperspect.a012732.
Coin, F., J.C. Marinoni, C. Rodolfo, S. Fribourg, a M. Pedrini, and J.M. 
Egly. 1998. Mutations in the XPD helicase gene result in 
XP and TTD phenotypes, preventing interaction between 
XPD and the p44 subunit of TFIIH. Nat. Genet. 20:184–8. 
doi:10.1038/2491.
Cole, A.R., L.P.C. Lewis, and H. Walden. 2010. The structure of 
the catalytic subunit FANCL of the Fanconi anemia core 
complex. Nat. Struct. Mol. Biol. 17:294–8. doi:10.1038/
nsmb.1759.
Cox, I.J., and C.J. Sheppard. 1983. Scanning optical microscope 
incorporating a digital framestore and microcomputer. 
Appl. Opt. 22:1474. doi:10.1364/AO.22.001474.
Davidovits, P., and M.D. Egger. 1969. Scanning laser microscope. 
Nature. 223:831.
Davidovits, P., and M.D. Egger. 1971. Scanning laser microscope for 
biological investigations. Appl. Opt. 10:1615–9.
Deans, A.J., and S.C. West. 2011. DNA interstrand crosslink repair 
and cancer. Nat. Rev. Cancer. 11:467–80. doi:10.1038/
nrc3088.
Demple, B., and J.-S. Sung. 2005. Molecular and biological 
roles of Ape1 protein in mammalian base excision 
repair. DNA Repair (Amst). 4:1442–9. doi:10.1016/j.
dnarep.2005.09.004.
37
General introduction
I
Deshaies, R.J., and C. a P. Joazeiro. 2009. RING domain E3 ubiquitin 
ligases. Annu. Rev. Biochem. 78:399–434. doi:10.1146/
annurev.biochem.78.101807.093809.
Dianov, G.L., and U. Hübscher. 2013. Mammalian base excision 
repair: the forgotten archangel. Nucleic Acids Res. 
41:3483–90. doi:10.1093/nar/gkt076.
DiGiovanna, J.J., and K.H. Kraemer. 2012. Shining a light on 
xeroderma pigmentosum. J. Invest. Dermatol. 132:785–
96. doi:10.1038/jid.2011.426.
Drake, J.W. 1991. Spontaneous mutation. Annu. Rev. Genet. 
25:125–46. doi:10.1146/annurev.ge.25.120191.001013.
Dundr, M., U. Hoffmann-Rohrer, Q. Hu, I. Grummt, L.I. Rothblum, 
R.D. Phair, and T. Misteli. 2002. A kinetic framework for a 
mammalian RNA polymerase in vivo. Science. 298:1623–6. 
doi:10.1126/science.1076164.
Engelward, B.P., G. Weeda, M.D. Wyatt, J.L. Broekhof, J. de Wit, I. 
Donker, J.M. Allan, B. Gold, J.H. Hoeijmakers, and L.D. 
Samson. 1997. Base excision repair deficient mice lacking 
the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. 
Sci. U. S. A. 94:13087–92.
Essers, J., A. Houtsmuller, L. van Veelen, C. Paulusma, A.L. Nigg, A. 
Pastink, W. Vermeulen, J.H.J. Hoeijmakers, and R. Kanaar. 
2002. Nuclear dynamics of RAD52 group homologous 
recombination proteins in response to DNA damage. 
EMBO J. 21:2030–2037.
Falck, J., J. Coates, and S.P. Jackson. 2005. Conserved modes of 
recruitment of ATM, ATR and DNA-PKcs to sites of DNA 
damage. Nature. 434:605–11. doi:10.1038/nature03442.
Farla, P., R. Hersmus, B. Geverts, P.O. Mari, A.L. Nigg, H.J. Dubbink, 
J. Trapman, and A.B. Houtsmuller. 2004. The androgen 
receptor ligand-binding domain stabilizes DNA binding 
in living cells. J. Struct. Biol. 147:50–61. doi:10.1016/j.
jsb.2004.01.002.
Finkel, T. 2011. Signal transduction by reactive oxygen species. J. 
Cell Biol. 194:7–15. doi:10.1083/jcb.201102095.
Fishel, R., M.K. Lescoe, M.R. Rao, N.G. Copeland, N.A. Jenkins, J. 
Garber, M. Kane, and R. Kolodner. 1993. The human 
mutator gene homolog MSH2 and its association with 
hereditary nonpolyposis colon cancer. Cell. 75:1027–38.
Fitch, M.E., I. V. Cross, S.J. Turner, S. Adimoolam, C.X. Lin, K.G. 
Williams, and J.M. Ford. 2003. The DDB2 nucleotide 
excision repair gene product p48 enhances global 
genomic repair in p53 deficient human fibroblasts. 
DNA Repair (Amst). 2:819–826. doi:10.1016/S1568-
7864(03)00066-1.
Foiani, M., A. Pellicioli, M. Lopes, C. Lucca, M. Ferrari, G. Liberi, M.M. 
Falconi, and P. Plevani. 2000. DNA damage checkpoints 
and DNA replication controls in Saccharomyces cere Õ 
isiae.
Fousteri, M., W. Vermeulen, A. a van Zeeland, and L.H.F. Mullenders. 
2006. Cockayne syndrome A and B proteins differentially 
regulate recruitment of chromatin remodeling and repair 
factors to stalled RNA polymerase II in vivo. Mol. Cell. 
23:471–82. doi:10.1016/j.molcel.2006.06.029.
Fulford, J., H. Nikjoo, D.T. Goodhead, and P. O’Neill. 2001. Yields 
of SSB and DSB induced in DNA by Al(K) ultrasoft 
X-rays and alpha-particles: comparison of experimental 
and simulated yields. Int. J. Radiat. Biol. 77:1053–66. 
doi:10.1080/09553000110069308.
Garner, E., and A. Smogorzewska. 2011. Ubiquitylation and the 
Fanconi anemia pathway. FEBS Lett. 585:2853–60. 
doi:10.1016/j.febslet.2011.04.078.
Van Gent, D.C., J.H. Hoeijmakers, and R. Kanaar. 2001. Chromosomal 
stability and the DNA double-stranded break connection. 
Nat. Rev. Genet. 2:196–206. doi:10.1038/35056049.
Giannattasio, M., F. Lazzaro, P. Plevani, and M. Muzi-Falconi. 2005. 
The DNA damage checkpoint response requires histone 
H2B ubiquitination by Rad6-Bre1 and H3 methylation 
by Dot1. J. Biol. Chem. 280:9879–86. doi:10.1074/jbc.
M414453200.
Giglia-Mari, G., F. Coin, J. a Ranish, D. Hoogstraten, A. Theil, N. 
Wijgers, N.G.J. Jaspers, A. Raams, M. Argentini, P.J. van 
der Spek, E. Botta, M. Stefanini, J.-M. Egly, R. Aebersold, 
J.H.J. Hoeijmakers, and W. Vermeulen. 2004. A new, 
tenth subunit of TFIIH is responsible for the DNA repair 
syndrome trichothiodystrophy group A. Nat. Genet. 
36:714–9. doi:10.1038/ng1387.
Gillet, L.C.J., and O.D. Schärer. 2006. Molecular mechanisms of 
mammalian global genome nucleotide excision repair. 
Chem. Rev. 106:253–76. doi:10.1021/cr040483f.
Gottlieb, T., and S. Jackson. 1993. The DNA-dependent protein 
kinase: requirement for DNA ends and association 
with Ku antigen. Cell. 72:131–42. doi:10.1016/0092-
8674(93)90057-W.
Gourdin, A.M., L. van Cuijk, M. Tresini, M.S. Luijsterburg, A.L. Nigg, 
G. Giglia-Mari, A.B. Houtsmuller, W. Vermeulen, and J. a 
Marteijn. 2014. Differential binding kinetics of replication 
protein A during replication and the pre- and post-incision 
steps of nucleotide excision repair. DNA Repair (Amst). 
24C:46–56. doi:10.1016/j.dnarep.2014.09.013.
Grabbe, C., and I. Dikic. 2009. Functional roles of ubiquitin-
like domain (ULD) and ubiquitin-binding domain 
(UBD) containing proteins. Chem. Rev. 109:1481–94. 
doi:10.1021/cr800413p.
Grawunder, U., M. Wilm, X. Wu, and P. Kulesza. 1997. Activity of 
DNA ligase IV stimulated by complex formation with 
XRCC4 protein in mammalian cells. Nature. 388:492–5. 
doi:10.1038/41358.
Groisman, R., J. Polanowska, I. Kuraoka, J. Sawada, M. Saijo, R. 
Drapkin, A.F. Kisselev, K. Tanaka, and Y. Nakatani. 2003. The 
ubiquitin ligase activity in the DDB2 and CSA complexes 
is differentially regulated by the COP9 signalosome in 
response to DNA damage. Cell. 113:357–67.
Hanasoge, S., and M. Ljungman. 2007. H2AX phosphorylation after 
UV irradiation is triggered by DNA repair intermediates 
and is mediated by the ATR kinase. Carcinogenesis. 
28:2298–304. doi:10.1093/carcin/bgm157.
Hanawalt, P.C. 2002. Subpathways of nucleotide excision repair 
and their regulation. Oncogene. 21:8949–56. doi:10.1038/
sj.onc.1206096.
Hanawalt, P.C., and G. Spivak. 2008. Transcription-coupled DNA 
repair: two decades of progress and surprises. Nat. Rev. 
Mol. Cell Biol. 9:958–70. doi:10.1038/nrm2549.
Hang, B., B. Singer, G.P. Margison, and R.H. Elder. 1997. 
Targeted deletion of alkylpurine-DNA-N-glycosylase 
in mice eliminates repair of 1,N6-ethenoadenine 
and hypoxanthine but not of 3,N4-ethenocytosine or 
8-oxoguanine. Proc. Natl. Acad. Sci. U. S. A. 94:12869–74.
Hegde, M.L., T.K. Hazra, and S. Mitra. 2008. Early steps in the DNA 
base excision/single-strand interruption repair pathway 
in mammalian cells. Cell Res. 18:27–47. doi:10.1038/
cr.2008.8.
Heim, R., D.C. Prasher, and R.Y. Tsien. 1994. Wavelength mutations 
and posttranslational autoxidation of green fluorescent 
protein. Proc. Natl. Acad. Sci. U. S. A. 91:12501–4.
Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. 
Annu. Rev. Biochem. 67:425–79. doi:10.1146/annurev.
biochem.67.1.425.
Hicke, L. 1999. Gettin’ down with ubiquitin: turning off cell-surface 
receptors, transporters and channels. Trends Cell Biol. 
9:107–12.
38
I
Hoogstraten, D., S. Bergink, J.M.Y. Ng, V.H.M. Verbiest, M.S. 
Luijsterburg, B. Geverts, A. Raams, C. Dinant, J.H.J. 
Hoeijmakers, W. Vermeulen, and A.B. Houtsmuller. 
2008. Versatile DNA damage detection by the global 
genome nucleotide excision repair protein XPC. J. Cell Sci. 
121:2850–9. doi:10.1242/jcs.031708.
Hoogstraten, D., A.L. Nigg, H. Heath, L.H.F. Mullenders, R. van Driel, 
J.H.J. Hoeijmakers, W. Vermeulen, and A.B. Houtsmuller. 
2002. Rapid switching of TFIIH between RNA polymerase 
I and II transcription and DNA repair in vivo. Mol. Cell. 
10:1163–74.
Houtsmuller, A.B., S. Rademakers, A. Nigg, D. Hoogstraten, J.H. 
Hoeijmakers, and W. Vermeulen. 1999. Action of DNA 
repair endonuclease ERCC1/XPF in living cells. Science. 
284:958–61.
Huang, N., N.K. Banavali, and A.D. MacKerell. 2003. Protein-
facilitated base flipping in DNA by cytosine-5-
methyltransferase. Proc. Natl. Acad. Sci. U. S. A. 100:68–
73. doi:10.1073/pnas.0135427100.
Inagaki, A., S. Schoenmakers, and W.M. Baarends. 2010. and 
transcriptional silencing in meiosis. 255–266.
Iyama, T., and D.M. Wilson. 2013. DNA repair mechanisms in 
dividing and non-dividing cells. DNA Repair (Amst). 
12:620–36. doi:10.1016/j.dnarep.2013.04.015.
Iyer, R.R., A. Pluciennik, V. Burdett, and P.L. Modrich. 2006. DNA 
mismatch repair: functions and mechanisms. Chem. Rev. 
106:302–23. doi:10.1021/cr0404794.
Jackson, S.P., and J. Bartek. 2009. The DNA-damage response 
in human biology and disease. Nature. 461:1071–8. 
doi:10.1038/nature08467.
De Jager, M., J. van Noort, D.C. van Gent, C. Dekker, R. Kanaar, 
and C. Wyman. 2001. Human Rad50/Mre11 is a flexible 
complex that can tether DNA ends. Mol. Cell. 8:1129–35. 
doi:10.1016/S1097-2765(01)00381-1.
Jin, J., X. Li, S.P. Gygi, and J.W. Harper. 2007. Dual E1 activation 
systems for ubiquitin differentially regulate E2 enzyme 
charging. Nature. 447:1135–8. doi:10.1038/nature05902.
Kamitani, T., K. Kito, H.P. Nguyen, and E.T.H. Yeh. 1997. 
Characterization of NEDD8, a Developmentally Down-
regulated Ubiquitin-like Protein. J. Biol. Chem. 272:28557–
28562. doi:10.1074/jbc.272.45.28557.
Kanaar, R., J.H. Hoeijmakers, and D.C. van Gent. 1998. Molecular 
mechanisms of DNA double strand break repair. Trends 
Cell Biol. 8:483–9.
Kee, Y., and A.D. D’Andrea. 2012. Molecular pathogenesis and 
clinical management of Fanconi anemia. J. Clin. Invest. 
122:3799–806. doi:10.1172/JCI58321.
Kholodenko, B. 2006. Cell-signalling dynamics in time and space. 
Nat. Rev. Mol. cell Biol. 7:165–176.
Kim, H., and A.D. D’Andrea. 2012. Regulation of DNA cross-link 
repair by the Fanconi anemia/BRCA pathway. Genes Dev. 
26:1393–408. doi:10.1101/gad.195248.112.
Kim, H.C., and J.M. Huibregtse. 2009. Polyubiquitination by HECT 
E3s and the determinants of chain type specificity. Mol. 
Cell. Biol. 29:3307–18. doi:10.1128/MCB.00240-09.
Kim, J., and B. Choi. 1995. The Solution Structure of DNA 
Duplex-Decamer Containing the (6-4) Photoproduct of 
Thymidylyl(3′[to]5′)Thymidine by NMR and Relaxation 
Matrix Refinement. Eur. J. Biochem. 228:849–854.
Kim, Y.-J., and D.M. Wilson. 2012. Overview of base excision repair 
biochemistry. Curr. Mol. Pharmacol. 5:3–13.
Kisby, G.E., J. Milne, and C. Sweatt. 1997. Evidence of reduced 
DNA repair in amyotrophic lateral sclerosis brain tissue. 
Neuroreport. 8:1337–40. doi:10.1097/00001756-
199704140-00004.
Klungland, a., I. Rosewell, S. Hollenbach, E. Larsen, G. Daly, B. Epe, E. 
Seeberg, T. Lindahl, and D.E. Barnes. 1999. Accumulation 
of premutagenic DNA lesions in mice defective in removal 
of oxidative base damage. Proc. Natl. Acad. Sci. U. S. A. 
96:13300–5. doi:10.1073/pnas.96.23.13300.
Komander, D., M.J. Clague, and S. Urbé. 2009. Breaking the chains: 
structure and function of the deubiquitinases. Nat. Rev. 
Mol. Cell Biol. 10:550–63. doi:10.1038/nrm2731.
Komander, D., and M. Rape. 2012. The ubiquitin code. Annu. 
Rev. Biochem. 81:203–29. doi:10.1146/annurev-
biochem-060310-170328.
Koppel, D.E., D. Axelrod, J. Schlessinger, E.L. Elson, and W.W. Webb. 
1976. Dynamics of fluorescence marker concentration as 
a probe of mobility. Biophys. J. 16:1315–29. doi:10.1016/
S0006-3495(76)85776-1.
Koundrioukoff, S., S. Polo, and G. Almouzni. 2004. Interplay 
between chromatin and cell cycle checkpoints in the 
context of ATR/ATM-dependent checkpoints. DNA Repair 
(Amst). 3:969–78. doi:10.1016/j.dnarep.2004.03.010.
Kulathu, Y., and D. Komander. 2012. Atypical ubiquitylation - the 
unexplored world of polyubiquitin beyond Lys48 and 
Lys63 linkages. Nat. Rev. Mol. Cell Biol. 13:508–23. 
doi:10.1038/nrm3394.
Kuo, M.H., and C.D. Allis. 1998. Roles of histone acetyltransferases 
and deacetylases in gene regulation. Bioessays. 20:615–
26. doi:10.1002/(SICI)1521-1878(199808)20:8<615::AID-
BIES4>3.0.CO;2-H.
De Laat, W.L., E. Appeldoorn, K. Sugasawa, E. Weterings, N.G. 
Jaspers, and J.H. Hoeijmakers. 1998. DNA-binding polarity 
of human replication protein A positions nucleases in 
nucleotide excision repair. Genes Dev. 12:2598–609.
Lavin, M.F. 2008. Ataxia-telangiectasia: from a rare disorder to a 
paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell 
Biol. 9:759–69. doi:10.1038/nrm2514.
Lee, S., J. Moore, A. Holmes, and K. Umezu. 1998. Saccharomyces 
Ku70, Mre11/Rad50, and RPA Proteins Regulate 
Adaptation to G2/M Arrest after DNA Damage. Cell. 
94:399–409. doi:10.1016/S0092-8674(00)81482-8.
Li, W., M.H. Bengtson, A. Ulbrich, A. Matsuda, V. a Reddy, A. Orth, 
S.K. Chanda, S. Batalov, and C. a P. Joazeiro. 2008. 
Genome-wide and functional annotation of human E3 
ubiquitin ligases identifies MULAN, a mitochondrial E3 
that regulates the organelle’s dynamics and signaling. 
PLoS One. 3:e1487. doi:10.1371/journal.pone.0001487.
Li, W., and Y. Ye. 2008. Polyubiquitin chains: functions, structures, 
and mechanisms. Cell. Mol. Life Sci. 65:2397–406. 
doi:10.1007/s00018-008-8090-6.
Lippincott-Schwartz, J., and G.H. Patterson. 2003. Development 
and use of fluorescent protein markers in living cells. 
Science. 300:87–91. doi:10.1126/science.1082520.
Lisby, M., and R. Rothstein. 2009. Choreography of recombination 
proteins during the DNA damage response. DNA Repair 
(Amst). 8:1068–76. doi:10.1016/j.dnarep.2009.04.007.
Ljungman, M., and F. Zhang. 1996. Blockage of RNA polymerase 
as a possible trigger for u.v. light-induced apoptosis. 
Oncogene. 13:823–31.
Ljungman, M., F. Zhang, F. Chen, a J. Rainbow, and B.C. McKay. 
1999. Inhibition of RNA polymerase II as a trigger for 
the p53 response. Oncogene. 18:583–92. doi:10.1038/
sj.onc.1202356.
39
General introduction
I
Luijsterburg, M.S., M. Lindh, K. Acs, M.G. Vrouwe, A. Pines, H. van 
Attikum, L.H. Mullenders, and N.P. Dantuma. 2012. DDB2 
promotes chromatin decondensation at UV-induced 
DNA damage. J. Cell Biol. 197:267–81. doi:10.1083/
jcb.201106074.
Lukyanov, K., D. Chudakov, S. Lukyanov, and V. V Verkhusha. 2005. 
Photoactivatable fluorescent proteins. Nat. Rev. Mol. Cell 
Biol. 6:885–891.
Ma, Y., U. Pannicke, K. Schwarz, and M.R. Lieber. 2002. Hairpin 
opening and overhang processing by an Artemis/DNA-
dependent protein kinase complex in nonhomologous 
end joining and V(D)J recombination. Cell. 108:781–94. 
doi:10.1016/S0092-8674(02)00671-2.
Mahaney, B.L., K. Meek, and S.P. Lees-Miller. 2009. Repair of 
ionizing radiation-induced DNA double-strand breaks by 
non-homologous end-joining. Biochem. J. 417:639–50. 
doi:10.1042/BJ20080413.
Mari, P.-O., B.I. Florea, S.P. Persengiev, N.S. Verkaik, H.T. 
Brüggenwirth, M. Modesti, G. Giglia-Mari, K. Bezstarosti, 
J.A.A. Demmers, T.M. Luider, A.B. Houtsmuller, and 
D.C. van Gent. 2006. Dynamic assembly of end-joining 
complexes requires interaction between Ku70/80 and 
XRCC4. Proc. Natl. Acad. Sci. U. S. A. 103:18597–18602. 
doi:10.1073/pnas.0609061103.
Marini, F., T. Nardo, M. Giannattasio, M. Minuzzo, M. Stefanini, 
P. Plevani, and M. Muzi Falconi. 2006. DNA nucleotide 
excision repair-dependent signaling to checkpoint 
activation. Proc. Natl. Acad. Sci. U. S. A. 103:17325–30. 
doi:10.1073/pnas.0605446103.
Markson, G., C. Kiel, R. Hyde, S. Brown, P. Charalabous, A. Bremm, J. 
Semple, J. Woodsmith, S. Duley, K. Salehi-Ashtiani, M. Vidal, 
D. Komander, L. Serrano, P. Lehner, and C.M. Sanderson. 
2009. Analysis of the human E2 ubiquitin conjugating 
enzyme protein interaction network. Genome Res. 
19:1905–11. doi:10.1101/gr.093963.109.
Marteijn, J. a, S. Bekker-Jensen, N. Mailand, H. Lans, P. Schwertman, 
A.M. Gourdin, N.P. Dantuma, J. Lukas, and W. Vermeulen. 
2009. Nucleotide excision repair-induced H2A 
ubiquitination is dependent on MDC1 and RNF8 and 
reveals a universal DNA damage response. J. Cell Biol. 
186:835–47. doi:10.1083/jcb.200902150.
Masuda, H., Y. Takenaka, A. Yamaguchi, S. Nishikawa, and H. 
Mizuno. 2006. A novel yellowish-green fluorescent protein 
from the marine copepod, Chiridius poppei, and its use 
as a reporter protein in HeLa cells. Gene. 372:18–25. 
doi:10.1016/j.gene.2005.11.031.
Masutani, C., K. Sugasawa, J. Yanagisawa, T. Sonoyama, M. Ui, T. 
Enomoto, K. Takio, K. Tanaka, P.J. van der Spek, and D. 
Bootsma. 1994. Purification and cloning of a nucleotide 
excision repair complex involving the xeroderma 
pigmentosum group C protein and a human homologue 
of yeast RAD23. EMBO J. 13:1831–43.
Mattern, K.A., S.J.J. Swiggers, A.L. Nigg, B. Löwenbreg, A.B. 
Houtsmuller, and J. Zijlmans. 2004. Dynamics of Protein 
Binding to Telomeres in Living Cells : Implications for 
Telomere Structure and Function Dynamics of Protein 
Binding to Telomeres in Living Cells : Implications for 
Telomere Structure and Function. Mol. Cell. Biol. 24:5589–
5594. doi:10.1128/MCB.24.12.5587.
Matunis, M.J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-
like modification modulates the partitioning of the Ran-
GTPase-activating protein RanGAP1 between the cytosol 
and the nuclear pore complex. J. Cell Biol. 135:1457–70.
Matz, M. V, a F. Fradkov, Y. a Labas, a P. Savitsky, a G. Zaraisky, 
M.L. Markelov, and S. a Lukyanov. 1999. Fluorescent 
proteins from nonbioluminescent Anthozoa species. Nat. 
Biotechnol. 17:969–73. doi:10.1038/13657.
Maynard, S., S.H. Schurman, C. Harboe, N.C. de Souza-Pinto, 
and V. a Bohr. 2009. Base excision repair of oxidative 
DNA damage and association with cancer and aging. 
Carcinogenesis. 30:2–10. doi:10.1093/carcin/bgn250.
Mckay, B.C., M. Ljungman, and A.J. Rainbow. 1998. Persistent DNA 
damage induced by ultraviolet light inhibits p21 waf1 
and bax expression : implications for DNA repair , UV 
sensitivity and the induction of apoptosis.
McNally, J.G., W.G. Müller, D. Walker, R. Wolford, and G.L. Hager. 
2000. The Glucocorticoid Receptor: Rapid Exchange with 
Regulatory Sites in Living Cells. Science (80-. ). 287:1262–
1265. doi:10.1126/science.287.5456.1262.
Michelle, C., P. Vourc’h, L. Mignon, and C.R. Andres. 2009. What 
was the set of ubiquitin and ubiquitin-like conjugating 
enzymes in the eukaryote common ancestor? J. Mol. Evol. 
68:616–28. doi:10.1007/s00239-009-9225-6.
Min, J.-H., and N.P. Pavletich. 2007. Recognition of DNA damage 
by the Rad4 nucleotide excision repair protein. Nature. 
449:570–5. doi:10.1038/nature06155.
Mochizuki, N., S. Yamashita, K. Kurokawa, Y. Ohba, T. Nagai, A. 
Miyawaki, and M. Matsuda. 2001. Spatio-temporal images 
of growth-factor-induced activation of Ras and Rap1. 
Nature. 411:1065–1068.
Modrich, P. 2006. Mechanisms in eukaryotic mismatch repair. J. 
Biol. Chem. 281:30305–9. doi:10.1074/jbc.R600022200.
Moser, J., H. Kool, I. Giakzidis, K. Caldecott, L.H.F. Mullenders, and 
M.I. Fousteri. 2007. Sealing of chromosomal DNA nicks 
during nucleotide excision repair requires XRCC1 and 
DNA ligase III alpha in a cell-cycle-specific manner. Mol. 
Cell. 27:311–23. doi:10.1016/j.molcel.2007.06.014.
Moser, J., M. Volker, H. Kool, S. Alekseev, H. Vrieling, A. Yasui, A. a van 
Zeeland, and L.H.F. Mullenders. 2005. The UV-damaged 
DNA binding protein mediates efficient targeting of the 
nucleotide excision repair complex to UV-induced photo 
lesions. DNA Repair (Amst). 4:571–82. doi:10.1016/j.
dnarep.2005.01.001.
Muniandy, P.A., J. Liu, A. Majumdar, S. Liu, and M.M. Seidman. 
2010. DNA interstrand crosslink repair in mammalian 
cells: step by step. Crit. Rev. Biochem. Mol. Biol. 45:23–49. 
doi:10.3109/10409230903501819.
Nakasone, M.A., N. Livnat-Levanon, M.H. Glickman, R.E. Cohen, and 
D. Fushman. 2013. Mixed-linkage ubiquitin chains send 
mixed messages. Structure. 21:727–40. doi:10.1016/j.
str.2013.02.019.
Nance, M. a, and S. a Berry. 1992. Cockayne syndrome: review 
of 140 cases. Am. J. Med. Genet. 42:68–84. doi:10.1002/
ajmg.1320420115.
Ng, J.M.Y., W. Vermeulen, G.T.J. van der Horst, S. Bergink, K. 
Sugasawa, H. Vrieling, and J.H.J. Hoeijmakers. 2003. A novel 
regulation mechanism of DNA repair by damage-induced 
and RAD23-dependent stabilization of xeroderma 
pigmentosum group C protein. Genes Dev. 17:1630–45. 
doi:10.1101/gad.260003.
Niedernhofer, L.J., V. a Bohr, M. Sander, and K.H. Kraemer. 
2011. Xeroderma pigmentosum and other diseases of 
human premature aging and DNA repair: molecules to 
patients. Mech. Ageing Dev. 132:340–7. doi:10.1016/j.
mad.2011.06.004.
Niedernhofer, L.J., G. a Garinis, A. Raams, A.S. Lalai, A.R. Robinson, 
E. Appeldoorn, H. Odijk, R. Oostendorp, A. Ahmad, W. van 
Leeuwen, A.F. Theil, W. Vermeulen, G.T.J. van der Horst, 
P. Meinecke, W.J. Kleijer, J. Vijg, N.G.J. Jaspers, and J.H.J. 
Hoeijmakers. 2006. A new progeroid syndrome reveals 
that genotoxic stress suppresses the somatotroph axis. 
Nature. 444:1038–43. doi:10.1038/nature05456.
Nijman, S.M.B., T.T. Huang, A.M.G. Dirac, T.R. Brummelkamp, R.M. 
Kerkhoven, A.D. D’Andrea, and R. Bernards. 2005a. The 
deubiquitinating enzyme USP1 regulates the Fanconi 
anemia pathway. Mol. Cell. 17:331–9. doi:10.1016/j.
molcel.2005.01.008.
40
I
Nijman, S.M.B., M.P. a Luna-Vargas, A. Velds, T.R. Brummelkamp, 
A.M.G. Dirac, T.K. Sixma, and R. Bernards. 2005b. A genomic 
and functional inventory of deubiquitinating enzymes. 
Cell. 123:773–86. doi:10.1016/j.cell.2005.11.007.
Nishi, R., Y. Okuda, E. Watanabe, T. Mori, S. Iwai, C. Masutani, K. 
Sugasawa, and F. Hanaoka. 2005. Centrin 2 stimulates 
nucleotide excision repair by interacting with xeroderma 
pigmentosum group C protein. Mol. Cell. Biol. 25:5664–
74. doi:10.1128/MCB.25.13.5664-5674.2005.
Nishizuka, Y., K. Ueda, K. Nakazawa, and O. Hayaishi. 1967. Studies 
on the Polymer of Adenosine Diphosphate Ribose I. 
ENZYMIC FORMATION FROM NICOTINAMIDE ADENINE 
DINUCLEOTIDE IN MAMMALIAN NUCLEI. J. Biol. Chem. 
242:3164–3171.
Noll, D.M., T.M. Mason, and P.S. Miller. 2006. Formation and repair 
of interstrand cross-links in DNA. Chem. Rev. 106:277–
301. doi:10.1021/cr040478b.
O’Donovan, A., A. Davies, and J. Moggs. 1994. XPG endonuclease 
makes the 3′ incision in human DNA nucleotide excision 
repair. Zhurnal Eksp. i Teor. Fiz. 371:1994.
Ogi, T., S. Limsirichaikul, R.M. Overmeer, M. Volker, K. Takenaka, 
R. Cloney, Y. Nakazawa, A. Niimi, Y. Miki, N.G. Jaspers, 
L.H.F. Mullenders, S. Yamashita, M.I. Fousteri, and A.R. 
Lehmann. 2010. Three DNA polymerases, recruited by 
different mechanisms, carry out NER repair synthesis 
in human cells. Mol. Cell. 37:714–27. doi:10.1016/j.
molcel.2010.02.009.
Papadopoulos, N., N.C. Nicolaides, Y.F. Wei, S.M. Ruben, K.C. Carter, 
C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C.M. Fraser, 
and M.D. Adams. 1994. Mutation of a mutL homolog in 
hereditary colon cancer. Science. 263:1625–9.
Pelzer, C., I. Kassner, K. Matentzoglu, R.K. Singh, H.-P. Wollscheid, M. 
Scheffner, G. Schmidtke, and M. Groettrup. 2007. UBE1L2, 
a novel E1 enzyme specific for ubiquitin. J. Biol. Chem. 
282:23010–4. doi:10.1074/jbc.C700111200.
Peters, R., J. Peters, K.H. Tews, and W. Bähr. 1974. A microfluorimetric 
study of translational diffusion in erythrocyte membranes. 
Biochim. Biophys. Acta. 367:282–94.
Phair, R., and T. Misteli. 2000. High mobility of proteins in 
the mammalian cell nucleus. Nature. 404:604–9. 
doi:10.1038/35007077.
Pickart, C.M. 2001. Mechanisms underlying ubiquitination. 
Annu. Rev. Biochem. 70:503–33. doi:10.1146/annurev.
biochem.70.1.503.
Pines, A., L. Hameetman, J. de Wilde, S. Alekseev, F.R. de Gruijl, 
H. Vrieling, and L.H.F. Mullenders. 2010. Enhanced 
global genome nucleotide excision repair reduces 
UV carcinogenesis and nullifies strand bias in p53 
mutations in Csb-/- mice. J. Invest. Dermatol. 130:1746–9. 
doi:10.1038/jid.2010.18.
Pines, A., M.G. Vrouwe, J. a Marteijn, D. Typas, M.S. Luijsterburg, 
M. Cansoy, P. Hensbergen, A. Deelder, A. de Groot, S. 
Matsumoto, K. Sugasawa, N. Thoma, W. Vermeulen, 
H. Vrieling, and L. Mullenders. 2012. PARP1 promotes 
nucleotide excision repair through DDB2 stabilization and 
recruitment of ALC1. J. Cell Biol. 199:235–49. doi:10.1083/
jcb.201112132.
Pluciennik, A., L. Dzantiev, R.R. Iyer, N. Constantin, F.A. Kadyrov, 
and P. Modrich. 2010. PCNA function in the activation 
and strand direction of MutLα endonuclease in mismatch 
repair. Proc. Natl. Acad. Sci. U. S. A. 107:16066–71. 
doi:10.1073/pnas.1010662107.
Poulsen, S.L., R.K. Hansen, S. a Wagner, L. van Cuijk, G.J. van Belle, W. 
Streicher, M. Wikström, C. Choudhary, A.B. Houtsmuller, 
J. a Marteijn, S. Bekker-Jensen, and N. Mailand. 2013. 
RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that 
facilitates the DNA damage response. J. Cell Biol. 201:797–
807. doi:10.1083/jcb.201212075.
Prudden, J., S. Pebernard, G. Raffa, D. a Slavin, J.J.P. Perry, J. a Tainer, 
C.H. McGowan, and M.N. Boddy. 2007. SUMO-targeted 
ubiquitin ligases in genome stability. EMBO J. 26:4089–
101. doi:10.1038/sj.emboj.7601838.
Puszyński, K., B. Hat, and T. Lipniacki. 2008. Oscillations and 
bistability in the stochastic model of p53 regulation. J. 
Theor. Biol. 254:452–65. doi:10.1016/j.jtbi.2008.05.039.
Rademakers, S., M. Volker, D. Hoogstraten, A.L. Nigg, M.J. Moné, 
A.A. Van Zeeland, J.H.J. Hoeijmakers, A.B. Houtsmuller, and 
W. Vermeulen. 2003. Xeroderma pigmentosum group A 
protein loads as a separate factor onto DNA lesions. Mol. 
Cell. Biol. 23:5755–67. doi:10.1128/MCB.23.16.5755.
Ramanathan, B., and M.J. Smerdon. 1989. Enhanced DNA repair 
synthesis in hyperacetylated nucleosomes. J. Biol. Chem. 
264:11026–34.
Ranish, J.A., S. Hahn, Y. Lu, E.C. Yi, X. Li, J. Eng, and R. Aebersold. 
2004. Identification of TFB5, a new component of general 
transcription and DNA repair factor IIH. Nat. Genet. 
36:707–13. doi:10.1038/ng1385.
Ravanat, J.L., T. Douki, and J. Cadet. 2001. Direct and indirect 
effects of UV radiation on DNA and its components. J. 
Photochem. Photobiol. B. 63:88–102.
Remington, S.J. 2006. Fluorescent proteins: maturation, 
photochemistry and photophysics. Curr. Opin. Struct. Biol. 
16:714–21. doi:10.1016/j.sbi.2006.10.001.
Robertson, a B., a Klungland, T. Rognes, and I. Leiros. 2009. DNA 
repair in mammalian cells: Base excision repair: the long 
and short of it. Cell. Mol. Life Sci. 66:981–93. doi:10.1007/
s00018-009-8736-z.
Van Royen, M.E., P. Farla, K. a Mattern, B. Geverts, J. Trapman, 
and A.B. Houtsmuller. 2009. Fluorescence recovery 
after photobleaching (FRAP) to study nuclear protein 
dynamics in living cells. Methods Mol. Biol. 464:363–85. 
doi:10.1007/978-1-60327-461-6_20.
Ryan, D.P., T.S. Hong, and N. Bardeesy. 2014. Pancreatic 
adenocarcinoma. N. Engl. J. Med. 371:1039–49. 
doi:10.1056/NEJMra1404198.
Sancar, A. 1996. DNA excision repair. Annu. Rev. Biochem. 65:43–
81. doi:10.1146/annurev.bi.65.070196.000355.
Schaeffer, L., R. Roy, S. Humbert, V. Moncollin, W. Vermeulen, J.H. 
Hoeijmakers, P. Chambon, and J.M. Egly. 1993. DNA repair 
helicase: a component of BTF2 (TFIIH) basic transcription 
factor. Science. 260:58–63.
Schärer, O.D. 2013. Nucleotide excision repair in eukaryotes. Cold 
Spring Harb. Perspect. Biol. 5:a012609. doi:10.1101/
cshperspect.a012609.
Scheffner, M., and S. Kumar. 2014. Mammalian HECT ubiquitin-
protein ligases: biological and pathophysiological aspects. 
Biochim. Biophys. Acta. 1843:61–74. doi:10.1016/j.
bbamcr.2013.03.024.
Schwab, R. a, A.N. Blackford, and W. Niedzwiedz. 2010. ATR 
activation and replication fork restart are defective in 
FANCM-deficient cells. EMBO J. 29:806–18. doi:10.1038/
emboj.2009.385.
Scrima, A., R. Konícková, B.K. Czyzewski, Y. Kawasaki, P.D. Jeffrey, 
R. Groisman, Y. Nakatani, S. Iwai, N.P. Pavletich, and 
N.H. Thomä. 2008. Structural basis of UV DNA-damage 
recognition by the DDB1-DDB2 complex. Cell. 135:1213–
23. doi:10.1016/j.cell.2008.10.045.
Shagin, D. a, E. V Barsova, Y.G. Yanushevich, A.F. Fradkov, K. a 
Lukyanov, Y. a Labas, T.N. Semenova, J. a Ugalde, A. 
Meyers, J.M. Nunez, E. a Widder, S. a Lukyanov, and 
M. V Matz. 2004. GFP-like proteins as ubiquitous 
metazoan superfamily: evolution of functional features 
and structural complexity. Mol. Biol. Evol. 21:841–50. 
doi:10.1093/molbev/msh079.
Shaner, N.C., G.H. Patterson, and M.W. Davidson. 2007. Advances 
in fluorescent protein technology. J. Cell Sci. 120:4247–60. 
doi:10.1242/jcs.005801.
Siggia, E.D., J. Lippincott-schwartz, and S. Bekiranov. 2000. Diffusion 
in Inhomogeneous Media : Theory and Simulations 
Applied to. Biophys. J. 79:1761–1770.
Sijbers, A.M., W.L. de Laat, R.R. Ariza, M. Biggerstaff, Y.F. Wei, J.G. 
Moggs, K.C. Carter, B.K. Shell, E. Evans, M.C. de Jong, S. 
Rademakers, J. de Rooij, N.G. Jaspers, J.H. Hoeijmakers, 
and R.D. Wood. 1996. Xeroderma pigmentosum group 
F caused by a defect in a structure-specific DNA repair 
endonuclease. Cell. 86:811–22.
Soumpasis, D. 1983. Theoretical analysis of fluorescence 
photobleaching recovery experiments. Biophys. J. 41:95–
97.
Spence, J., R.R. Gali, G. Dittmar, F. Sherman, M. Karin, D. Finley, and 
N. York. 2000. Cell Cycle – Regulated Modification of the 
Ribosome by a Variant Multiubiquitin Chain University of 
California at San Diego. 102:67–76.
Starcevic, D., S. Dalal, and J.B. Sweasy. 2004. Is there a link between 
DNA polymerase beta and cancer? Cell Cycle. 3:998–1001. 
doi:10.4161/cc.3.8.1062.
Stenoien, D.L., K. Patel, M.G. Mancini, M. Dutertre, C.L. Smith, 
B.W. O’Malley, and M. a Mancini. 2001. FRAP reveals 
that mobility of oestrogen receptor-alpha is ligand- 
and proteasome-dependent. Nat. Cell Biol. 3:15–23. 
doi:10.1038/35050515.
Struewing, J.P., P. Hartge, S. Wacholder, S.M. Baker, M. Berlin, M. 
McAdams, M.M. Timmerman, L.C. Brody, and M.A. Tucker. 
1997. The risk of cancer associated with specific mutations 
of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. 
Med. 336:1401–8. doi:10.1056/NEJM199705153362001.
Sugasawa, K., J. Akagi, R. Nishi, S. Iwai, and F. Hanaoka. 2009. 
Two-step recognition of DNA damage for mammalian 
nucleotide excision repair: Directional binding of the XPC 
complex and DNA strand scanning. Mol. Cell. 36:642–53. 
doi:10.1016/j.molcel.2009.09.035.
Sugasawa, K., J.M.. Ng, C. Masutani, S. Iwai, P.J. van der Spek, A.P.. 
Eker, F. Hanaoka, D. Bootsma, and J.H.. Hoeijmakers. 1998. 
Xeroderma pigmentosum group C protein complex is the 
initiator of global genome nucleotide excision repair. Mol. 
Cell. 2:223–32. doi:10.1016/S1097-2765(00)80132-X.
Sugasawa, K., T. Okamoto, Y. Shimizu, C. Masutani, S. Iwai, and 
F. Hanaoka. 2001. A multistep damage recognition 
mechanism for global genomic nucleotide excision repair. 
Genes Dev. 15:507–21. doi:10.1101/gad.866301.
Sugasawa, K., Y. Okuda, M. Saijo, R. Nishi, N. Matsuda, G. Chu, T. 
Mori, S. Iwai, K. Tanaka, K. Tanaka, and F. Hanaoka. 2005. 
UV-induced ubiquitylation of XPC protein mediated by 
UV-DDB-ubiquitin ligase complex. Cell. 121:387–400. 
doi:10.1016/j.cell.2005.02.035.
Sun, H., J.D. Leverson, and T. Hunter. 2007. Conserved function of 
RNF4 family proteins in eukaryotes: targeting a ubiquitin 
ligase to SUMOylated proteins. EMBO J. 26:4102–12. 
doi:10.1038/sj.emboj.7601839.
Sung, P., and H. Klein. 2006. Mechanism of homologous 
recombination: mediators and helicases take on 
regulatory functions. Nat. Rev. Mol. Cell Biol. 7:739–50. 
doi:10. 1038/nrm2008.
Tauchi, H., J. Kobayashi, and K. Morishima. 2002. Nbs1 is essential 
for DNA repair by homologous recombination in 
higher vertebrate cells. Nature. 420:93–8. doi:10.1038/
nature01125.
Tsien, R.Y. 1998. The green fluorescent protein. Annu. Rev. Biochem. 
67:509–544. doi:10.1146/annurev.biochem.67.1.509.
Tyson, J.J., K.C. Chen, and B. Novak. 2003. Sniffers, buzzers, toggles 
and blinkers: dynamics of regulatory and signaling 
pathways in the cell. Curr. Opin. Cell Biol. 15:221–231. 
doi:10.1016/S0955-0674(03)00017-6.
Uzunova, K., K. Göttsche, M. Miteva, S.R. Weisshaar, C. Glanemann, 
M. Schnellhardt, M. Niessen, H. Scheel, K. Hofmann, E.S. 
Johnson, G.J.K. Praefcke, and R.J. Dohmen. 2007. Ubiquitin-
dependent proteolytic control of SUMO conjugates. J. Biol. 
Chem. 282:34167–75. doi:10.1074/jbc.M706505200.
Volker, M., M.J. Moné, P. Karmakar, a van Hoffen, W. Schul, W. 
Vermeulen, J.H. Hoeijmakers, R. van Driel, a a van Zeeland, 
and L.H. Mullenders. 2001. Sequential assembly of the 
nucleotide excision repair factors in vivo. Mol. Cell. 8:213–
24.
Wakasugi, M., A. Kawashima, H. Morioka, S. Linn, A. Sancar, T. Mori, 
O. Nikaido, and T. Matsunaga. 2002. DDB accumulates 
at DNA damage sites immediately after UV irradiation 
and directly stimulates nucleotide excision repair. J. Biol. 
Chem. 277:1637–40. doi:10.1074/jbc.C100610200.
Walker, J., R. Corpina, and J. Goldberg. 2001. Structure of the 
Ku heterodimer bound to DNA and its implications 
for double-strand break repair. Nature. 412:607–14. 
doi:10.1038/35088000.
Wang, Q.-E., Q. Zhu, G. Wani, M. a El-Mahdy, J. Li, and A. a Wani. 
2005. DNA repair factor XPC is modified by SUMO-1 
and ubiquitin following UV irradiation. Nucleic Acids Res. 
33:4023–34. doi:10.1093/nar/gki684.
Waris, G., and H. Ahsan. 2006. Reactive oxygen species: role in the 
development of cancer and various chronic conditions. J. 
Carcinog. 5:14. doi:10.1186/1477-3163-5-14.
Wenzel, D.M., and R.E. Klevit. 2012. Following Ariadne’s thread: a 
new perspective on RBR ubiquitin ligases. BMC Biol. 10:24. 
doi:10.1186/1741-7007-10-24.
Weterings, E., and D.C. van Gent. 2004. The mechanism of 
non-homologous end-joining: a synopsis of synapsis. 
DNA Repair (Amst). 3:1425–35. doi:10.1016/j.
dnarep.2004.06.003.
Van Wijk, S.J.L., and H.T.M. Timmers. 2010. The family of ubiquitin-
conjugating enzymes (E2s): deciding between life and 
death of proteins. FASEB J. 24:981–93. doi:10.1096/fj.09-
136259.
Willig, K.I., R.R. Kellner, R. Medda, B. Hein, S. Jakobs, and S.W. Hell. 
2006. Nanoscale resolution in GFP-based microscopy. 
Nat. Methods. 3:721–3. doi:10.1038/nmeth922.
Xiong, W., and J.E. Ferrell. 2003. A positive-feedback-based bistable 
“memory module” that governs a cell fate decision. 
Nature. 426:460–5. doi:10.1038/nature02089.
Yeh, J.I., A.S. Levine, S. Du, U. Chinte, H. Ghodke, H. Wang, H. Shi, 
C.L. Hsieh, J.F. Conway, B. Van Houten, and V. Rapić-
Otrin. 2012. Damaged DNA induced UV-damaged DNA-
binding protein (UV-DDB) dimerization and its roles in 
chromatinized DNA repair. Proc. Natl. Acad. Sci. U. S. A. 
109:E2737–46. doi:10.1073/pnas.1110067109.
Zhang, X.-P., F. Liu, and W. Wang. 2011. Two-phase dynamics of p53 
in the DNA damage response. Proc. Natl. Acad. Sci. U. S. A. 
108:8990–5. doi:10.1073/pnas.1100600108.
Zotter, A., M.S. Luijsterburg, D.O. Warmerdam, S. Ibrahim, A. Nigg, 
W. a van Cappellen, J.H.J. Hoeijmakers, R. van Driel, W. 
Vermeulen, and A.B. Houtsmuller. 2006. Recruitment of 
the nucleotide excision repair endonuclease XPG to sites 
of UV-induced dna damage depends on functional TFIIH. 
Mol. Cell. Biol. 26:8868–79. doi:10.1128/MCB.00695-06.
Zurita, M., and C. Merino. 2003. The transcriptional complexity 
of the TFIIH complex. Trends Genet. 19:578–84. 
doi:10.1016/j.tig.2003.08.005.

Chapter II
RNF111/Arkadia is a SUMO-targeted ubiquitin 
ligase that facilitates the DNA damage response
Sara L. Poulsen1, Rebecca K. Hansen1, Sebastian A. Wagner2, Loes van Cuijk4, Gijsbert J. van 
Belle5, Werner Streicher3, Mats Wikström3, Chunaram Choudhary2, Adriaan B. Houtsmuller5, 
Jurgen A. Marteijn4, Simon Bekker-Jensen1, and Niels Mailand1
1Ubiquitin Signaling Group, Department of Disease Biology, 2Department of Proteomics, and 3Protein Function 
and Interactions Group, The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, 
DK-2200 Copenhagen, Denmark 4Department of Genetics and 5Department of Pathology, Josephine Nefkens 
Institute, Erasmus Medical Center, 3015 GE Rotterdam, Netherlands
Published in Journal of Cell Biology 2013 Jun 10; 201(6):797-807 
44
II
Abstract
Protein modifications by ubiquitin and small ubiquitin- like modifier (SUMO) play key roles in cellular 
signaling pathways. SUMO-targeted ubiquitin ligases (STUbLs) directly couple these modifications 
by selectively recognizing SUMOylated target proteins through SUMO- interacting motifs (SIMs), 
promoting their K48-linked ubiquitylation and degradation. Only a single mammalian STUbL, 
RNF4, has been identified. We show that human RNF111/Arkadia is a new STUbL, which used 
three adjacent SIMs for specific recognition of poly-SUMO2/3 chains, and used Ubc13–Mms2 as 
a cognate E2 enzyme to promote non-proteolytic, K63-linked ubiquitylation of SUMOylated target 
proteins. We demonstrate that RNF111 promoted ubiquitylation of SUMOylated XPC (xeroderma 
pigmentosum C) protein, a central DNA damage recognition factor in nucleotide excision repair 
(NER) extensively regulated by ultraviolet (UV)-induced SUMOylation and ubiquitylation. Moreover, 
we show that RNF111 facilitated NER by regulating the recruitment of XPC to UV- damaged DNA. 
Our findings establish RNF111 as a new STUbL that directly links non-proteolytic ubiquitylation 
and SUMOylation in the DNA damage response.
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Introduction
Protein modification by ubiquitin and the small ubiquitin-like modifier (SUMO) play important, often 
interconnected, regulatory roles in numerous signaling pathways in eukaryotic cells (Kerscher et 
al., 2006; Gareau and Lima, 2010; Komander and Rape, 2012). Similar enzymatic cascades involving 
activating (E1), conjugating (E2), and ligase (E3) enzymes underlie protein modification by ubiquitin 
and SUMO (Kerscher et al., 2006). Although no consensus sequences surrounding ubiquitylation 
sites have been described, SUMOylation is frequently, but not always, targeted to K-X-E/D motifs 
or an inverted version of this sequence (Matic et al., 2010). Three different SUMO isoforms, 
SUMO1–3, are expressed in cells, and although SUMO2 and SUMO3 are 97% identical and thus 
often referred to as SUMO2/3, SUMO1 and SUMO2/3 only share ~50% sequence identity (Gareau 
and Lima, 2010). Both ubiquitin and SUMO can be attached to target proteins as single moieties 
but additionally share the ability to form chains via internal lysine residues. Unlike ubiquitin, only 
a single lysine residue in SUMO that con- forms to the SUMO consensus sequence is used for 
chain formation, and this ability is exclusive to SUMO2/3 (Tatham et al., 2001; Komander and Rape, 
2012). 
Different polyubiquitin chains have distinct cellular functions (Komander and Rape, 2012). Although 
most of the known ubiquitylation processes generate K48-linked chains, which tar- get substrates for 
degradation by the 26S proteasome, protein ubiquitylation does not always promote destruction; 
in particular, K63-linked polyubiquitylation, catalyzed by the E2 enzyme Ubc13 in conjunction with 
its partner proteins Mms2 or Uev1, is a non-degradative modification used in a range of signaling 
path- ways, including cellular stress responses such as DNA damage and inflammatory responses 
(Chen and Sun, 2009; Al-Hakim et al., 2010; Komander and Rape, 2012). The function of poly- SUMO 
chains is less well understood, but roles in processes such as chromosome segregation, DNA 
damage, and heat shock responses have been described (Schwartz et al., 2007; Golebiowski et al., 
2009; Yin et al., 2012). Several cellular processes, including the DNA damage response, are intimately 
co-regulated by ubiquitin- and SUMO-mediated signaling (Kerscher et al., 2006; Bergink and 
Jentsch, 2009; Bekker-Jensen and Mailand, 2011). The discovery of SUMO-targeted ubiquitin ligases 
(STUbLs) revealed a further, direct interplay between these modifications. By means of tandem 
SUMO-interacting motifs (SIMs)(Hecker et al., 2006), STUbLs recognize poly-SUMOylated proteins 
and target them for K48-linked polyubiquitylation and degradation via their E3 ubiquitin ligase 
activities (Prudden et al., 2007; Sun et al., 2007). Accordingly, although SUMOylation is not a 
degradative modification per se, it can indirectly promote proteasomal destruction via STUbLs. 
Only a few STUBLs have been identified so far, including Slx5-Slx8 in Saccharomyces cerevisiae, 
Rfp1/Rfp2-Slx8 in Schizosaccharomyces pombe, and RNF4 in mammalian cells. All of these 
enzymes play important roles in maintenance of genome stability (Prudden et al., 2007; Sun et 
al., 2007; Galanty et al., 2012; Yin et al., 2012), consistent with the extensive involvement of both 
ubiquitin and SUMO in cellular responses to DNA damage. 
In a search for new SUMO-binding proteins, we discovered that the human RNF111 ubiquitin 
ligase (also known as Arkadia) is a STUbL, which can promote non-proteolytic ubiquitylation 
of target proteins through cognate E2 enzymes such as Ubc13. We demonstrate that RNF111 
has a physiological role in nucleotide excision repair (NER), catalyzing DNA damage–induced 
ubiquitylation of SUMOylated XPC (xeroderma pigmentosum C). Our findings reveal direct coupling 
between non-proteolytic ubiquitylation and SUMOylation in the DNA damage response.
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Figure 1. Human RNF111 binds to poly-SUMOylated proteins via an N-terminal SIM region. 
(A) Schematic of human RNF111/Arkadia. The RING domain, two putative NLSs (Episkopou et al., 2001), 
and three SUMO-interacting motifs (SIMs; top), conserved in higher vertebrates (bottom), are shown. Core 
hydrophobic SIM residues are highlighted in green. (B) Amino acid substitutions (highlighted in red) in the 
RNF111 SIM region to disrupt its SUMO-binding ability (*SIM). (C) S-FLAG-Strep–tagged RNF111 (SFS-RNF111) 
proteins expressed in U2OS cells were purified on Strep-Tactin Sepharose, incubated with purified SUMO2 
or poly-SUMO2 (3–8), and washed extensively. Bound complexes were immunoblotted with the SUMO2 
antibody. WCE, whole-cell extract. (D) HeLa cells stably expressing FLAG-SUMO isoforms were transfected 
with Strep-HA-RNF111 plasmids as indicated. Whole-cell extracts were subjected to Strep-Tactin pull-down 
and immunoblotting with the FLAG antibody. (E) Plasmon surface resonance analysis of poly-SUMO2 binding 
kinetics of RNF111 fragments spanning the SIMs. Data shown are from a single representative experiment out 
of three repeats. MW, molecular weight.
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Results and discussion
RNF111 recognizes poly-SUMO chains via tandem SIMs
In a search for proteins containing SIMs, we noted that the human RNF111/Arkadia E3 ubiquitin 
ligase, which has been shown to function in amplification of TGF-β signaling pathways (Miyazono 
and Koinuma, 2011) contains three highly conserved, potential SIMs in its N-terminal region 
(Fig. 1, A and B). To test whether these putative SIMs are functional SUMO- binding modules, we 
generated an RNF111 mutant (*SIM) in which the core hydrophobic residues in each of the three 
SIMs were mutated to alanines, predicted to disrupt their SUMO- binding ability (Fig. 1 B)(Hecker 
et al., 2006). We first assessed the SUMO-binding ability of ectopically expressed Strep-tagged 
forms of RNF111 wild type (WT) or *SIM purified on Strep- Tactin agarose. We found that RNF111 
bound purified poly- SUMO2 chains with high affinity in vitro but was virtually unable to bind free 
SUMO2 (Fig. 1 C). This was fully dependent on the integrity of the SIM motifs, as the RNF111 *SIM 
mutant did not interact with poly-SUMO2 (Fig. 1 C). To test whether RNF111 binds to SUMOylated 
proteins in cells, we overexpressed RNF111 WT or *SIM in cells stably expressing FLAG-SUMO1 
or 2 and analyzed their interactions in immunoprecipitation (IP) experiments. Consistent with in 
vitro binding experiments, RNF111 interacted with high–molecular weight SUMOylated species, 
but not free SUMO2, in a SIM-dependent manner (Fig. 1 D and not depicted). Moreover, RNF111 
selectively interacted with proteins modified with SUMO2 but not SUMO1 (Fig. 1 D), in agreement 
with the notion that SUMO2, but not SUMO1, forms poly-SUMO chains in vivo (Tatham et al., 
2001). Surface plasmon resonance analysis showed that the RNF111 SIM region bound directly to 
poly-SUMO2 with a Kd of ~15 µM, whereas the *SIM mutations reduced binding to a Kd > 80 µM 
(Fig. 1 E). These data demonstrate that RNF111 interacts with poly-SUMOylated proteins via three 
N-terminal SIM motifs, in accordance with recent findings that showed an additive contribution of 
each SIM to poly-SUMO binding (Sun and Hunter, 2012).
RNF111 promotes Ubc13–Mms2-dependent ubiquitylation
To gain insight into the functional significance of RNF111 SUMO binding, we performed quantitative 
mass spectrometry (MS)–based analysis of cellular RNF111-interacting proteins (Fig. 2 A and 
Fig. S1 A). Several potential RNF111-binding factors were identified by this approach, including 
components of the AP2 (clathrin adaptor 2) complex, consistent with the known role of RNF111 in 
regulating endocytosis via interaction with this complex (Fig. S1, A and B)(Miyazono and Koinuma, 
2011). Among the RNF111-associated proteins, we also found two E2 ubiquitin–conjugating 
enzymes: Ubc13–Mms2, which specifically catalyzes K63-linked ubiquitin chain formation, and 
UBE2O, a large E2 enzyme of unknown function (Fig. 2 A and Fig. S1 B). The presence of both 
Ubc13 and Mms2 lends strong support to the possibility that this complex is a physiological E2 
partner for RNF111. We validated the interactions between RNF111 and Ubc13 or UBE2O by 
reciprocal co-IP analysis (Fig. 2 B and Fig. S2, A and B). In contrast, we did not observe binding 
of RNF4, the known mammalian STUbL, to Ubc13 under a range of conditions (Fig. S2, C and D). 
Because RNF111 promotes degradation of factors in
TGF-β signaling pathways, the interaction with Ubc13–Mms2 was unexpected, and we set out to 
investigate its physiological relevance. We noted that endogenous RNF111 is primarily localized 
in the nucleus (Fig. 2 C), suggesting that in addition to facilitating amplification of TGF-β signaling 
and endocytosis, RNF111 might have other important nuclear functions. To test whether RNF111 
has E3 ligase activity in the presence of Ubc13–Mms2, we performed in vitro ubiquitylation assays 
using ectopic RNF111 immunopurified from cells. Because RNF111 appeared to form homodimers 
in cells (unpublished data), we depleted endogenous RNF111 to remove background E3 ligase 
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Figure 2. RNF111 has STUbL activity in the presence of Ubc13–Mms2. (A) MS-based analysis of RNF111-
interacting proteins. U2OS and U2OS/GFP- RNF111 cells were grown in light and heavy SILAC medium, 
respectively. GFP-RNF111 and associated proteins enriched on GFP-Trap resin were analyzed by MS. Plot 
shows z scores (from SILAC heavy/light ratios) and total intensity of identified proteins. RNF111, Ubc13 
(UBE2N), and Mms2 (MMS2) are highlighted. See also Fig. S1 (A and B). (B) U2OS cells were co-transfected 
with indicated combinations of GFP-RNF111 and Strep-HA-Ubc13 plasmids. Whole-cell extracts (WCE) were 
subjected to Strep-Tactin pull-down followed by immunoblotting with GFP and HA antibodies. (C) U2OS cells 
transfected with non-targeting (control [CTRL]) or RNF111 siRNAs were collected 72 h later and processed for 
immunostaining (top) or immunoblot (bottom) with RNF111 antibody. Asterisk indicates a nonspecific band. 
Bar, 10 µm. (D) Extracts of U2OS cells sequentially transfected with RNF111 siRNA and S-FLAG- Strep–tagged 
RNF111 (SFS-RNF111) plasmids were subjected to Strep-Tactin pull-down. Bound complexes were incubated 
with ubiquitylation reaction mixture containing E1, Ubc13–Mms2 complex, and HA-ubiquitin as indicated and 
washed extensively, and RNF111 E3 ligase activity was analyzed by immunoblotting with the HA antibody. (E) 
As in D, except that ubiquitylation reactions were performed in the presence or absence of poly-SUMO2 (3–8) 
chains followed by immunoblotting with HA and SUMO2 antibodies. MW, molecular weight.
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activity of co-purifying endogenous RNF111. We found that RNF111 was highly active as an E3 
ligase in the presence of purified Ubc13–Mms2, as judged from its auto-ubiquitylation (Fig. 2 D). 
As expected, this required the integrity of the RNF111 RING domain (Fig. 2 D), whereas mutation of 
the SIMs did not impair intrinsic RNF111 E3 ligase activity (Fig. S2 E). In addition to Ubc13–Mms2, 
RNF111 was active with more generic E2 enzymes, such as UbcH5, as expected (Fig. S2 F). To test 
whether RNF111 has STUbL activity in the presence of Ubc13–Mms2, we analyzed the impact 
of SUMO2 on RNF111 E3 ligase activity. Strikingly, we found that poly- SUMO2 chains, but not 
free SUMO2, were efficiently targeted for Ubc13–Mms2-dependent ubiquitylation by RNF111 in a 
manner fully dependent on the integrity of the SIMs (Fig. 2 E and not depicted). We conclude from 
these experiments that RNF111 functions as a STUbL that employs Ubc13–Mms2 and likely other 
cognate E2 partners in ubiquitylation of SUMOylated substrates.
RNF111 promotes UV-induced ubiquitylation of XPC
We next attempted to identify physiological substrates for the STUbL activity of RNF111. The NER 
factor XPC is known to undergo both SUMOylation and ubiquitylation in response to UV radiation, 
and the UV-induced ubiquitin chains on XPC do not appear to destine XPC for proteasomal 
destruction (Sugasawa et al., 2005; Wang et al., 2005). We reasoned that SUMOylated XPC might be 
a candidate target of the Ubc13–Mms2-dependent E3 ligase activity of RNF111. Indeed, knockdown 
of RNF111 by any of several independent siRNAs impaired UV-induced ubiquitylation but not 
SUMOylation of XPC (Fig. 3, A and B; and Fig. S3, A and B), suggesting that XPC is SUMOylated before 
ubiquitylation by RNF111. The slow-migrating, UV- inducible XPC species seen in immunoblots 
represent a mixture of ubiquitin- and SUMO-modified forms; hence, the dramatic decrease in XPC 
ubiquitylation but not SUMOylation in RNF111- depleted cells manifests less prominently in total 
XPC blots (Fig. 3 A). Consistent with a direct role of RNF111 in ubiquitylating XPC after UV, we found 
that elevated levels of RNF111 augmented the UV-induced increase in XPC-GFP ubiquitylation (Fig. 
3 C). In contrast, depletion of RNF4, the known STUbL in mammalian cells, had no effect on UV-
induced XPC ubiquitylation (Fig. S3 C). The ability of RNF111 to promote Ubc13– Mms2-dependent 
ubiquitylation prompted us to test whether UV-induced XPC ubiquitylation required Ubc13 
function. Like RNF111 knockdown, depletion of Ubc13 decreased UV-induced XPC ubiquitylation 
substantially (Fig. 3 D and Fig. S3 D), suggesting that RNF111-dependent XPC ubiquitylation after 
UV exposure was, at least partially, mediated by Ubc13-dependent, non-proteolytic ubiquitylation. 
To further probe the basis of RNF111-dependent XPC ubiquitylation in response to UV, we asked 
whether RNF111 and XPC interact in cells. Indeed, UV induced prominent, but transient, interaction 
between RNF111 and XPC at early time points after UV (Fig. 3 E). Interestingly, like several known 
NER factors, both endogenous and ectopic RNF111 underwent partial degradation after UV in a 
proteasome-dependent manner, which, however, did not require the intrinsic E3 ligase activity of 
RNF111 (Fig. 3, E and F; and Fig. S3 E). In general, the kinetics of UV-induced RNF111 interaction 
with XPC and degradation correlated with that of XPC ubiquitylation after UV exposure (Fig. 3, E 
and F; and Fig. S3 F).
RNF111 selectively ubiquitylates SUMOylated XPC
The aforementioned findings suggested that RNF111 targets SUMOylated XPC for ubiquitylation 
in response to UV. Hence, we tested whether RNF111 specifically interacts with SUMO- modified 
XPC via its SIMs, using a strategy wherein GFP- tagged XPC immunopurified from cells was 
SUMOylated in vitro and then incubated with extracts of cells transfected with WT or mutant 
forms of ectopic RNF111 (Fig. 4 A). Under these conditions, RNF111 efficiently interacted with 
XPC, but only if XPC had been pre-SUMOylated, and this required the integrity of the RNF111 
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Figure 3. RNF111 promotes UV-induced ubiquitylation of XPC. (A) U2OS or U2OS/Strep-HA-ubiquitin cells 
transfected with control (-) or RNF111 siRNAs were exposed or not exposed to UV and collected 1 h later, and 
XPC ubiquitylation was analyzed by immunoblotting Strep-Tactin pull-downs of whole- cell extracts (WCE) with 
the XPC antibody. (B) HeLa/FLAG-SUMO2 cells transfected with control (-) or RNF111 siRNAs and left untreated 
or induced to express FLAG-SUMO2 by addition of doxycycline (DOX) were exposed or not exposed to UV 
and collected 1 h later. Cells were lysed under denaturing conditions, and XPC SUMOylation was analyzed by 
immunoblotting of FLAG IPs with XPC antibody. (C) U2OS/Strep-HA-ubiquitin cells transfected with empty vector 
(-) or FLAG-RNF111 plasmid were exposed or not exposed to UV and collected 1 h later. XPC ubiquitylation was 
analyzed as in A. (D) XPC ubiquitylation in U2OS/Strep-HA-ubiquitin cells depleted of RNF111 or Ubc13 was 
analyzed as in A. Ubc13 knockdown efficiency is shown in Fig. S3 D. (E) Extracts of U2OS/GFP-RNF111 cells 
collected at the indicated times after UV radiation were subjected to GFP IP followed by immunoblotting with 
XPC antibody. (F) Extracts of U2OS cells incubated with or without MG132, exposed to UV 30 min later, and 
collected at the indicated times after UV were analyzed by immunoblotting with the RNF111 antibody. Asterisks 
denote a nonspecific band. MM, molecular mass.
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SIMs (Fig. 4 B), in agreement with the notion that RNF111 specifically recognizes SUMOylated 
XPC. We next tested whether RNF111 functions as a STUbL for XPC. To do this, we extended the 
setup to monitor SUMO- dependent RNF111-XPC binding, by subjecting the bound complexes 
to an in vitro ubiquitylation assay in the presence of Ubc13–Mms2 as an E2 (Fig. 4 A). Although 
a background level of Ubc13–Mms2-dependent ubiquitylation of XPC-GFP could be seen in the 
absence of ectopically expressed RNF111 (Fig. 4 C, compare lanes 1–6), the addition of RNF111 
WT markedly enhanced XPC ubiquitylation (Fig. 4 C, compare lanes 6 and 7) but only if XPC had 
been pre-SUMOylated (Fig. 4 C, compare lanes 2, 3, and 7). Importantly, this increase in RNF111-
dependent XPC ubiquitylation required the functional integrity of both the RNF111 RING and SIM 
domains (Fig. 4 C, compare lanes 7–9). These data suggest that RNF111 acts as a STUbL for XPC, 
catalyzing its non-proteolytic ubiquitylation in response to UV damage.
RNF111 promotes NER by regulating the interaction of XPC with damaged DNA
Because RNF111 promotes ubiquitylation of XPC after UV, we asked whether RNF111 regulates 
NER. Although UV- induced ubiquitylation of XPC has been suggested to increase its DNA-binding 
affinity (Sugasawa et al., 2005), the exact role of this modification in NER is unclear. Previous work 
suggested that XPC is ubiquitylated by CRL4DDB2, an E3 ligase complex functioning as a proximal 
sensor of UV lesions in DNA (Sugasawa et al., 2005). It is possible that XPC is ubiquitylated by both 
CRL4DDB2 and RNF111 in response to UV. Indeed, using MS, we found that XPC ubiquitylation 
involves a variety of ubiquitin chains and ≥15 individual ubiquitylation sites (unpublished data)
(Povlsen et al., 2012); hence, the nature and regulation of XPC ubiquitylation appears to be highly 
complex, likely involving several E3 ligases. To determine whether RNF111 loss affects NER, we 
measured UV-induced DNA repair synthesis (UDS) in RNF111-/- mouse embryonic fibroblasts 
(MEFs)(Mavrakis et al., 2007). Strikingly, these MEFs showed a marked reduction in UDS, as was 
also observed in XPC-/- MEFs (Fig. 5 A). Moreover, using two independent siRNAs, we found that 
RNF111 knockdown resulted in increased accumulation of XPC-GFP to locally UV-irradiated 
chromatin, whereas knockdown of DDB2 had the opposite effect, as previously observed (Fig. 
5, B and C)(Nishi et al., 2009). Hence, although DDB2 and RNF111 have opposing effects on XPC 
accumulation at UV lesions, interfering with the proper kinetics of XPC interaction with damaged 
chromatin by inactivation of either E3 reduces the efficiency of NER. These data suggest that 
RNF111 has a physiological role in promoting NER by regulating ubiquitylation of XPC and its 
association with damaged DNA.
Our findings show that RNF111 is a STUbL that promotes non-proteolytic ubiquitylation of at least 
a subset of its substrates, including XPC, implying that STUbL activity is not confined to RNF4 in 
higher vertebrates and that STUbLs do not always target substrates for proteasomal degradation. 
Although Ubc13–Mms2 appears to be a major cognate E2 enzyme for RNF111 in cells, RNF111 
also interacts with other E2 enzymes and is known to promote ubiquitin-dependent degradation 
of TGF-β signaling factors (Koinuma et al., 2003; Levy et al., 2007; Nagano et al., 2007). Hence, 
depending on the context, RNF111 may work with different E2s to promote degradative or non-
proteolytic ubiquitylation of SUMOylated substrate proteins. Despite the fact that both RNF4 
and RNF111 interact with poly-SUMOylated proteins through tandem SIMs, they appear to have 
largely non-overlapping roles in the cell. For in- stance, RNF4, but not RNF111, was dispensable for 
UV-induced ubiquitylation of XPC, whereas RNF111 was not recruited to laser micro-irradiation-
induced DNA double-strand breaks, un- like RNF4 (unpublished data)(Galanty et al., 2012; Yin et 
al., 2012). This distribution of labor between RNF4 and RNF111 in targeting distinct subsets of 
SUMOylated factors may reflect differences in the SUMO-binding properties of their tandem SIMs, 
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Figure 4. RNF111 ubiquitylates XPC in a SUMOylation-dependent manner. (A) Outline of in vitro SUMO-
binding and STUbL assays. XPC-GFP expressed in U2OS cells was immunopurified on GFP-Trap resin and 
subjected to in vitro SUMOylation. After washing, the XPC-GFP–containing beads were incubated with extracts 
of cells transfected or not transfected with S-FLAG-Strep-RNF111 (SFS-RNF111) constructs, washed again, 
and processed for immunoblotting (IB) of bound SFS-RNF111 with FLAG antibody (i) or subjected to in vitro 
ubiquitylation followed by washing and immunoblotting with the HA antibody to analyze ubiquitin ligase 
activity (ii). (B) SUMOylation-dependent binding of RNF111 to XPC, analyzed as described in A. (C) Analysis 
of SUMOylation- dependent XPC ubiquitylation by RNF111 was performed as described in A. MW, molecular 
weight.
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which have a distinct configuration, as well as differential target-binding specificity contributed by 
other domains in these proteins.
Although our comprehensive analysis of RNF111-binding factors in unperturbed cells uncovered 
several E2 partner proteins, we did not detect any known components of TGF-β signaling pathways, 
nor XPC. Given the involvement of RNF111 in regulating these proteins, we speculate that 
processes mediated by the RNF111 STUbL activity may, in many cases, be induced by stimuli such 
as TGF-β or UV treatment, which may promote SUMOylation of specific factors and thus trigger 
their RNF111-mediated ubiquitylation. This is consistent with previous findings that elevated levels 
of RNF111 only cause degradation of SnoN in TGF-β–stimulated cells (Levy et al., 2007). Based on 
the large and heterogeneous group of proteins identified by MS as putative RNF111-interacting 
proteins, we propose that RNF111, like RNF4, is a multi-functional STUbL regulating a diverse 
range of cellular signaling processes, determined to a large extent by the SUMOylation state of 
target proteins. This scenario reconciles the involvement of RNF111 in radically different cellular 
processes, such as TGF-β signaling and endocytosis (Miyazono and Koinuma, 2011), and NER. 
Whether the ability of RNF111 to ubiquitylate proteins in the former processes involves its STUbL 
activity remains to be ad- dressed. Our findings shed further light on how STUbLs directly couple 
ubiquitylation and SUMOylation in important cellular signaling pathways.
Figure 5. RNF111 promotes NER by regulating XPC recruitment to UV- damaged DNA. (A) UDS of the 
indicated MEF cell lines, determined by EdU incorporation for 3 h after exposure to 16 J/m2 UV-C. Error bars 
indicate SDs of three independent experiments. (B) Cells stably expressing XPC-GFP were transfected with in-
dicated siRNAs and locally exposed to laser-induced UV-C damage. XPC-GFP fluorescence intensity at the dam- 
aged area relative to pre-damage intensity was recorded in time using live-cell confocal imaging (mean of three 
independent experiments, n = 8 cells per experiment, ±SD). (C) As in B, except that cells were transfected with 
control (CTRL) or DDB2 siRNA. Results of a representative experiment (n = 8 cells per sample, ±SEM) are shown.
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Materials and methods
Plasmids and siRNA 
Full-length human RNF111 cDNA was amplified by PCR and inserted into pEGFP-C1 (Takara Bio 
Inc.) and pcDNA4/TO (Invitrogen) containing N-terminal Strep-HA or S-FLAG-Strep tags to generate 
mammalian expression constructs for GFP-, Strep-HA–, and S-FLAG-Strep–tagged RNF111, 
respectively. The RNF111 *RING (W963A) point mutation was introduced using the site-directed 
mutagenesis kit (QuikChange; Agilent Technologies). The RNF111 *SIM mutations (VVVI(300–303)
AAAA, VEIV(326–329)AAAA, and VVDL(382–385)AAAA) were introduced by replacing part of the 
coding sequence of human RNF111 (nucleotides 665–1,677 of the RNF111 ORF) with a synthetic 
gene spanning this region and containing the mutated *SIM sequence using the unique KpnI and 
EcoNI sites in RNF111. All constructs were verified by sequencing. Constructs expressing Strep-
HA–tagged Ubc13 and GFP-XPC were described previously (Bekker-jensen et al., 2010). Plasmid 
transfections were performed using GeneJuice (EMD Millipore) according to the manufacturer’s 
instructions. siRNA transfections were performed with Lipofectamine RNAiMAX (Invitrogen) as 
described. siRNA target sequences used in this study were control, 5’-GGGAUACCUAGACGUUCUA-3’; 
RNF111 (#1), 5’-GGAUAUUAAUGCAGAGGAA-3’; RNF111 (#4), 5’-GGAUAUGAAGAGUGAGAUU-3’; 
Ubc13, 5’-GAGCAUGGACUAGGCUAUA-3’; XPC, 5’-GCAAAUGGCUUCUAUCGAAUU-3’; DDB2, 
5’-CCCAGAUCCUAAUUUCAAA-3’; RNF4 (#1), 5’-GCUAAUACUUGCCCAACUU-3’; and RNF4 (#2), 
5’-GACAGAGACGUAUAUCUGA-3’.
Cell culture
Human U2OS and HeLa cells were cultured in DMEM containing 10% fetal bovine serum. SV40-
immortalized XP4PA cells stably expressing XPC- GFP (Hoogstraten et al., 2008) were cultured 
in DMEM containing 5% fetal bovine serum and 2 mM L-glutamine. RNF111-/- primary mouse 
fibroblasts of mixed 129Sv/MF1 genetic backgrounds (provided by V. Episkopou, Imperial College 
London, London, England, UK) (Mavrakis et al., 2007), and XPC-/- MEFs in which exons 4–7 of the 
XPC gene were deleted (Sands et al., 1995) were cultured in a 1:1 ratio of Ham’s F10 and DMEM 
supplemented with 10% fetal calf serum and 1% nonessential amino acids. To generate cell lines 
stably expressing GFP-tagged WT and mutant RNF111 alleles, U2OS cells were co-transfected with 
GFP-RNF111 constructs and pBabe-puromycin plasmid, and positive clones were selected with 1 
µg/ml puromycin. A stable U2OS/ Strep-HA-ubiquitin cell line (Danielsen et al., 2011) was generated 
by selecting cells transfected with Strep-HA-ubiquitin expression plasmid in medium containing 
400 µg/ml G418 until resistant clones grew out. Stable HeLa cell lines expressing FLAG-SUMO1/2 
in a doxycycline-inducible manner (Danielsen et al., 2012) were generated by co-transfection of 
HeLa/FRT/TRex cells (Invitrogen) with pcDNA5/FRT/TO-3×FLAG-SUMO1/2 and pOG44 followed by 
selection with 200 µg/ml Hygromycin B. Unless stated otherwise, cells were exposed to 30 J/m2 
UV and collected 1 h later.
MS-based analysis of RNF111-interacting proteins
For stable isotope labeling by amino acids in cell culture (SILAC) labeling, U2OS or U2OS/GFP-
RNF111 cells were cultured for 14 d in Eagle’s minimum essential medium (Sigma-Aldrich) 
supplemented with L-arginine and L-lysine or L-arginine-U-13C6-15N4 and L-lysine-U-13C6-
15N2 (Cambridge Isotope Laboratories), respectively (Ong, 2002). Cells were lysed in EBC buffer 
supplemented with protease and phosphatase inhibitor cock- tails (Roche), and GFP-RNF111 and its 
interacting proteins were enriched using GFP-Trap resin. Proteins were resolved by SDS-PAGE and 
in-gel digested with trypsin. Peptide fractions were analyzed on a quadrupole mass spectrometer 
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(Q Exactive; Orbitrap; Thermo Fisher Scientific) equipped with a nanoflow HPLC system (Thermo 
Fisher Scientific)(Michalski et al., 2011). Raw data files were analyzed using MaxQuant software 
(version 1.2.2.9;)(Cox and Mann, 2008). Parent ion and MS2 spectra were searched against protein 
sequences obtained from the UniProt knowledge base using the Andromeda search engine (Cox 
et al., 2011). Spectra were searched with a mass tolerance of 6 ppm in MS mode and 20 ppm 
in higher-energy C-trap dissociation MS2 mode, strict trypsin specificity, and allowing up to two 
missed cleavage sites. Cysteine carbamidomethylation was included as a fixed modification, and 
N-terminal protein acetylation was included as variable modification. The dataset was filtered based 
on posterior error probability to arrive at a false discovery rate <1% for peptide spectrum matches 
and protein groups. For calculation of z scores, the protein group ratios were logarithmized, and 
the standard deviation was estimated separately for ratios below and above 0 based on the 0.159 
and 0.841 quantile (Cox and Mann, 2008).
Immunochemical methods and antibodies
Immunoblotting, IP, and Strep-Tactin pull-downs were performed as previously described 
(Poulsen et al., 2012). In brief, cells were lysed in EBC buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 
mM EDTA, 1 mM DTT, and 0.5% NP-40) or denaturing buffer (20 mM Tris, pH 7.5, 50 mM NaCl, 1 
mM EDTA, 1 mM DTT, 0.5% NP-40, 0.5% sodium deoxycholate, and 0.5% SDS) supplemented with 
protease and phosphatase inhibitors and incubated on ice for 10 min, and lysates were cleared 
by centrifugation for 10 min at 20,000 rpm. Lysates were incubated with FLAG agarose (Sigma-
Aldrich), GFP-Trap agarose (ChromoTek), or Strep-Tactin Sepharose (IBA BioTAGnology) for 1.5 h 
on an end-over-end rotator at 4°C, washed five times with EBC buffer or denaturing buffer, and 
re-suspended in 2× Laemmli sample buffer. 
Antibodies used in this study included mouse monoclonals to RNF111 (M05; Abnova), GFP (sc-
9996) and β-actin (sc-130301; Santa Cruz Bio- technology, Inc.), and FLAG (F1804; Sigma-Aldrich), 
rat monoclonal to HA (Roche), and rabbit polyclonals to XPC (Bethyl Laboratories, Inc.), SUMO1 
(ab32058), SUMO2/3 (ab3742), β-tubulin (ab6046; Abcam), and Ubc13 (4919; Cell Signaling 
Technology). Rabbit polyclonal RNF4 antibody was a gift of J. Palvimo (University of Eastern Finland, 
Kuopio, Finland).
Immunofluorescence staining, microscopy, and laser microirradiation
Cells were fixed in 4% formaldehyde, permeabilized with PBS containing 0.2% Triton X-100 for 
5 min, and incubated with primary antibodies diluted in DMEM for 1 h at room temperature. 
After staining with secondary anti- bodies (Alexa Fluor 488 and 568; Life Technologies) for 30 
min, coverslips were mounted in Vectashield mounting medium (Vector Laboratories) containing 
nuclear stain DAPI. Confocal images were acquired on a microscope (LSM 510; Carl Zeiss) mounted 
on a confocal laser-scanning microscope (Axiovert 100M; Carl Zeiss) equipped with Plan-Neofluar 
40×/1.3 NA oil immersion objective. Dual-color confocal images were acquired with standard 
settings using laser lines 488 and 543 nm for excitation of Alexa Fluor 488 and Alexa Fluor 568 
dyes (Molecular Probes/Invitrogen), respectively. Band pass filters 505–530 and 560–615 nm were 
used to collect the emitted fluorescence signals. Image acquisition and analysis was performed 
with LSM ZEN software (Carl Zeiss). Raw images were exported as TIF files, and if adjustments in 
image contrast and brightness were applied, identical set- tings were used on all images of a given 
experiment.
In vitro ubiquitylation, SUMOylation, and binding experiments 
To analyze in vitro binding of RNF111 to SUMO, S-FLAG-Strep-RNF111 constructs were 
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overexpressed in U2OS cells, purified on Strep-Tactin Sepharose, and incubated with purified free 
SUMO1, SUMO2, or poly-SUMO chains (3–8; all obtained from Boston Biochem) for 2 h at 4°C. 
Bound complexes were washed extensively in EBC buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 
mM EDTA, 1 mM DTT, and 0.5% NP-40), and immobilized material was resolved by SDS-PAGE and 
analyzed by immunoblotting.
For in vitro RNF111 ubiquitylation assays, S-FLAG-Strep-RNF111purified from cells as described in 
the previous section and incubated in 20 µl ubiquitylation assay buffer (50 mM Tris, pH 7.5, 5 mM 
MgCl2, 2 mM NaF, 2 mM ATP, and 0.6 mM DTT) supplemented with 60 ng E1, 300 ng E2 (Ubc13–
Mms2 complex or UbcH5c), and 5 µg HA-ubiquitin (all ob- tained from Boston Biochem) for 1 h at 
37°C. Reactions were stopped by addition of Laemmli sample buffer, resolved by SDS-PAGE, and 
immuno- blotted with the HA antibody. 
For in vitro SUMOylation and STUbL assays, XPC-GFP ectopically expressed in U2OS cells was 
captured on GFP-Trap resin and incubated with 100 ng SAE1/2, 200 ng Ubc9, and 3 µg SUMO2 
(all obtained from Boston Biochem) in ubiquitylation assay buffer for 1 h at 37°C. The beads were 
washed extensively in EBC buffer and incubated with extracts of U2OS cells transfected with WT 
or mutant versions of S-FLAG-Strep-RNF111 for 2 h at 4°C. The immobilized material was then 
washed in EBC and pro- cessed for immunoblotting or subjected to in vitro ubiquitylation assay as 
described in the previous section. 
For surface plasmon resonance analysis, recombinant His6-tagged fragments (WT and *SIM) of 
human RNF111 (encompassing amino acids 282–411) were expressed in Escherichia coli and 
purified on an ÄKTAxpress system (GE Healthcare). The His6 tag was removed with tobacco 
etch virus protease, and the RNF111 fragments were further purified using reverse- phase 
chromatography on an UltiMate 3000 system (Dionex), using C18 columns (Phenomenex). Eluted 
proteins were lyophilized, and their masses were verified by SDS-PAGE and MS. Poly-SUMO2 
chains (3–8) were immobilized on a CM5 sensor chip using standard amine-coupling chem- istry. 
Before titration experiments, the RNF111(282–411) fragments were dialyzed in running buffer (10 
mM Hepes, pH 7.4, 150 mM NaCl, and 0.005% P20). After each titration point, the surface was 
regenerated using 10 mM glycine, pH 2.5. All data were collected on an instrument (T200; Biacore) 
at 25°C and analyzed using the T200 evaluation software (Biacore), in which the data were fitted 
to a steady-state model.
UDS and XPC-GFP accumulation kinetics assays 
UDS was performed as described previously (Limsirichaikul et al., 2009; Schwertman et al., 2012). 
In brief, MEFs were seeded on coverslips 3 d before the UDS assay and cultured in medium 
without serum to reduce the number of S-phase cells. Cells were exposed to 16 J/m2 UV-C and 
labeled with 5-ethynyl,2’-deoxyuridine (EdU) for 3 h. Subsequently, cells were fixed with 3.7% 
formaldehyde, and EdU incorporation was visualized using Alexa Fluor 594 nm (Click-iT) according 
to manufacturer’s protocol (Invitrogen). UDS was quantified in ≥75 cells by measuring the overall 
nuclear fluorescence using ImageJ software (National Institutes of Health). Images were obtained 
using a microscope (LSM-700; Carl Zeiss). Kinetic study of XPC-GFP accumulation was performed 
in SV40-transformed XP4PA cells stably expressing XPC-GFP as described previously (Dinant et 
al., 2007). In brief, cells were cultured on 25-mm quartz coverslips (SPI Supplies) and imaged 
on a laser-scanning confocal micro- scope (SP5; Leica) using an Ultrafluar quartz 100×, 1.35 NA 
glycerol immersion lens (Carl Zeiss) at 37°C and 5% CO2. Imaging medium was the same as culture 
medium. For UV laser irradiation, a 2-mW pulsed (7.8 kHz) diode pumped solid-state laser emitting 
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at 266 nm (DPSL; Rapp OptoElectronic) was connected to the microscope (SP5) with all-quartz 
optics. Treated nuclei were imaged using the same scanning speed, zoom factor, and laser power. 
Images were acquired using the LAS AF software (Leica). Data analysis was performed using the 
ImageJ software package. Measured fluorescence levels were determined in the specific region of 
the damage in the nucleus over time and corrected for background values. Resulting curves show 
the relative amount of protein in the damaged area over time and were normalized to 1 for the 
data points before damage.
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Supplemental figures
Figure S1. Analysis of cellular RNF111- interacting proteins. (A) MS-based analysis of RNF111-interacting 
proteins. U2OS or U2OS/GFP-RNF111 cells grown in light or heavy SILAC medium, respectively, were lysed and 
subjected to GFP IP. Subsequently, samples were combined, resolved by SDS-PAGE, and analyzed by MS. SILAC 
(heavy/light) ratios for individual proteins were determined. m/z, mass per charge. (B) Overview of selected 
proteins with high SILAC (heavy/light) ratios identified by the experimental approach outlined in A. DUB, deu-
biquitylating enzyme.
A
B
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Figure S2. RNF111 promotes Ubc13–Mms2-dependent ubiquitylation. (A) U2OS cells were cotransfected 
with indicated combinations of GFP-RNF111 and Strep-HA-Ubc13 plasmids. Whole-cell extracts (WCE) were 
subjected to GFP IP followed by immunoblotting with HA antibody. (B) U2OS cells were cotransfected with the 
indicated combinations of FLAG-UBE2O and Strep-HA-RNF111 plasmids. Whole-cell extracts were subjected 
to FLAG IP followed by immunoblotting with HA antibody. (C) As in A, except that cells were transfected with 
combinations of GFP-RNF4 and Strep-HA-Ubc13 antibodies. (D) As in C, except that extracts were subjected to 
Strep-Tactin pull-down followed by immunoblotting with the GFP antibody. (E) Extracts of U2OS cells sequen-
tially transfected with RNF111 siRNA and S-FLAG-Strep–tagged RNF111 (SFS-RNF111) plasmids as indicated 
were subjected to Strep-Tactin pull-down. Bound complexes were incubated with ubiquitylation reaction mix-
ture containing E1, Ubc13–Mms2 complex, and HA-ubiquitin as indicated and washed extensively, and RNF111 
auto-ubiquitylation activity was analyzed by immunoblotting with HA antibody. (F) As in E, except that UbcH5a 
was used as an E2 enzyme instead of Ubc13–Mms2 where indicated. MW, molecular weight.
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Figure S3. RNF111 promotes UV-induced ubiquitylation of XPC. (A) U2OS or U2OS/Strep-HA-ubiquitin cells 
transfected with control (?) or XPC siRNAs were exposed or not exposed to UV as indicated and collected 1 h 
later, and XPC ubiquitylation was analyzed by immunoblotting Strep-Tactin pull-downs of whole-cell extracts 
(WCE) with XPC antibody. (B) As in A, except that cells were transfected with indicated control (CTRL) or RNF111 
siRNAs. (C) As in A, except that cells were transfected with indicated control, RNF111, or RNF4 siRNAs. (D) 
Knockdown efficiency of Ubc13 siRNA. U2OS/Strep-HA-ubiquitin cells were transfected with control (-) or 
Ubc13 siRNAs, collected 72 h later, and analyzed by immunoblotting with the Ubc13 antibody. (E) U2OS cell 
lines stably expressing Strep-HA–tagged RNF111 WT or *R mutant were collected at the indicated times after 
exposure to UV and analyzed by immuno- blotting with HA antibody. (F) Time course analysis of UV-induced 
XPC ubiquitylation. U2OS/Strep-HA-ubiquitin cells were collected at the indicated times after exposure to UV, 
and XPC ubiquitylation was analyzed as in A. MW, molecular weight.
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Abstract
 
XPC recognizes UV-induced DNA lesions and initiates their removal by Nucleotide Excision Repair 
(NER). Damage recognition in NER is tightly controlled by ubiquitin and SUMO modifications. 
Recent studies have shown that the SUMO-targeted ubiquitin ligase RNF111 promotes K63-linked 
ubiquitylation of SUMOylated XPC after DNA damage. However, the exact regulatory function of 
these modifications in vivo remains elusive. Here we show that RNF111 is required for efficient 
repair of UV-induced DNA lesions. RNF111-mediated ubiquitylation promotes the release of 
XPC from damaged DNA after NER initiation, and is needed for stable incorporation of the NER 
endonucleases XPG and ERCC1/XPF. Our data suggest that RNF111, together with the CRL4DDB2 
ubiquitin ligase complex, is responsible for sequential XPC ubiquitylation, which regulates the 
recruitment and release of XPC and is crucial for efficient progression of the NER reaction, thereby 
providing an extra layer of quality control of NER. 
67
SUMO and ubiquitin-dependent XPC exchange drives nucleotide excision repair
III
Introduction
DNA integrity is constantly challenged by internal and external DNA-damaging agents that induce 
DNA lesions. When not properly repaired, DNA lesions may result in malignant transformation or 
accelerated ageing. Different DNA repair mechanisms exist that collectively remove most lesions 
and safeguard genome stability. Nucleotide excision repair (NER) is one of these mechanisms, 
which removes - in a multi step process - a wide variety of helix-distorting lesions, including UV-
induced cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine-pyrimidone photoproducts 
(6-4PPs) (Marteijn et al., 2014). Lesions located in the transcribed strand of active genes block 
elongating RNA polymerase II and are specifically processed by a dedicated transcription-coupled 
NER (TC-NER) sub-pathway. However, the vast majority of helix-distorting DNA lesions located 
anywere in the genome are targeted by the global genome NER sub-pathway (GG-NER) (Marteijn 
et al., 2014). After damage recognition by one of these sub-pathways, the 10 subunit TFIIH 
complex is recruited (Volker et al., 2001; Yokoi et al., 2000) to unwind the DNA around the lesion. 
TFIIH and XPA, which also bind the damaged strand (Camenisch et al., 2006), verify the presence 
of lesions (Sugasawa et al., 2009). Next, RPA binds the undamaged strand and plays a role in 
correct positioning of the structure-specific endonucleases XPG and ERCC1/XPF to excise a ~25 
nt stretch of single-strand DNA containing the lesion (de Laat et al., 1998). The activity of these 
endonucleases and thereby the excision of the DNA lesion is tightly orchestrated. First XPG is 
recruited either independently (Zotter et al., 2006) or through its interaction with TFIIH (Ito et 
al., 2007). Next ERCC1/XPF is recruited which can only incise the DNA in the presence of XPG. 
Only after the 5’ incision has been completed by ERCC1/XPF, the 3’ incision by XPG is triggered 
(Staresincic et al., 2009). After incision, the DNA is restored to its original state by DNA synthesis 
and ligation steps.
Within GG-NER, DNA damage recognition occurs through binding of the XPC-complex to 
lesion-induced helix distortions (Min and Pavletich, 2007) and is essential for assembly of the 
core NER factors and progression of the NER reaction(Volker et al., 2001). XPC is part of a 
heterotrimeric complex together with one of the two mammalian orthologs (RAD23A or RAD23B) 
of the Saccharomyces cerevisiae Rad23p (Masutani et al., 1994) and centrin2 (Araki et al., 2001). 
Although XPC is the main DNA damage sensor of GG-NER, it does not efficiently recognize UV-
induced CPDs, which are the most abundant UV-induced DNA lesions. For efficient repair of these 
lesions initial binding of the UV-DDB complex, a heterodimer consisting of DDB1 and DDB2 (XPE), 
is required (Scrima et al., 2011; Wakasugi et al., 2002). UV-DDB is not only involved in damage 
detection, but together with Cullin-4A (CUL4A) and Rbx1/Roc1 (Groisman et al., 2003) this complex 
possesses E3 ubiquitin ligase activity that - amongst others - mediates polyubiquitylation of the 
DNA damage sensors DDB2 and XPC. As ubiquitin can use all seven internal lysine residues (K6, 
K11, K27, K29, K33, K48 and K63) and its N-terminus for chain formation, different chain linkages 
can be formed. These various polyubiquitin chain types have distinct structures and different 
consequences for the target protein (Kulathu and Komander, 2012). While ubiquitylated DDB2 
is targeted for degradation (Scrima et al., 2011), ubiquitylated XPC is not, but acquires increased 
affinity for damaged DNA in vitro (Sugasawa et al., 2005). Following UV-irradiation XPC is not only 
modified by ubiquitin, but also by the small ubiquitin-like modifier (SUMO) (Silver et al., 2011; Wang 
et al., 2007; Wang et al., 2005) in a DDB2-, and XPA-dependent manner (Wang et al., 2007; Wang 
et al., 2005), which was shown to protect XPC from proteasomal degradation . 
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Figure1. RNF111 is necessary for efficient GG-NER. (A) Representative pictures of Unscheduled DNA 
Synthesis of the indicated MEFs, determined by EdU incorporation over 3 h after UV-irradiation (16 J m-2). Scale 
bar, 25 µm. (B) Quantification of UDS levels in MEFs, as determined by EdU incorporation over a time period 
of 3 h or 9 h after UV-irradiation (16 J m-2). UDS levels in WT MEFs were set at 100% (n>100 cells per sample, in 
at least two independent experiment; mean ± SD). (C) 6-4PP removal assayed by immunofluorescence, using a 
6-4PP specific antibody. The indicated MEFs were UV-irradiated (10 J m-2) and allowed to repair 6-4PPs for the 
indicated time points. Relative fluorescence directly after UV was set at 100%. (n>70 cells, three independent 
experiments; mean ± SD).
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Recently, an additional ubiquitin E3 ligase; RNF111, that promotes XPC ubiquitylation was 
identified (Poulsen et al., 2013). RNF111, also known as Arkadia, was originally named after the 
arkadia mutation in mice. Homozygous Arkadia mutants are non-viable since they fail to form 
the regulatory primitive node, which is crucial during early gastrulation. This problem in the 
development of the mouse embryo is most likely caused by the loss of the ubiquitin ligase activity 
of RNF111 that promotes transforming growth factor β (TGF-β) signaling (Episkopou et al., 2001; 
Mavrakis et al., 2007). RNF111 belongs to the class of SUMO-targeted ubiquitin ligases (STUbLs), 
which facilitate crosstalk between SUMOylation and ubiquitylation. Accordingly, RNF111 specifically 
targets SUMOylated XPC and modifies it with K63-linked ubiquitin chains dependent on the 
E2-conjugating enzyme UBC13 (Poulsen et al., 2013). Together these observations illustrate the 
importance of ubiquitin and ubiquitin-like modifications in regulating the DNA damage recognition 
factors that initiate NER (van Cuijk et al., 2014). In this study, we investigated the molecular function 
of the RNF111-dependent ubiquitylation of XPC and its role in NER. We show that although 
RNF111 is not essential for GG-NER, it strongly enhances the repair reaction by stimulating the 
release of XPC from damaged DNA, thereby enabling the progress of NER by recruitment of the 
endonucleases XPG and XPF/ERCC1.
Results
RNF111 is required for efficient GG-NER
To study the role of RNF111 during NER we first determined the repair capacity in the absence 
of RNF111 by measuring the UV-induced unscheduled DNA synthesis (UDS) in the first 3 h after 
UV (Mavrakis et al., 2007), which is a measure of GG-NER activity. In line with a previous study 
(Poulsen et al., 2013), NER-deficient Xpc-/- MEFs and Rnf111-/- MEFs (clone A and B) displayed a 
strongly reduced repair capacity as compared to NER-proficient wild type (WT) MEFs (Fig. 1A and 
B). To test whether this reduced repair capacity in Rnf111-/- MEFs is caused by a blocked or delayed 
NER reaction, 6-4PP repair kinetics were determined in WT, Xpc-/- and Rnf111-/-MEFs. Cells were 
fixed at different time points after global UV-irradiation (10 J m-2) and immunostained for 6-4PPs. 
In WT MEFs the vast majority (≈ 75%) of 6-4PPs was removed within 6 h after UV-irradiation (Fig. 
1C and Supplementary Fig. 1A). As expected, 6-4PP repair was not observed in GG-NER-deficient 
Xpc-/- MEFs, not even after 24 h. Rnf111-/- MEFs displayed an intermediate phenotype; 6 h after 
UV-irradiation 6-4PP removal was severely inhibited, with approximately 70% of these lesions 
remaining (Fig. 1C and Supplementary Fig. 1A). Strikingly, 24 h after UV exposure 6-4PP repair was 
almost completed, suggesting that the NER reaction is not fully blocked, but rather seems to be 
retarded. This was further corroborated by measuring UDS levels over an increased time window 
of 9 h instead of 3 h. UDS levels of Xpc-/- MEFs remained low, indicative of their full repair deficiency. 
However, residual UDS levels in Rnf111-/-MEFs increased from 40% over 3 h, up to 60-80% after 9 h 
as compared to WT MEFs (Fig. 1B and Supplementary Fig. 1B). Together these results indicate that 
although RNF111 is not essential for GG-NER, it strongly enhances the repair reaction.
RNF111 is required for XPC release from sites of UV damage
RNF111 ubiquitylates XPC in response to UV (Poulsen et al., 2013). Therefore, the reduced 
GG-NER capacity in the absence of RNF111 suggests that RNF111-dependent ubiquitylation 
facilitates GG-NER by regulating XPC function. To further investigate this, we measured XPC-GFP 
accumulation kinetics at sites of local UV-C laser (266 nm) induced DNA damage (LUD) using 
quantitative live cell confocal imaging. Surprisingly, knockdown of RNF111, using two independent 
siRNAs (Supplementary Fig. 1C) resulted in a 2-fold increase in XPC-GFP accumulation at LUD 
(Fig. 2A and Supplementary Fig. 1D). These data argue for an increase in XPC binding to lesions 
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Figure 2. RNF111 is required for XPC release. (A) Relative XPC-GFP accumulation at sites of local UV-
damage (LUD) in control and RNF111 depleted cells. GFP fluorescence intensity at UV-C laser induced 
LUD was measured over time using live cell confocal imaging and quantified to pre-damage intensity set 
at 1 at t=0 (n>15 cells per sample, measured in two independent experiments; mean ± 2* SEM). (B) Top 
panel: Representative immunofluorescence pictures of co-localization of XPC with CPD at LUD in WT and 
Rnf111-/-MEFs at the indicated time points after UV-irradiation (60 J m-2) are shown. Scale bars: 5µm. Lower 
panel: Quantification of the XPC co-localization with CPD (n>50 cells with LUD were analyzed per sample 
in three independent experiments; mean ± SD). (C) Top panel: FRAP analysis of XPC-GFP in mock treated 
or global UV-irradiated (10 J m-2) XP4PA (XPC-deficient) cells, upon transfection with the indicated siRNA’s. 
XPC-GFP was bleached in a small strip within the nucleus and fluorescence recovery was measured over 
45 s and normalized to pre-bleach intensity (n=40; from two independent experiments mean ± 2* SEM). 
The immobilized fraction (%) = 1-((Average fluorescence intensity UV-irradiated cells - the first data point after 
bleaching) / (Average fluorescence intensity unchallenged cells - the first data point after bleaching), is plotted in 
the lower panel. The immobilized fraction was calculated over the last 10s. (D) Inverse FRAP (iFRAP) analysis of 
XPC-GFP at LUD. XP4PA cells stably expressing XPC-GFP were transfected with the indicated siRNA’s. 72h after 
transfection, cells were locally exposed to a 266 nm UV-C laser. After the accumulation plateau was reached 
(5 min after exposure) the undamaged part of the nucleus was continuously bleached and fluorescence in the 
damaged area was monitored. Fluorescence was normalized to pre-bleach intensity (n>15 cells per sample, 
measured in two independent experiments; mean ± SEM).
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in the absence of RNF111 and suggest an improved DNA damage detection, which is seemingly 
at odds with the observed reduction in repair capacity in the absence of RNF111. The RNF111-
dependent XPC binding properties were further investigated by determining long term binding 
of XPC to DNA damage by scoring XPC co-localization with a damage marker (anti-CPD) using 
immunofluorescence (Fig. 2B). At 30 min after local UV-irradiation, no difference in co-localization 
of XPC with LUD was observed. However, at later time points (4, 6 and 8 h) after UV a strikingly 
higher co-localization with LUD was observed in Rnf111-/- MEFs as compared to WT MEFs (Fig. 
2B). Similar results were observed in U2OS cells treated with two different siRNAs targeting 
RNF111 (Supplementary Fig. 2). In contrast, knockdown of RNF4, another STUbL involved in the 
mammalian DNA damage response (Galanty et al., 2012; Yin et al., 2012), had no effect on the UV-
induced co-localization of XPC with DNA damage (Supplementary Fig. 2), showing the specificity of 
RNF111 for XPC regulation. This increased XPC accumulation could either be explained by a more 
stable binding of XPC to DNA damage or by a higher concentration of substrates, as RNF111 loss 
resulted in slower repair kinetics, or both. To distinguish between these possibilities and to resolve 
the apparent contradiction between more XPC binding and slower repair, we determined XPC 
using fluorescence recovery after photobleaching (FRAP) on XPC-GFP in RNF111-depleted cells. 
The mobility of XPC-GFP was unaffected by RNF111 depletion under unperturbed conditions (Fig. 
2C, 0 J m-2)), indicating that the probing of DNA by XPC in the absence of UV-lesions is not affected 
(Hoogstraten et al., 2008). Upon UV-exposure (10 J m-2) XPC is engaged in damage recognition, 
resulting in an increased XPC-GFP immobilization (Hoogstraten et al., 2008). Knockdown of RNF111 
resulted in a further increase in XPC-GFP immobilization, as shown by the FRAP curves (Fig. 2C, 
upper panel) and by plotting of the calculated immobile fractions (Fig. 2C, lower panel). These data 
suggest that XPC is more strongly associated with damaged DNA in the absence of RNF111, which 
might be a consequence of increased association (Kon) and/or decreased dissociation kinetics (Koff). 
To study whether the Koff is affected, we applied inverse FRAP (iFRAP) to measure the dissociation 
of XPC from sites of DNA damage. To this end, LUD was first introduced to locally accumulate 
XPC-GFP until steady-state was reached. Subsequently, the entire nucleus, with exception of the 
damaged area, was continuously bleached and the loss of fluorescence at the site of damage was 
measured at regular time intervals (Fig. 2D). Depletion of RNF111 resulted in reduced dissociation 
kinetics (Koff) of XPC-GFP at LUD (t1/2=33-43 s) as compared to control transfected cells (t1/2=24 
s), indicative of an increased residence time. Together our results suggest that RNF111 plays an 
important role in promoting the release of XPC from damaged DNA. The reduced clearance of XPC 
from damaged sites may thus explain the increased accumulation of XPC-GFP at LUD and may 
cause the delayed repair.
RNF111 is essential for efficient XPG and XPF/ERCC1 loading
Our finding that knockdown of RNF111 results in prolonged binding of XPC to DNA damage 
provides a good model system to study NER factor handover during the repair reaction and to 
determine which NER factors depend on XPC release to be incorporated into the NER complex. 
To this end, we tested whether a panel of NER factors (DDB2, XPB, XPG, XPF and ERCC1) co-
localized to LUD 30 min after UV-irradiation (60 J m-2), as marked by CPD-photolyase-mCherry 
(Aydin et al., 2014), in RNF111 siRNA-depleted U2OS cells. Co-localization of early factors, like 
DDB2 (upstream of XPC) and XPB (subunit of TFIIH, directly downstream of XPC) with the DNA 
damage marker, was not affected by RNF111 knockdown. Interestingly, co-localization of the 
endonucleases XPG and XPF/ERCC1 with DNA damage was significantly lower (20-50%) in RNF111-
depleted cells than in control siRNA-transfected cells (Fig. 3A). In contrast, depletion of RNF4 had 
no effect on UV-induced co-localization of NER factors with DNA damage (Fig. 3A). To study the 
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Figure 3. RNF111 is required for binding of XPG and XPF/ERCC1 to the NER complex. (A) U2OS cells 
expressing CPD-photolyase-mCherry were transfected with the indicated siRNA’s three days before the 
immunofluorescence experiment. Cells were local UV-irradiated (60 J m-2) and immunostained for the indicated 
proteins 30 min later. The percentage of co-localization with the damage marker CPD-photolyase-mCherry at 
LUD is plotted in the graph (n>50cells containing a LUD were scored in at least three independent experiments; 
mean ± SD). (B) The immobilized fraction of XPB-GFP, GFP-XPA, XPG-GFP and ERCC1-GFP as determined by 
FRAP analysis in mock or UV-treated (10 J m-2) cells upon transfection with the indicated siRNA’s (n>32 cells 
from at least 2 independent experiments; mean ± 2* SEM). (C) Cells stably expressing XPG-GFP and ERCC1-
GFP transfected with the indicated siRNA’s were locally irradiated using a 266 nm UV-C laser. GFP fluorescence 
intensity at LUD was monitored for 6 min, with 10 s intervals and normalized to pre-damage values. (n=24 cells 
from three independent experiments; mean ± SEM).
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in vivo binding characteristics of these factors to active NER complexes in the absence of RNF111 
in a quantitative manner, we determined the mobility of these proteins by FRAP analysis in RNF111 
depleted cells expressing GFP-tagged versions of XPB, XPA, XPG and ERCC1 upon UV irradiation. 
Previous studies have shown that for each of these NER factors a clear UV-induced immobilization 
could be measured by FRAP (Hoogstraten et al., 2002; Houtsmuller et al., 1999; Rademakers et 
al., 2003; Zotter et al., 2006). Under unperturbed conditions (0 J m-2), no difference in mobility was 
observed for the indicated NER factors between control and RNF111 depleted cells (Fig.3B). In 
contrast, after UV-irradiation (10 J m-2) both the XPB and XPA proteins showed a further increased 
immobilization upon RNF111 depletion, similar to what was observed for XPC (Fig. 2C). These 
results suggest that, like XPC, also XPB and XPA are more associated with DNA damage in the 
absence of RNF111. This increased association most likely represents longer dwell times of these 
factors into transiently trapped NER reaction intermediates that cannot finalize the repair reaction 
due to loss of RNF111. FRAP analysis of XPG-GFP and ERCC1-GFP in cells lacking RNF111 revealed 
a striking opposite effect shown by a dramatic decrease in UV-induced immobilization, in line 
with the immunofluorescence experiments. This strong reduction of UV-induced immobilization 
likely reflects the inability of these endonucleases to stably integrate into active NER complexes in 
the absence of RNF111 (Fig. 3B). This was further confirmed by the strongly reduced UV-induced 
accumulation of XPG-GFP and ERCC1-GFP to LUD in living cells upon RNF111 depletion, almost to 
the same extent as observed upon siRNA mediated XPA depletion (Fig. 3C). As ERCC1/XPF binding 
to DNA damage is dependent on the presence of XPG (Staresincic et al., 2009), these data suggest 
that when XPC remains bound to the initiating NER complex, both XPG and XPF/ERCC1 cannot be 
efficiently recruited to or stably incorporated in the NER complex.
XPC release and ongoing NER is SUMO and K63-chain dependent
As RNF111 is a STUbL that mediates UV-induced K63-linked ubiquitylation of XPC (Poulsen et 
al., 2013), we investigated whether K63-linked ubiquitylation is required for XPC release from 
DNA damage and subsequent recruitment of the NER endonucleases. Towards this goal, siRNA 
targeting UBC13, the cognate E2-enzyme promoting K63-linked ubiquitylation (David et al., 2010; 
Komander and Rape, 2012), was used and XPC co-localization at LUD with CPD as damage marker 
was scored in U2OS cells at several time points after UV-irradiation. UBC13 depletion, as confirmed 
by western blot (Supplementary Fig. 3A), resulted in prolonged XPC co-localization with sites of 
DNA damage (Fig. 4A, red bars), similar to the observations in Rnf111-/- cells. In contrast, depletion 
of another E2 conjugating enzyme, UBE2Q2, which is not involved in K63-mediated ubiquitylation 
(David et al., 2010) had no effect on UV-induced co-localization of XPC with DNA damage (Fig. 4A, 
light blue bars). RNF111-mediated XPC ubiquitylation is dependent on XPC SUMOylation (Poulsen 
et al., 2013). Therefore, we depleted UBC9, the E2 conjugating enzyme crucial for SUMOylation 
(Vertegaal, 2007), which indeed also resulted in more XPC co-localization with LUD at later time 
points (Fig. 4A, orange bars). Moreover, FRAP analysis of XPC-GFP showed that depletion of either 
UBC9 or UBC13 resulted in an increased UV-induced immobilization (Fig. 4B), to a similar extent 
as seen for RNF111 depletion. In addition, FRAP studies on ERCC1-GFP showed a decrease in UV-
induced immobilization upon depletion of UBC9 or UBC13 (Fig. 4C), indicating that XPC release 
from damaged DNA and the subsequent stable incorporation of the NER endonucleases into 
the repair complex is not only dependent on RNF111, but also on SUMOylation and K63-linked 
ubiquitylation. To address whether the SUMO-dependent ubiquitylation of XPC itself is sufficient 
to explain the observed effects on the release of XPC and recruitment of the downstream NER 
endonucleases, we set out to generate an XPC mutant that was refractory to SUMOylation 
(Poulsen et al., 2013; Wang et al., 2005). With this approach, RNF111-mediated XPC ubiquitylation 
would be inhibited without affecting RNF111 activity towards other putative substrates. 
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Figure 4. XPC release is SUMO and K63-ubiquitylation dependent. (A) Top panel: Representative pictures of 
co-localization of XPC with CPD at LUD in U2OS cells transfected with the indicated siRNA’s 30 min or 4 h after 
local UV-irradiation (60 J m-2) are shown. Scale bar: 5µm. Bottom panel: Quantification of XPC co-localization 
with the damage marker CPD. (n≈50 cells containing a LUD were scored per sample in three independent 
experiments; mean ± SD). The immobilized fraction of XPC-GFP (B) or ERCC1-GFP (C) as determined by FRAP 
analysis in mock or UV-treated (10 J m-2) cells depleted by siRNA of UBC9 or UBC13 (n=40 from 2 experiments; 
mean ± 2* SEM). (D) HeLa/FLAG-SUMO2 cells were transfected with plasmids expressing WT or K8R XPC-
GFP, then left untreated or incubated with doxycycline (DOX) to induce FLAG-SUMO2 expression. One 
hour after UV exposure (16 J m-2), cells were lysed under denaturing conditions, and XPC SUMOylation was 
analyzed by immunoblotting of FLAG IPs with GFP antibody. (E) The immobilized fraction of WT XPC-GFP or 
K8R XPC-GFP as determined by FRAP analysis in mock or UV-treated (10 J m-2) cells (n>40 from 3 experiments; 
mean ± 2* SEM). (F) Cells stably expressing WT XPC-GFP or K8R XPC-GFP were locally irradiated using a 266 
nm UV-C laser. GFP fluorescence intensity at UV-C laser induced LUD was measured over time using live cell 
confocal imaging and quantified to pre-damage intensity set at 1 at t=0 (n>25 cells per sample, measured in 
two independent experiments; mean ± SEM). (G) XP4PA cells stably expressing WT XPC-GFP of K8R XPC-GFP 
were locally UV-irradiated (60 J m-2) and immunostained for endogenous XPB, ERCC1 and XPF proteins 30 min 
later. The percentage of co-localization with GFP-XPC at LUD is plotted in the graph (n>100 cells containing a 
LUD were scored in at two independent experiments; mean ± SD).
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Using the GPS-SUMO algorithm (Zhao et al., 2014) we identified 8 putative SUMOylation sites in 
XPC (Supplementary Fig. 3B). By mutating each of the 8 lysine residues present in these SUMO 
consensus sites to arginines, we obtained an XPC mutant (K8R XPC-GFP) that could no longer 
be SUMOylated (Fig. 4D). The K8R XPC-GFP mutant was stably expressed in XP-C cells and its 
mobility and DNA damage kinetics were analyzed using live cell imaging. No difference in mobility 
was detected under unperturbed conditions (0 J m-2) as determined by FRAP. However, upon UV-
induced DNA damage (10 J m-2) the K8R XPC-GFP was more immobilized than WT XPC-GFP, to a 
similar magnitude as was observed after depletion of RNF111 or UBC9 (Fig. 4E). In line with this, 
the K8R XPC mutant showed an approximately 2-fold increase in accumulation at LUD compared 
to WT XPC. Finally, similar to RNF111 depletion, we observed a clear reduction in ERCC1 and XPF 
accumulation at LUD in K8R XPC-GFP compared to WT XPC-GFP expressing cells (Fig.4G), while no 
difference in the localization of XPB was found. Together these experiments demonstrate that the 
XPC release and subsequent binding of the NER endonucleases is dependent on the SUMOylation 
of XPC.
Discussion
The recent identification of RNF111 as a SUMO-targeted ubiquitin ligase (STUbL) involved in UV-
induced ubiquitylation of XPC (Poulsen et al., 2013) has added another level of complexity to 
the ubiquitin-dependent regulation of this DNA damage sensor, as previously also CRL4DDB2 was 
identified as an E3-ligase complex acting on XPC (Sugasawa et al., 2005). Interestingly, while both 
ubiquitin ligase activities are required for efficient GG-NER, they may have opposing effects on 
XPC. Whereas CRL4DDB2-induced ubiquitylation has been suggested to increase XPC DNA binding 
affinity in vitro (Sugasawa et al., 2005), we provide evidence that RNF111 and its cognate E2 - UBC13 
- are required for efficient release of XPC from UV-lesions, which permits the progress of the NER 
reaction. How can XPC ubiquitylation by two different E3 ligases have such a diverse functional 
outcome? One obvious explanation is that these E3 ligases modify XPC with different types of 
ubiquitin chains. While RNF111 in cooperation with UBC13 generates K63-linked ubiquitin chains 
on XPC, the exact type of ubiquitin chains formed by CRL4DDB2 is currently unknown. However, in 
line with the finding that CRL4DDB2 auto-ubiquitylates DDB2 resulting in its subsequent degradation 
(Chen et al., 2001; Nag et al., 2001; Puumalainen et al., 2014; Rapic-Otrin et al., 2002), most CRL4-
type ubiquitin ligases promote proteasomal degradation of their substrates (Hannah and Zhou, 
2009; Higa and Zhang, 2007), which suggests that CRL4DDB2 might form K48-linked ubiquitin chains 
on XPC. If indeed XPC is ubiquitylated by K48 chains in response to UV to increase its DNA binding 
affinity, other factors may shield or protect it from proteolytic attack. One such candidate is the 
XPC complex partner RAD23B, which is known to protect XPC from proteasomal degradation, 
already in non UV-challenged cells (Ng et al., 2003). Other proteins involved in the stabilization 
of XPC might be the deubiquitylating enzymes (DUBs) OTUD4 and USP7, which were shown to 
deubiquitylate XPC upon UV-induced DNA damage (He et al., 2014; Lubin et al., 2014). It will be 
interesting to study whether these DUBs are only involved in the protection of XPC from proteolytic 
degradation or if they are also important for ubiquitin chain editing on XPC. In this latter scenario, 
XPC would first be ubiquitylated by CRL4DDB2 after which the K48-linked ubiquitin chains might be 
trimmed down to permit K63-linked ubiquitylation by RNF111 on the same lysines modified by 
CRL4DDB2, resulting in the subsequent release of XPC from sites of DNA damage. 
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Figure 5. Proposed model for RNF111-dependent XPC ubiquitylation in controlling NER. In WT cells 
SUMOylated XPC is ubiquitylated by RNF111, promoting its release from damaged DNA. This RNF111-mediated 
XPC release facilitates XPG and ERCC1/XPF recruitment, thereby enabling an efficient NER reaction. In 
RNF111-/- cells, where XPC is not modified by RNF111-dependent K63 ubiquitin chains, XPC remains more 
stably associated with the pre-incision NER complex. This interferes with proper loading of XPG, thereby 
inhibiting the NER reaction. Branched ‘Ub’ represents K48-linked Ub chains, linear ‘Ub’ represents K63-linked 
Ub chains; ‘S’ represents SUMOylation; ‘1’ and ‘2’ represent DDB1 and DDB2, respectively.
Intriguingly, the RNF111-mediated ubiquitylation occurs on one of the NER-initiating enzymes, but 
it affects one of the last NER steps; the loading of the endonucleases XPG and ERCC1/XPF. While 
we cannot exclude that RNF111 might also target other NER factors downstream of XPC that may 
contribute to the reduced NER-incision complex assembly, the reduced accumulation of ERCC1 
and XPF at sites of UV damage in cells expressing an XPC mutant that cannot be SUMOylated 
(Fig.4D-G) strongly suggests that this is caused by the action of RNF111 on XPC. In addition, no 
UV-damage induced SUMO modification of other NER factors have been described thus far. We 
therefore propose a model in which chromatin-bound, SUMOylated XPC is ubiquitylated by RNF111 
upon DNA damage (Poulsen et al., 2013), thereby stimulating its release from the NER pre-incision 
complex that contains TFIIH and XPA (Fig. 3B). This key step most likely generates better access of 
XPG or increased stable binding of XPG to the NER pre-incision complex. In addition, more efficient 
binding of XPG will promote the 5’ incision by ERCC1/XPF and progression of the NER reaction 
(Fig. 5, left panel). In contrast, in the absence of RNF111, damage-bound SUMOylated XPC is not 
ubiquitylated and remains stably bound to the NER complex, interfering with XPG loading and 
the subsequent recruitment of ERCC1/XPF, which are required for the excision of the damaged 
DNA strand by these endonucleases (Fig. 1B and Fig. 5, right panel). The need for XPC release 
for proper XPG incorporation into the NER complex is in line with in vitro experiments showing 
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that upon the arrival of RPA and XPG, XPC is released from the NER complex (Riedl et al., 2003). 
It should also be noted that the position where XPC is bound, the junction between ds-DNA and 
ss-DNA at the strand opposite of the lesion, 3’ with respect to the lesion-containing strand (Min 
and Pavletich, 2007), is also the site where the XPG endonuclease acts. For this reason of potential 
steric hindrance, it is logical to assume that XPC must be released prior to XPG loading.
Further research should uncover whether the ubiquitin-binding UBM domain present in 
XPG (Fagbemi et al., 2011) might play a role in this process. UBM domains have been shown 
to interact with mono-ubiquitin and K63-linked, but not K48-linked, chains (Burschowsky et al., 
2011). This suggests that XPG might be able to interact with the K63-linked ubiquitylated form 
of XPC, generated by RNF111. In addition to the presence of TFIIH, this interaction could be 
required for efficient recruitment of XPG and for the subsequent or simultaneous extraction of 
XPC from the NER pre-incision complex (Zotter et al., 2006). Furthermore, it has been shown that 
XPG constitutively interacts with TFIIH (Ito et al., 2007), which may suggest that TFIIH brings XPG 
into the NER complex. Interestingly however, and in line with earlier observations (Zotter et al., 
2006), our data suggest that XPG is recruited to sites of DNA damage independent of TFIIH as it 
shows different RNF111-dependent binding kinetics than TFIIH: upon RNF111 knockdown XPB is 
more stably immobilized on sites of DNA damage, whereas XPG immobilization could hardly be 
detected. However, another possibility is that XPG arrives as part of the TFIIH complex at sites of 
DNA damage, but will dissociate as long as XPC remains bound to the pre-incision NER complex. 
The dynamic DNA association of XPC (Hoogstraten et al., 2008) could give XPG the possibility to 
compete with XPC for binding to the NER pre-incision complexes even if XPC release is slowed 
down in the absence of RNF111-mediated ubiquitylation. This will eventually result in a functional 
NER reaction, however at a much slower rate, which could explain the proficient, but strongly 
delayed, NER phenotype upon RNF111 knockdown (Fig. 1B and C). 
Based on current knowledge it is expected that the different ubiquitylation events on XPC are 
regulated in a tightly coordinated manner to ensure that XPC binds and dissociates at the right 
time and place. Within NER, different – partially overlapping - stages can be recognized, e.g. 
damage recognition and verification, establishment of the pre-incision complex and final dual 
incision. All steps prior to the actual incision are considered to be reversible, but once the incision 
by ERCC1/XPF is made the process reaches a “point of no return” (Marteijn et al., 2014). We 
speculate that in response to UV, XPC is first modified by CRL4DDB2, resulting in more stable binding 
to sites of DNA damage. Subsequently, XPC is SUMOylated and recognized by RNF111, which 
mediates K63-linked ubiquitylation of XPC to promote its release from the NER complex. This XPC 
SUMOylation is dependent on the presence of DDB2 and XPA (Wang et al., 2005). As XPA plays an 
important role during the damage verification step, it is expected that this XPC SUMOylation and 
its subsequent release occurs only upon damage verification by the NER pre-incision complex 
(Fig. 5). We propose that RNF111-mediated ubiquitylation of XPC, required for stable integration 
of XPG, marks a decisive stage in the progression of NER reaction to reach the “point of no return”. 
In summary, we have uncovered a new layer of ubiquitin regulation of the DNA damage 
recognition step of NER. We propose a first-in/first-out model: the ubiquitylation-driven release of 
the NER-initiating factor XPC is required to make room for the incorporation of the downstream 
NER endonucleases. This UBC13 and RNF111-dependent process is required to pass the NER 
reaction through the successive steps thereby facilitating efficient damage removal. In addition to 
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the regulation by RNF111 and UBC13 as XPC ubiquitylation factors, this process is dependent on 
SUMOylation mediated by UBC9. This indicates the importance of crosstalk between SUMOylation 
and ubiquitylation in the regulation of damage recognition. Our findings not only show the 
importance of precise regulation of damage recognition, but also the regulation of the progression 
of the NER reaction. Taken together, we conclude that RNF111-mediated ubiquitylation of XPC is a 
key regulator of NER efficiency. The sequential SUMOylation and differential ubiquitylation of XPC 
to control the NER reaction might serve as a paradigm for the spatiotemporal regulation of other 
processes involving different types of sequential post-translational protein modifications.
Methods
Cell culture and treatments
U2OS cells also including those expressing CPD-photolyase-mCherry (Aydin et al., 2014) and 
the SV40-immortalized human fibroblasts: XP4PA (expressing XPC-GFP) (Hoogstraten et al., 
2008), XPCS2BA (expressing XPB-GFP) (Hoogstraten et al., 2002), XP2OS (expressing GFP-XPA) 
(Rademakers et al., 2003) and XPCS1RO (expressing XPG-GFP) (Zotter et al., 2006) were cultured 
under standard conditions in DMEM/F10 supplemented with 10% fetal calf serum (FCS) and 
1% penicillin-streptomycin (PS) at 37oC and 5% CO2. Wild type (clone A littermate of Xpc-/-and 
clone B littermate of Rnf111-/-), Xpc-/- (Sands et al., 1995) and two independent clones of Rnf111-/- 
knockout MEFs, indicated as A and B (Mavrakis et al., 2007) were grown in DMEM/F10 containing 
10% FCS, 1% PS and 1% non-essential amino acids. HeLa cells stable expressing FLAG-SUMO2 
in a doxycycline-inducible manner were generated by co-transfection of HeLa/FRT/TRex cells 
(Invitrogen) with pcDNA5/FRT/TO-3×FLAG-SUMO2 and pOG44 followed by selection with 200 µg/
ml Hygromycin B (Danielsen et al., 2012; Poulsen et al., 2013).
For global and local UV irradiation cells were treated with a UV-C germicidal lamp (254 nm, Philips) 
at the indicated dose (Marteijn et al., 2009). Local UV irradiation was applied through an isopore 
membrane filter (Millipore), containing 5µm pores.
siRNA transfections were performed using hiperfect (Qiagen) or RNAiMax (Invitrogen)2-3 
days before the described experiments according to manufacturer’s protocol. siRNA 
target sequence used were: CTRL (Thermo Scientific Dharmacon, D10-001210-05), 
RNF111(A) (5’-GGAUAUUAAUGCAGAGGAA-3’), RNF111(B) (Invitrogen, HSS182646), RNF4 
(5’-GAAUGGACGUCUCAUCGUU-3’), UBC9 (5’-GGGAUUGGUUUGGCAAGAA-3’), UBC13 
(5’-GAGCAUGGACUAGGCUAUA-3’), UBE2Q2 (Thermo Scientific Dharmacon, L-008326-01) and 
XPA (5’-CUGAUGAUAAACACAAGCUUAUU-3’).
Construction and expression of ERCC1-GFP and K8R XPC-GFP
ERCC1-GFP was PCR amplified from the plasmid pBL-ERCC1-GFP-hisha using the following 
primers: Fw 5’-CCACATGGACCCTGGGAAGGACAAAG–3’ Rv 5’- CTACTTGTACAGCTCGTCCATGCCGA 
– 3’ ,cloned into pENTR-D-TOPO (invitrogen) and recombined into the pLenti PGK Blast Destination 
vector (Addgene, plasmid 19065) using the Gateway LR Clonase II Enzyme Mix (Invitrogen). 
Third-generation lentivirus was produced in HEK293T cells and used to generate U2OS stably 
expressing ERCC1-GFP by Blasticidin selection. K8R XPC-GFP construct was generated by fusion 
PCR performed by Baseclear (Leiden, The Netherlands) and was sequence verified. 
Unscheduled DNA Synthesis (UDS)
Fluorescent-based UDS was performed as described (Nakazawa et al., 2010). In short, MEFs were 
79
SUMO and ubiquitin-dependent XPC exchange drives nucleotide excision repair
III
seeded on 24mm coverslips three days before the UDS assay and cultured in serum free medium 
to reduce the number of S-phase cells. Cells were UV irradiated with 16J m-2 and incubated for 
3 or 9h in medium containing 5-ethynyl-2’-deoxyuridine (EdU; Invitrogen). Subsequently, cells 
were washed with PBS and fixed with 3.7% formaldehyde. Cells were permeabilized with 0.5% 
triton in PBS and EdU incorporation was visualized using Click-it Alexa Fluor 594 according to 
manufacturer’s instructions (Invitrogen). Images were obtained using a LSM700 microscope 
equipped with a 63x oil Plan-apochromat 1.4 NA oil immersion lens (Carl Zeiss Micro imaging Inc.). 
Repair capacity, quantified in at least 100 cells by determining the overall nuclear fluorescence 
using ImageJ software, was normalized to fluorescence in wild type cells which was set at 100%.
Live cell confocal laser-scanning microscopy
For local UV-C irradiation in living cells, a 2 mW pulsed (7.8 kHz) diode pumped solid state laser 
emitting at 266 nm (Rapp Opto Electronic, Hamburg GmbH) was connected to a Leica SP5 laser-
scanning confocal microscope as described (Dinant et al., 2007; Schwertman et al., 2012). Cells 
were grown on quartz coverslips and imaged and irradiated at the indicated dose using an 
Ultrafluar quartz 100x, 1.35 NA glycerol immersion lens (Carl Zeiss) at 37˚C and 5% CO2. Imaging 
medium was the same as culture medium. Images were acquired using the LAS AF software 
(Leica). Accumulation kinetics were quantified using FIJI image analysis software. Resulting curves 
were normalized to the relative fluorescence before irradiation and corrected for background 
values. To determine the dissociation kinetics of XPC from damaged DNA, the undamaged part of 
the nucleus was continuously bleached and the fluorescence decrease in the local damage was 
measured. 
For FRAP analysis (Houtsmuller and Vermeulen, 2001), a narrow strip spanning the nucleus 
(512-16 pixels at zoom 8 was bleached for 100 ms using 100% of the power of a 488nm laser. 
Recovery of fluorescence in the strip was monitored every 22ms at 2% power of a 488 nm laser 
until fluorescence reached a steady-state level. All Frap data was acquired on a Leica SP5 laser-
scanning confocal microscope equipped with a 63x/1.4NA HCX PL APO CS oil-immersion objective 
and normalized to the average pre-bleach fluorescence after subtraction of the background 
signal At least two independent experiments of >12 cells were performed for each condition. 
To determine the immobile fraction (Fimm) from the FRAP measurements, we renormalized the 
data, using the fluorescence intensity recorded immediately after bleaching (I0) and the average 
fluorescence between 35 and 45s after the start of the FRAP experiment (once recovery is 
complete) from the unchallenged cells (Ifinal, unc) and UV-irradiated cells (Ifinal, uv) and using the formula: 
Fimm = 1 - (Ifinal, uv - I0, uv) / (Ifinal, unc - I0,uv).
Western blot
Cells were collected by scraping in 200ul 2x sample buffer and boiled at 98oC for 3min. Lysates 
were separated by SDS PAGE and transferred to a PVDF membrane (0.45 um). Membranes were 
blocked with 5% milk in PBS for 1h at RT and incubated with primary antibodies against RNF111 
(H00054778-M05, Abnova), UBC9 (sc-5231,Santa Cruz Biotechnology), UBC13 (ab38795, abcam) 
and Tubulin (T5286, Sigma Aldrich). Membranes were washed 5 times for 5 min with PBS containing 
0.05% Tween and incubated with secondary antibodies from LI-COR to visualize antibody 
complexes with the Odyssey CLx Infrared Imaging System (LI-COR Biosciences). Uncropped scan 
of the western blots depicted in figure 4D can be found in Supplementary Fig. 3C. 
Immunofluorescence
Cells were grown on 24 mm coverslips and fixed using 2% paraformaldehyde supplemented with 
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triton X-100. For XPG stainings, cells were fixed with 2% paraformaldehyde. Subsequently cells 
were permeabilized with PBS containing 0.1% triton X-100 and washed with PBS containing 0.15% 
glycine and 0.5% BSA. To visualize CPD or 6-4pp, nuclear DNA was denatured by incubation with 
0.07M NaOH for 5 min at room temperature. Coverslips were washed with PBS containing 0.15% 
glycine and 0.5% BSA and incubated with primary antibodies for 1-2 h at room temperature. Cells 
were washed three times and two times for 10min with 0.1% triton X-100 and once with PBS 
containing 0.15% glycine and 0.5% BSA. To visualize primary antibodies coverslips were incubated 
for 1 hour with secondary antibodies labeled with ALEXA fluorochromes 488 or 555 (Invitrogen). 
Again cells were washed with 0.1% Triton X-100 and PBS+. Subsequently coverslips were 
embedded in Dapi Vectashield mounting medium (Vector Laboratories). Images were obtained 
using a LSM700 microscope equipped with a 63x oil Plan-apochromat1.4. NA oil immersion lens 
(Carl Zeiss Microimaging Inc.). The following primary antibodies were used : anti-CPD(1:1000; TDM-
2;MBL International), anti-DDB2 (1:400; MybioSource), anti-XPC (1:200; fraction 5), anti-TFIIH p89 
(1:1000; S19; Santa Cruz), anti-XPG (1:400; 8H7; Thermo Scientific), anti-XPF (1:100; 3F2, Santa 
Cruz) and anti-ERCC1 (1:200; D10; Santa Cruz).
Quantification of 6-4PP removal by immunofluorescence
MEFs were cultured to 80% confluence on 24 mm coverslips and exposed to global UV-irradiation 
(10J m-2). Cells were fixed after various time points and immunostained with anti-6-4pp (1:1000; 
64M-2; Cosmo Bio), as described above. Images were obtained using a Zeiss LSM 510 META 
confocal microscope equipped with a 63x oil Plan-apochromat 1.4 NA oil immersion lens. 6-4PP 
levels were quantified in at least 70 cells per sample by measuring the overall nuclear fluorescence 
using ImageJ software, which was set at 100% for 0h after UV-irradiation.
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Supplemental figures
Supplementary Figure 1. (A) Representative pictures of the presence of 6-4PP in the indicated MEFs at the 
indicated times after UV-irradiation, measured by immunofluorescence. Scale bars: 25 µm. (B) Representative 
pictures of UDS of the indicated MEFs, determined by EdU incorporation over 9 h after UV-irradiation 
(16 J/m2). Scale bar: 25 µm. (C) Left panel: RNF111 protein levels, as determined by western blotting, in 
U2OS cell were determined 72 h after siRNA transfection with non-targeting (CTRL) or RNF111 siRNA A or B. 
Anti-Tubulin staining was used as loading control. Right panel: quantification of the western blots of the left panel. 
(D) Representative pictures (stills) of live-cell imaging analysis of XPC-GFP after LUD infliction in XP4PA cells 
transfected with CTRL and RNF111 siRNA A or B. Dotted circle indicates the site of damage infliction.
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Supplementary Figure 2. Top panel: Representative pictures of localization of XPC and CPD-photolyase-
mCherry at LUD in U2OS cells transfected with the indicated siRNA’s 30 min or 4 h after local UV-irradiation 
(60 J/m2) are shown. Scale bar: 5µm. Lower panel: Quantification of XPC co-localization with the damage 
marker CPD-photolyase-mCherry. (n≈50 cells containing a LUD were scored per sample in two independent 
experiments; mean ± SD).
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Supplementary Figure 3. (A) U2OS cells transfected with non-targeting (CTRL) siRNA or siRNA targeting UBC9 
or UBC13 were collected 48 h after siRNA transfection. The amount of protein was analyzed by immunoblotting 
using the indicated antibodies. Anti-Tubulin was used as loading control. (B) Table showing the putative 
SUMOylation sites of XPC, as identified by the GPS-SUMO algorithm. (C) Uncropped scan of Figure 4D.
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A
Summary
All life on earth can only exist because of the high stability and integrity of its genome. This integrity 
and stability is continuously challenged by internal and external DNA damaging agents that induce 
DNA lesions. If not properly repaired, these lesions may disrupt important cellular processes 
like replication and transcription. Eventually they can lead to accelerated ageing and malignant 
transformation of cells. Maintenance and protection of the DNA is therefore of crucial importance. 
To ensure this a complex network of dedicated DNA repair- and associated signalling pathways is 
in place. Collectively, these pathways are known as the DNA Damage Response (DDR). 
 Chapter I gives a general background for this thesis, introducing the DDR pathways and 
describes the current knowledge of which lesions they recognize and how they repair them. The 
Nucleotide excision repair (NER) pathway is examined in higher detail. This pathway recognizes and 
removes a wide variety of DNA lesions, including those induced by UV irradiation. Recognition of 
these lesions can occur via one of two different mechanisms: transcription-coupled repair (TC-NER) 
and global genome repair (GG-NER). In the TC-NER pathway, lesions are detected by the stalling of 
a RNA polymerase II (RNAP2) when it is actively transcribing a gene. Lesions in other parts of the 
genome, including the non-transcribed strands of active genes, are detected by GG-NER. The DNA 
binding protein Xeroderma pigmentosum group C (XPC) is the main damage sensor in GG-NER. After 
lesion recognition has taken place the core NER machinery is recruited and the damage is repaired. 
The chapter further introduces principles of regulation and signalling via post translational 
modifications (PTMs), with special interest for the process of (de)ubiquitylation. These PTMs are 
the basis for intricate signalling pathways, using positive and negative feedback loops, which are 
active in numerous biological systems. Furthermore, this chapter introduces confocal microscopy 
techniques, most importantly fluorescence recovery after photobleaching (FRAP), which are used 
in all the chapters of this thesis.
 Chapter II describes the identification of a new SUMO-targeted ubiquitin ligase (STUbL), 
RNF111/Arkadia. Immunoprecipitation (IP) experiments show RNF111 uses three adjacent Sumo 
Interacting Motives (SIMs) for specific recognition of poly-SUMO2/3 chains. To gain insight into 
the functional significance of RNF111 SUMO binding, quantitative mass spectrometry (MS)–based 
analysis of cellular RNF111-interacting proteins was performed. This approach identified the E2 
ligase UBC13-MMS2 as a cognate E2 enzyme to promote non-proteolytic, K63-linked ubiquitylation 
of SUMOylated target proteins. Damage sensor XPC is known to be SUMOylated upon UV 
irradiation and using knock down and IP experiments we show that RNF111 indeed ubiquitylates 
SUMOylated XPC. Using the Unscheduled DNA Synthesis (UDS) assay we show that when this 
SUMO mediated ubiquitylation of XPC is abrogated, the result is an impaired NER reaction. Using 
local UV-C laser irradiation microscopy techniques we show that more XPC accumulates at the site 
of damage. This leads to the hypothesis that the ubiquitylation by RNF111 of XPC is needed for its 
dissociation and normal progression of the NER reaction.
 Chapter III takes this hypothesis and investigates the molecular function of the RNF111-
dependent ubiquitylation of XPC and its role in NER. Using a UDS assay setup to measure over a 
longer period of time we although the NER reaction is impaired, it is not abolished, only severely 
slowed. Immunofluorescence experiments show a longer residence of XPC on lesions with a knock 
down of RNF111. FRAP experiments performed on XPC after UV irradiation with a knock down 
of RNF111 show that the immobile fraction increase 1.6 fold. To check if this is due to a higher 
Kon or a lower Koff iFRAP experiments on local damages were performed. These show a lower 
Koff when RNF111 is knocked down and point the need of RNF111 mediated ubiquitylation of 
XPC for efficient release of XPC from the damage. By performing more FRAP experiments, but 
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then using other factors of the NER pathway, we could determine where the NER reaction stalls. 
The factors XPA and XPB show similar results as XPC and are more and longer associated with 
the damage, where XPG and ERCC1 do not immobilize on the damage any more. As ERCC1/XPF 
binding to DNA damage is dependent on the presence of XPG , these data suggest that when 
XPC remains bound to the initiating NER complex, both XPG and ERCC1/XPF cannot be efficiently 
recruited to or stably incorporated in the NER complex. Similar results were found when either the 
cognate ubiquitin E2-enzyme UBC13 or the SUMO E2-enzyme UBC9 where knocked down. Taken 
together, we conclude that RNF111 mediated ubiquitylation of XPC is a key regulator of NER. The 
sequential SUMOylation and differential ubiquitylation of XPC to control the NER reaction might 
serve as a paradigm for the spatiotemporal regulation of other processes involving different types 
of sequential post-translational protein modifications.
 Chapter IV focusses on the binding behaviour of the damage sensor XPC at different 
doses of UV-C irradiation. Since there is not much known about the functioning of the NER 
pathway at low UV dose we designed FRAP experiments looking at just that. Contrary to an 
expected linear dose response induced by UV-C irradiation, we observed a switching behaviour 
in the binding properties of XPC. We find that below a threshold level of UV irradiation XPC does 
not immobilize and that core NER factors are not recruited, while this does occur above the 
threshold. Furthermore, we show that this bi-stable response is regulated by Cullin4A (Cul4a) 
dependent ubiquitylation of XPC. When Cul4a is knocked down, FRAP experiments show a linear 
dose response of XPC binding after increasing doses of UV-C irradiation. Using quantitative ms-
based techniques we identified lysine residue 174 as being highly ubiquitylated after UV. When we 
subjected the XPC mutant K174R to similar FRAP experiments we again found abolishment of the 
switching behavior. To further investigate the accumulation of core NER factors below and above 
the threshold dose of UV irradiation, we used a U2OS cell line containing a stably integrated Tet-
inducible transcription array. Using this system we could visually discriminate between the two 
damage recognition system in NER. Indeed below the threshold core NER factors accumulated on 
the array where transcription was taking place. Above the threshold this accumulation was lost 
in the background accumulation. Together these findings suggest a prioritizing mechanism which 
allows cells under mild genotoxic stress to prioritize repair of lesions detected by RNA polymerase 
II in transcribed strands of active genes, which may constitute a more acute threat to cellular 
homeostasis than damage in non-transcribed DNA.
 Chapter V utilizes the bi-stable switch described in Chapter IV as model for bi-stability. 
Using in house Monte Carlo simulation software we dissect the switch of XPC using in silico 
experiments. The simulations gave us the chance to test the possible models we hypothesised 
in a fast and flexible manner. By starting with a model which reacts in a linear dose dependant 
manner and enhancing that model with an in detail studied self-enhancing feedback loop system, 
we managed to create a bi-stably responding system. The readout of this system also recreated 
the in vivo obtained data very closely. We also saw a difference in systems with and without a 
damage marking ability. If this system was present the system would switch later compared to 
a non-damage marking system. After showing that repair of transcribed genes is hampered by 
competition for downstream factors we hypothesized that the observed bimodal switch ensures 
priority for repair of transcribed genes. Only when the damage load is so high that the structural 
integrity of the DNA is threatened is it acceptable for coding genes to wait on repair. Build-up of 
damages outside of active genes would continue in such a system, until the threshold value is 
reached and the system switches.
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Samenvatting
Al het leven op aarde kan alleen maar bestaan vanwege de hoge stabiliteit en integriteit van het 
genoom. Deze integriteit en stabiliteit worden continue verstoord door interne en externe DNA 
beschadigende invloeden, welke DNA schades kunnen veroorzaken. Wanneer deze schades niet 
worden gerepareerd, kunnen belangrijke cellulaire processen, zoals replicatie of transcriptie, 
worden verstoord. Dit kan uiteindelijk leiden tot versnelde veroudering of de kwaadaardige trans-
formatie van cellen. Onderhoud en bescherming van het DNA is daarom van cruciaal belang. Dit 
wordt bewerkstelligd door een complex netwerk van gespecialiseerde DNA herstel- en daaraan 
gelieerde signaaltransductiewegen. Samen staan deze mechanismen bekend als de DNA schade 
respons (DDR).
 Hoofdstuk I schetst de algemene achtergrond voor dit proefschrift. Verder worden de 
verschillende DDR routes geïntroduceerd, welke schades ze herkennen en hoe deze worden gere-
pareerd. De Nucleotide Excisie Herstel (NER) route wordt in meer detail besproken. Deze herstel-
route herkent en repareert een grote variëteit aan DNA schades, waaronder schades veroorzaakt 
door UV straling. Herkenning van deze schades geschied over het algemeen via een van de twee 
beschikbare mechanismen: transcriptie gekoppeld herstel (TC-NER) en globaal genoom herstel 
(GG-NER). Bij TC-NER worden schades herkend door het eiwit RNA polymerase II (RNAP2) tijdens 
het transcriberen van actieve genen. Schades in andere stukken van het genoom, inclusief de niet 
getranscribeerde streng van de actieve genen, worden gedetecteerd via GG-NER. Het DNA bind-
end eiwit Xeroderma pigmentosum group C (XPC) is de belangrijkste schade sensor in GG-NER. 
Wanneer de schadeherkenning heeft plaatst gevonden wordt de rest van de NER herstel eiwitten 
gerekruteerd en de schade hersteld. Verder worden in dit hoofdstuk de principes van regulat-
ie en signaaltransductie via post-translationele modificaties (PTMs) geïntroduceerd, met speciale 
aandacht voor het proces van (de)ubiquitinatie. Deze PTMs vormen de basis voor complexe sig-
naaltransductiewegen, die gebruik maken van positieve en negatieve terugkoppelingen, welke 
veel voorkomen in biologische systemen. Ook worden in dit hoofdstuk verschillende confocale 
microscopie technieken geïntroduceerd. De meest belangrijke van deze genoemde technieken 
is fluorescence recovery after photobleaching (FRAP), die in alle hoofdstukken van dit proefschrift 
gebruikt wordt.
 Hoofdstuk II beschrijft de identificatie van een nieuwe SUMO-targeted ubiquitin ligase 
(STUbL) eiwit, RNF111/Arkadia. Immunoprecipitatie (IP) experimenten laten zien dat RNF111 drie 
naast elkaar gelegen SUMO Interactie Motieven (SIMs) gebruikt voor specifieke herkenning van 
poly-SUMO2/3 ketens. Om meer inzicht te krijgen in de functionele significatie van de binding 
van RNF111 aan SUMO zijn er op kwantitatieve massa spectrometrie (MS) gebaseerde analyses 
van cellulair RNF111 interacterende eiwitten uitgevoerd. Uit deze analyses blijkt dat de E2 ligase 
UBC13-MMS2 het verwante E2 enzym is. Dit enzym bevordert de non-proteolytische, K63 gelinkte 
ubiquitinering van geSUMOyleerde eiwitten. Het is bekend dat de schade sensor XPC wordt geSY-
MOyleerd na bloot gesteld te zijn aan UV licht. Verdere experimenten laten inderdaad zien dat 
RNF111 geSUMOyleerd XPC ubiquitineerd. Het Unscheduled DNA Synthesis (UDS) assay laat zien 
dat wanneer deze SUMO gemedieerde ubiquitinering verstoord wordt de NER reactie niet meer 
efficiënt verloopt. Door gebruik te maken van lokale bestraling met behulp van UV-C laser bes-
tralingstechnieken is de ophoping van XPC op de gecreëerde schade gevolgd. Wanneer er geen 
RNF111 aanwezig is in deze cellen is er meer ophoping van XPC te zien. Dit leidt tot de hypothese 
dat de ubiquitinering van XPC door RNF111 nodig is voor de dissociatie van de schadesensor en 
voor normale progressie van de NER reactie.
 Hoofdstuk III gaat verder met deze hypothese en bekijkt het verdere moleculaire func-
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tioneren van RNF111-afhankelijke ubiquitinering van XPC en de rol die deze heeft in NER. Door 
gebruik te maken van een UDS assay, die meet over een langere periode, laten we zien dat hoewel 
de NER reactie wel vertraagd word, maar niet compleet verstoord. Immunofluorescentie experi-
menten tonen aan dat wanneer de hoeveelheid RNF111 verminderd is, XPC langer aanwezig is op 
schades. Ook uit FRAP experimenten op dergelijk behandelde cellen blijkt dat de immobiele fractie 
van XPC in de cel 1,6 keer hoger is dan onder controle omstandigheden. Om te kijken of deze lan-
gere retentie van XPC veroorzaakt wordt door een hogere Kon of een lagere Koff dan onder normale 
omstandigheden zijn iFRAP experimenten op lokale schades uitgevoerd. In cellen waar de hoev-
eelheid RNF111 in is verminderd blijkt XPC een lagere Koff te hebben. Deze data lijken inderdaad 
te bevestigen dat RNF111-afhankelijke ubiquitinering van XPC nodig is voor het efficiënt loslaten 
van de gedetecteerde schade. Door FRAP experimenten uit te voeren op andere factoren welke 
een rol spelen in NER konden we nagaan waar de reactie vast loopt als er geen RNF111 aanwezig 
is. FRAP experimenten met factoren als XPA en XPB lieten vergelijkbare resultaten zien als XPC; 
meer van het eiwit zat langer vast op schades. Factoren die pas later tijdens de NER reactie een 
rol spelen, zoals XPG en ERCC1, immobiliseerden niet meer op de schades. Gezien de binding van 
ERCC1/XPF aan een schade afhankelijk is van de aanwezigheid van XPG op de schade, suggereren 
deze metingen dat wanneer XPC gebonden blijft op het NER initiërend complex, zowel XPG als 
ERCC1/XPF niet meer efficiënt gerekruteerd en stabiel geïncorporeerd kunnen worden. Ook wan-
neer de hoeveelheden van het E2 enzym UBC13 of het SUMO E2 enzym UBC9 verminderd zijn, 
laten de FRAP experimenten eenzelfde resultaten zien. Uit al deze data samen is te concluderen 
dat de RNF111 gemedieerde ubiquitinering van XPC een sleutelrol speelt in NER. Deze wijze van 
controle over het NER proces, de sequentiële SUMOylatie en differentiële ubiquitinering van XPC, 
kan een nieuw paradigma zijn voor de spatio-temporele regulatie van andere processen waarbij 
verschillende soorten sequentiële post-translationele eiwit modificaties plaatsvinden.
 Hoofdstuk IV focust zich op het bindingsgedrag van de schade sensor XPC bij verschil-
lende hoeveelheden UVC straling. Gezien er nog niet veel bekend is over het functioneren van 
NER bij lage UV dosissen zijn er FRAP experimenten gedaan die juist daar naar kijken. Anders dan 
de verwachte lineaire dosis response na UV-C bestraling, namen we een omschakelend gedrag 
waar in de bindingseigenschappen van XPC. Bij een UV-C dosis lager dan de drempelwaarde zien 
we geen immobilisatie van XPC en geen rekrutering van de kern NER factoren, terwijl dit wel geb-
eurt boven de drempelwaarde. Verder laten we zien dat deze bi-stabiele response gereguleerd 
wordt door de ubiquitinering van XPC door Cullin4A (Cul4a). In cellen waar de hoeveelheid Cul4a 
is vermindert laten FRAP experimenten een lineaire dosis response van XPC binding zien na be-
straling met een steeds oplopende dosis UV-C straling. Door gebruik te maken van kwantitatieve 
massaspectrometrie technieken is lysine 174 van het XPC eiwit geïdentificeerd als residu welke na 
UV-C bestraling het meest wordt gebuiquitineerd. Een gemuteerde versie van het XPC eiwit, waar-
bij de lysine op plek 174 is vervangen door een arginine, blijkt bij eenzelfde FRAP experiment geen 
omschakelend gedrag meer te vertonen. Om de ophoping van kern NER factoren boven en onder 
de drempelwaarde verder te onderzoeken is er gebruik gemaakt van een U2OS cellijn welke een 
stabiel geïntegreerde Tet-induceerbare transcriptie array in zich draagt. Door gebruik te maken 
van dit systeem kan er visueel onderscheid gemaakt worden tussen de twee schadeherkennings-
mechanismen van NER. Bij blootstelling aan UV onder de drempelwaarde accumuleerde de kern 
NER factoren op de transcriptie array. Wanneer het experiment wordt herhaald met een dosis 
boven de drempelwaarde is deze accumulatie niet meer te zien door dat het weg valt in het ach-
tergrond signaal. Deze bevindingen suggereren een mechanisme wat bij cellen die blootgesteld 
zijn aan milde genotoxische stress de prioriteit legt bij schades die herkend zijn door RNA poly-
merase II in de getranscribeerde streng van actieve genen. Deze schades zijn waarschijnlijk een 
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meer acuut gevaar voor de homeostase in de cel dan schades in niet actief getranscribeerd DNA.
 Hoofdstuk V gebruikt de bi-stabiele schakeling die beschreven is in hoofdstuk IV om 
een minimaal model voor bi-stabiliteit te ontwerpen. We ontleden deze omschakeling in het bind-
ingsgedrag van XPC door gebruik te maken van eigen Monte Carlo simulatie software en het uitvo-
eren van in silico experimenten. Deze simulaties stelden ons in staat om snel en flexibel de door 
ons gehypothetiseerde modellen te testen. We zijn begonnen bij een model wat reageert op een 
lineaire dosis afhankelijke manier. Deze is vervolgens uitgebreid met een systeem van zelfverst-
erkende terugkoppelingen en hiermee is een bi-stabiel reagerend systeem gecreëerd. Niet alleen 
de overall reactie van het systeem, ook de gegenereerde FRAP curves zijn vergelijkbaar met de in 
vivo data. Tijdens het bestuderen van de verschillende modellen werd er ook een verschil gezien in 
modellen waar de schades wel of niet gemarkeerd worden na herkenning. Wanneer een systeem 
functioneert door middel van schademarkering blijkt het omslagpunt van het evenwicht bij een 
hogere schade dosis te liggen dan wanneer schades niet gemarkeerd worden. Verder laten we 
zien dat het herstel van schades in getranscribeerde genen wordt gehinderd door competitie voor 
late kern NER factoren. Dit versterkt ons vertrouwen in de hypothese dat de gevonden bimodale 
schakeling van XPC zorg draagt voor het prioriteren van reparatie van getranscribeerde genen. 
Pas wanneer het aantal schades zo groot wordt dat de structurele integriteit van het DNA bed-
reigt word is het acceptabel om coderende genen te laten wachten op reparatie. In een dergelijk 
systeem zal het aantal schades buiten de actieve genen op blijven lopen, tot uiteindelijk een drem-
pelwaarde bereikt wordt en het systeem omschakelt. 
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Dankwoord
En dan zijn we eindelijk daar aangeland waar je zo lang naar uitkijkt. Alle hoofdstukken zijn 
geschreven, de lay-out is gedaan en zelfs dat ene hele moeilijk stukje is gedaan (NL samenvatting). 
Tijd om ‘even’ terug te kijken en alle mensen te bedanken die op de een of andere manier mee 
hebben geholpen aan het tot stand komen van dit proefschrift. En dat blijken er in mijn geval heel 
veel te zijn, wat maar weer aangeeft dat een promotietraject alleen doen gewoonweg niet kan.
Adriaan, heel erg bedankt voor de kans om in je groep te werken. Niet alleen op het gebied van 
microscopie heb ik heel veel van je geleerd, ook hoe kansen de wereld beïnvloeden en bij elkaar 
houden staat me nu scherp voor ogen. Verder bedankt voor de vele nevengesprekken tijdens 
de werkbesprekingen over alles wat de wereld bezig houd. Alhoewel we soms van denkbeelden 
verschillen is er erg veel overlap en konden we daar uren over praten. Dank voor je openheid, 
het opendeur beleid wat je voert, het serieus nemen van ons als OIO’s en het aanmoedigen van 
regelmatige ‘werkbesprekingen’ op het terras. Dit alles is zo belangrijk voor de groep als geheel en 
ik hoop dat het zich in de toekomst voortzet. Het is een eer dat ik de eerste promovendus ben die 
jou als promotor heeft. Ik hoop dat er nog vele na mij zullen volgen.
Wim, bedankt dat ik ook in jouw groep mocht werken. De zeer intensieve samenwerking was heel 
belangrijk voor mijn promotie en dit alles was niet mogelijk geweest als je niet zo’n enorm goede 
groep bij elkaar had gezocht. Je dossierkennis en je inzicht in het biologische aspect van mijn 
proeven waren onmisbaar. Ik voelde me zeer welkom in de groep, mede door het deelnemen 
aan de labuitjes, de BBQ’s in je achtertuin en natuurlijk de aanwezige taart in de groep. Ook voor 
de open deur en de open mindset met betrekking tot mijn proeven en resultaten voor/tijdens/na 
onze gezamenlijke werkbesprekingen ben ik je erg dankbaar. 
Hartelijk dank aan de leescommissie en de overige leden van de commissie voor het kritisch lezen 
van mijn proefschrift. Pernette, dank voor de (helaas korte) samenwerking en de enorme bijdrage 
net aan het einde van mijn traject. Leon, dank voor de kritische feedback tijdens onze ZONMW 
meetings, maar ook voor de gezellige gesprekken daar omheen. Jan, dank voor je kritische bijdragen 
tijdens de werkbesprekingen en ik blijf onder de indruk van hoe je zo snel nieuwe inzichten kunt 
doorgronden en ook daar direct mee aan de slag kunt. Sjaak en Joost, dank voor de feedback en 
goede gespreken tijdens de winterschool. Erik, dank voor de input en het meedenken tijdens de 
gezamenlijke werkbesprekingen en de single molecule meetings.
Hoofdstuk 2 en 3 hadden er niet geweest zonder Jurgen. De samenwerking tijdens het RNF111 
project was geweldig. Alle technieken liepen en door je gestroomlijnde benadering hebben we in 
korte tijd een heel leuk verhaal neer weten te zetten. Dank dat je deze nederige koelkastenverkoper 
(IK VERKOCHT BRUINGOED!!!) in pak de kans hebt gegeven zijn vreemde microscopietechnieken 
los te laten op de vraagstukken. Ook voor je bijdrage aan het XPC verhaal, de werkbesprekingen 
en de steun via foute grappen en serieuze gespreken ben ik je heel dankbaar. Ik kom graag nog 
eens taart eten.
Hetzelfde geld voor Loes. Waar het in het begin leek dat onze onderzoeken verschillende kanten 
op gingen, kwamen we tegen het einde van onze promoties weer bij elkaar. Samen hebben we 
een verhaal neergezet waar we beiden trots op kunnen zijn. Ik was erg blij met onze gesprekken, 
of het nu ging over werk of privé, in de kweek of achter de microscoop.
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Aparte vermelding verdienen ook mijn paranimfen. Maarten, ook jij werkt aan DNA schade, 
jammer genoeg alleen aan de verkeerde soort ;). Nee het was erg prettig om iemand in de 
Houtsmuller groep te hebben die net van de andere kant keek zodat we veel kennis konden 
delen en discussiëren over artikelen en proeven. Ook je bijdrages aan de laatste Rad23B FRAPs 
stel ik erg op prijs. Tijdens het schrijven was het erg prettig om een directe lijn naar de groep 
te hebben zodat ik ook op de hoogte bleef. Ik hoop snel jouw promotie bij te mogen wonen! 
Imke, ik was heel blij dat ondanks dat Loes je net had weg gekaapt je toch ook bereid was om mijn 
paranimf te zijn. Naast onze gedeelde smart over de nukken van de SP5 microscopen was het 
gelukkig ook altijd erg gezellig. Het lachen om alle foute ideeën voor de promoties van anderen zal 
ik ook nooit vergeten. Op naar de foute grappen voor die van jou!
De Houtsmullergroep fungeerde als uitvalsbasis de afgelopen jaren en was een bron van 
gezelligheid en steun. Bart, dank voor het altijd tijd willen maken voor mijn vragen over de simulaties 
en de gesprekken tijdens borrels en koffiepauzes (eigenlijk ook altijd wel even tussendoor). Tsion, 
ongeveer tegelijk begonnen in de groep en er samen ‘groot geworden’. Dank voor alle hulp in het 
lab ,achter de microscoop en de daarbij behorende gezelligheid . Martijn, van student naar OIC 
medewerker, en wat hebben wij heerlijk kunnen discussiëren. Of het nu over maatschappelijke 
problemen was of een software probleem; praten, argumenteren en uiteindelijk naar een 
gezamenlijke visie komen. Dank voor de steun en voor het nodige tegengas! In de groep kon ik 
mijn enthousiasme over bepaalde soorten boeken gelukkig kwijt bij Karin, dank daarvoor. Altijd 
prettig om tussen het kweken door even over het laatst gelezen hoofdstuk te praten. Thomas, het 
positivisme wat je uitstraalt werkt enorm aanstekelijk, je vrolijkte mijn lange kweeksessies altijd erg 
op als je even binnen viel (letterlijk, ik schrok me vaak in eerste instantie wild :P). Jeroen, de beste 
student die ik bij het Erasmus heb mogen begeleiden! ;) Dank voor alle koffie en natuurlijk ook het 
gedane werk. Wanneer is die taart er nu precies? Ilona, ik voeg jou hier ook maar aan toe, je bent 
in mijn ogen ook onderdeel van de groep. Heel erg bedankt voor je bijdrages aan dit proefschrift, 
voornamelijk hoofdstuk 4. Mochten we ooit eens samen in Zoetermeer zijn moeten we zeker de ‘Big 
Five’ eens aflopen ;P. En natuurlijk heel veel dank aan Martin. Bijna dagelijks in de metro naar huis 
nog even praten over die of die resultaten, een paper of gewoon over dagelijkse dingen. Zonder 
jou steun en koppen koffie was ik er een stuk meer gehavend doorheen gekomen. Hedy, wellicht 
nooit officieel werkzaam in de Houtsmuller groep, je war er toch zeker er wel een onderdeel van. 
Dank je voor je al je steun, wetenschappelijke en net ‘iets’ minder wetenschappelijke gesprekken, 
en het zijn van zo’n ongelofelijk goede vriendin!
Alle microscopie in dit proefschrift was niet mogelijk zonder de enorm goede faciliteit die we in het 
Erasmus MC hebben. Dank daarom aan de mensen van het OIC voor het draaiende houden van 
alle microscopen. Gert en Gert-Jan, dank voor het geduld als ik weer kwam met vage klachten over 
net weer een andere SP5. Alex dank voor alle hulp met de LSM700 en de koffiepauzegesprekken 
over muziek, films en natuurlijk Game of Thrones. Johan, dank voor stimulerende discussies over 
alle data en voor het aanzetten tot het kijken van Twin Peaks!
Thanks to all the people of the Vermeulen group who tolerated my work discussions about all those 
FRAP experiments and strange simulations, and even provided me with much useful feedback on 
the topics. Maikel, thanks for the introduction to Rotterdam, I really love this city now… ow and 
for all the comic relief of course. It was a blast! Kasper, thanks for all the Mac knowhow, the GoT 
discussions and my daily dose of Dumpert. Thank you Özge, for the Turkish sweets and food, for 
the great stories about being a sales representative and for your trust in me. A lot of thanks goes 
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to Petra. Thanks for defending me just when I came out of my first job interview by saying ‘he is 
quite nice’, despite of my suit. But of course also for all the scientific input, the long talks behind 
the microscope, the boardgame nights and being a fertile ground for my ‘getting people addicted 
to certain book series’ plots <insert evil laugh here>. Franzi, thanks for the extra German lessons 
and the chances to teach you some funny and strange Dutch expressions. Mariangela, thanks for 
the help with the ERCC1 lines and I’m still very impressed with your great advances in speaking 
Dutch. Yasemin, thanks for the help with the last pieces of the RNF111 paper. I’m glad there is a 
strong Turkish presence back in the lab. Thanks Serena, for the short time I had someone else 
also working on XPC a bit, making talking about it with someone a bit easier ;) Christina, I hope you 
will mail if you have any other FRAP questions! Thanks for having someone to practice a secret 
handshake with, there should always be someone in a lab with whom you have that! Roel, short 
overlap, but thanks for the work on the RNF111 paper and the extra bad jokes during cake eating 
sessions. Karen, thanks for always having some time to stand around and talk, even if it meant 
turning of your gels for a bit or staying way longer than you were planning. Your support in the 
end was invaluable! Jana, I hope the Dutch weather didn’t (yet) ruin the positivity with which you 
started in The Netherlands. Good luck with your postdoc! Thank you Maria, for all the help with 
ATM and ATR inhibitors and allowing me to help with all your FRAP questions, in the end it really 
paid off. Even though you are now part of the PostDoc crew Arjan, I still want to thank you for all 
the bad jokes, movie and book talk, and serious conversations. Your opinion was always clear, 
but that was always the best way to start a discussion. Hannes, thanks for all the input on various 
topics of my thesis. Next to all the friendly banter about Futurama, science, and science fiction I 
highly appreciated our more personal conversations. Please keep doing that with all who might 
need it in the and outside the lab.
 
Of course my interactions with people in the Erasmus MC weren’t confined to these two groups. 
Far more people made my residing there the great experience it was. The collaborations, work 
discussions, the cake, and pub-quizzes with the people from the sixth floor were great. Thanks 
Anja, Nicole, Kishan, Inger, Paula, Klaas, Marcel, and Claire.
 
A lot of great people I met during the Kleinwalsertal Winterschools. Thank all of you for all the great 
time there, the scientific discussions and the great games of Werewolves. Especially I would like to 
thank Fabrizia. Although I will never completely trust you again since that one game ;), sharing our 
experiences during the last stages of the promotion helped me a lot!
Also in the JNI a lot of people were very supportive and a great help. Without going into details I 
would like to thank all of you for the input, help, and support during my period there. 
Maar de hulp en steun kwam niet alleen van binnen uit het Erasmus MC en de werkomgeving, 
ook vrienden en familie hebben daar enorm in bijgedragen. Jirka, ook al zat je de laatste jaren 
wat verder weg, je interesse, steun, enthousiasme, en vertrouwen waren en zijn nog steeds van 
onschatbare waarde. Dank voor het blijven luisteren, kritische vragen stellen en alle uitstapjes 
die de zon weer liet schijnen, ook al was het maar een beetje. Erik, de reis naar China met jou 
tijdens mijn PhD traject zal ik nooit vergeten. Het was een geweldige manier om afstand te nemen 
van alles. Ook zonder onze regelmatige (bordspel)avonden of LAN weekenden met de daarbij 
behorende diepe gesprekken was ik al lang afgehaakt. Bart, de avonden ToS/L4D/RL co-op waren 
soms hard nodig om wat te ontspannen en te ontladen. Dank voor het blijven luisteren, accepteren 
en aan het einde van een gesprek er toch weer om kunnen lachen (Black Humor FTW!).
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De vriendengroep uit Zoetermeer: Saskia, Almar, Wouter, Sanne, Lennart, Ineke, Mark, Irene, 
Astrid, Christian. Dank voor de steun en het blijvende begrip voor mijn drukke OIO bestaan. Ik heb 
veel te vaak ‘sorry ik kan niet want…’ moeten zeggen door experimenten en schrijfwerk. Almar en 
Sanne, succes met jullie PhD’s!
De rest van mijn vrienden ook bedankt. Bas, Chris, Kevin…. Ook tegen jullie sorry dat ik het zo druk 
had de laatste jaren. Jullie waren allemaal geïnteresseerd en bleven mij steunen ondanks mijn 
(virtuele) afwezigheid. Ik hoop snel jullie zowel virtueel als IRL weer meer te zien!
Einen großen Dank auch an die Familie Hessenkemper (inklusive der „kalten Seite“ ;)) für die 
Unterstützung während der letzten Phase meiner Doktorarbeit und den Momenten der Erholung 
zur richtigen Zeit. Es war sehr schön so herzlich aufgenommen zu werden und mit so viel Interesse 
für meine Forschung.
Vanaf het begin heeft mijn familie me door dik en dun gesteund. Valentijn, Madelief, Rozemarijn, 
Inger, Annick, Tom, Inez en Chris: Dank jullie voor de steun en het geïnteresseerd blijven in al 
die (ingewikkelde) dingen waar ik het altijd over had. Nicolaas-Jurgen, grote broer, zonder jouw 
grote voorbeeld en het mij altijd maar enthousiasmeren voor de wetenschap, was ik nooit zover 
gekomen. Dank voor al die feitjes, het maar blijven uitleggen hoe dingen werken en de interesse 
in mijn onderzoek. Lonneke, grote zus, zonder jou jarenlange coaching op het sociale vlak was dit 
boekje er nooit geweest. Dank voor de open deur, het altijd willen praten en het blijven doorvragen. 
Mam en Pap, dank jullie voor het altijd maar stimuleren van mijn nieuwsgierigheid (ook al moesten 
jullie daar voor stad en land aflopen), voor de onvoorwaardelijke zorgen en steun, voor het begrip 
voor alle stress en voor zo veel meer.
Liebe Wiebke, du bist die wichtigste “Entdeckung”, die ich während meiner Zeit am Erasmus MC 
gemacht habe. Vielen Dank für deine Liebe, dein Verständnis und deine Unterstützung. Jetzt, wo 
diese anstrengende Zeit für uns beide vorbei ist, freue ich mich darauf, mit dir gemeinsam unser 
“Adventure Book” zu füllen. Ich liebe dich!

